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Synopsis 
Epithelial sodium channels (ENaC) are of immense importance, controlling Na+ 
transport across epithelia and thus playing a critical role in all aspects of fluid clearance 
as well as numerous other functions. Although extensive studies have been carried out 
to invistegate the regulation mechanism of ENaC, many questions still remain unclear. 
Therefore, we employed various techniques including electrophysiology and molecular 
biology approaches to investigate the mechanisms underlying the regulation of ENaCs 
by lipid metabolites, oxygen and mechanical stress. 
We have identified profound regulation mechanisms of ENaC in distal renal epithelial 
cells and vascular endothelial cells by lipid metabolites, heme and mechanical forces. 
Our results revealed a novel O2 sensitive regulation pathway of ENaC channels, in which 
hemeoxygenase acts as the O2 sensor and the substrate and product of which either 
inhibits or stimulates ENaC activity. This finding may eventually lead to novel clinic 
strategies in dealing with diseases e.g. renal failure, kidney reperfusion injury, 
hypertension, pulmonary edema and pre-clampsia. In addition, we, at the first time, 
have revealed that ENaC is functionally expressed in a variety of endothelial cells and is 
able to serve as mechano-transducing sensors in the vascular endothelial cells which 
play important roles in vascular physiology and pathology progresses.  
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Chapter 1 
General Introduction 
  
 2 
1.1 Epithelial sodium channel 
The epithelial Na+ channel (ENaC) is localized at the apical or outward-facing 
membranes of many salt-reabsorbing epitheliums which facilitate Na+ movement across 
this membrane as a first step in the process of transepithelial Na+ transport. The 
channels can be defined functionally as components of the membrane that transports 
Na+ into the cell by electro-diffusion without coupling movements of other solutes and 
without the direct input of metabolic energy (Garty and Palmer 1997).  
ENaCs are located in the apical membrane of polarized epithelial cells where they 
mediate Na+ transport across tight epithelium. In contrast to other Na+ selective 
channels involved in the generation of electrical signals in excitable cells, the basic 
function of ENaC in polarized epithelial cells is to allow vectorial trans-cellular transport 
of Na+. This transepithelial Na+ transport through a cell basically involves two steps; the 
passive entry of Na+ into the cell on the apical membrane driven by the large 
electrochemical gradient for Na+ existing across the membrane; and the active Na+ 
transport across the basolateral membrane is accomplished by the Na+-K+- ATPase (Rick, 
Dorge et al. 1981; Huf and Mikulecky 1983; DeLong and Civan 1984; Palmer and Frindt 
1986; Palmer and Frindt 1986). ENaCs are a diverse group of ion channels displaying 
complex gating kinetics, intricate regulatory patterns and biophysical and 
pharmacological properties that are dependent upon their biochemical state and 
physical surroundings.  
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1.2 ENaC/DEG channel super family 
1.2.1 Members of super family 
The ENaC/degenerin gene family represents a new class of ion channels which include 
seven different gene branches. The most relevant ENaC/DEG sequences available to 
date can presently be distinguished as (Driscoll and Chalfie 1991; Canessa, Schild et al. 
1994; Adams, Anderson et al. 1998; Darboux, Lingueglia et al. 1998; Alvarez de la Rosa, 
Canessa et al. 2000; Hong, Mano et al. 2000; Venter, Adams et al. 2001):  a), the ENaC 
α-, β-, γ-, and δ-subunits;  b), the degenerins from Caenorhabditis elegans; c), 
acid-sensing ion channels (ASICs); d), the Drosophila proteins RPK/dGNaC1 and 
PPK/dmdNaC1;  e), the peptide-gated Na+ channel FaNaC of mollusks; and  f), FLR-1 
in C. elegans that is clearly distinct from the degenerins.  g), the mammalian BLINaC 
(brain- liver- intestine amiloride-sensitive Na+ channel) and hINaC (human intestine Na+ 
channel) genes encode Na+ channels that are clearly distinct from ENaC.  
The amino acid sequence identity between the different ENaC/DEG subfamilies is 
≈15–20%, whereas the identity within subfamilies is ≈30% for the different ENaC 
subunits; ≈30% for degenerins; 45–60% between the four ASIC genes ASIC1, ASIC2, 
ASIC3, and ASIC4; 38% for the two characterized Drosophila members; and ≈65% for the 
three FaNaC members. Acids-sensing ion channels (ASICs) and (BLINaC)/(hINaC) are the 
three ENaC/DEG channel groups found in vertebrates; the four ENaC/DEG channel 
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groups of invertebrates are: the degenerins from Caenorhabditis elegans; the 
Drosophila channels RPK/dGNaC1 and PPK/ dmdNaC1; FMRFamide-gated sodium 
channel (FaNaC), which is expressed in mollusks; FLR-1, which is the only characterized 
member of a group of C. elegans ENaC/DEG family members that are different from the 
degenerins. Degenerins and ENaC were the first two genes identified in this super 
family and were found to have substantial sequence homology. The name degenerin 
(DEG) comes from the cellular phenotype induced by mutations of the deg-1 gene and 
other related genes that result in selective degeneration of sensory neurons involved in 
touch sensitivity. ENaC has long been characterized by its Na+ selectivity and amiloride 
sensitive and known to play a crucial role in Na+ absorption in the distal part of the 
kidney tubule and to be the target of aldosterone action. Additional members of this 
ion channel family were subsequently identified by sequence homology and 
characterized by functional expression. The acid-sensing ion channels (ASICs) were 
originally called mammalian degenerins (MDEG) or brain Na+ channels (BNaC, BNC) 
because they were found to be expressed mainly in the central and peripheral nervous 
system. After the discovery of their activation by extracellular protons these channels 
were named acid-sensing ion channels (ASICs). At about the same time the 
FMRF-amide-gated ion channel (Fa- NaC) was cloned from the mollusk Helix aspersa. 
This channel forms its own subfamily within the ENaC/DEG family of ion channels.  
The known members of the ENaC/DEG gene family are wildly distributed in different 
tissues including transporting epithelia as well as neuronal excitable tissues. They 
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exhibit a high degree of functional heterogeneity including Na+ reabsorption, taste 
reception, touch sensation, and mechano-transduction. Depending on their function in 
the cell, these channels are either constitutively active like ENaC or activated by 
mechanical stimuli as postulated for C. elegans degenerins, or by ligands such as 
peptides or protons in the case of FaNaC and ASICs. 
1.2.2 Degenerins 
Degenerin genes MEC-4, MEC-10, UNC-8 UNC-105 and DEG-1 are the core elements of 
the mechanosensory complex of Caenorhabditis elegans. Elegant genetic analysis has 
identified these genes (Chelur, Ernstrom et al. 2002; Goodman, Ernstrom et al. 2002; 
Goodman and Schwarz 2003; Bianchi, Gerstbrein et al. 2004; O'Hagan, Chalfie et al. 
2005). The mutation of these genes specifically disrupts gentle body touch sensation 
and swelling and subsequent death of the cells.  These genes are called degenerins 
because their mutations cause cell degenerative phenotype (Driscoll and Chalfie 1991; 
Waldmann, Champigny et al. 1996; Mano and Driscoll 1999; Goodman, Ernstrom et al. 
2002; O'Hagan, Chalfie et al. 2005; Cueva, Mulholland et al. 2007; Zhang, Bianchi et al. 
2008).  
Degenerin subunits MEC-4 and MEC-10 form the core of MEC channel complex, which is 
believed to be the machano-transducer ion channel in C. elegans touch receptor 
neurons (Driscoll and Chalfie 1991; Hong, Mano et al. 2000).  The MEC channel has 
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long been supported by genetic and molecular data to respond to mechanical stimuli 
and was demonstrated to be gated by mechanical forces recently. A transient rise in 
intracellular Ca2+ concentration induced by MEC under mechano-stimuli has been 
observed. Furthermore, mutation on a certain point of the mec-4 causes channel 
hyperactivity, which is believe to permit excessive Na+ influx and possible Ca2+ entry into 
the cell which finally cause cell death (Mano and Driscoll 1999; Bianchi, Gerstbrein et al. 
2004). 
UNC-8 is expressed in interneurons, motoneurons, and some sensory neurons in 
Caenorhabditis elegans and is believed to form channel complex along with other 
proteins including DEL-1 (degenerinlike) in parts of the neurons. Similar to that of the 
MEC-4, mutation on UNC-8 causes hyperactive channels and results in swelling and 
death of motoneurons (Mano and Driscoll 1999). The hyperactivation-causing mutation 
is in the extracellular domain of UNC-8 (G387E) just after the first cysteine-rich domain. 
UNC-8 loss-of-function mutation experiments suggested that UNC-8 may function as a 
stretch receptor to mediate proprioception in motoneurons (Tavernarakis, Shreffler et al. 
1997) (Rajaram, Spangler et al. 1999; Tavernarakis, Everett et al. 2001; Sedensky, Siefker 
et al. 2004; Bianchi 2007). 
UNC-105 is expressed in the muscle cells of the body wall, and semidominant unc-105 
alleles induce hypercontraction of body wall muscles. One of these mutations causes 
hyperactivity of the channel as assayed in Xenopus oocytes. Hyperactivity of the mutant 
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channel is thought to cause excess ion influx with consequent hypercontraction. These 
data suggest that UNC-105 may be a stretch-sensitive channel gated by changes in 
molecular interactions occurred during locomotion. 
1.2.3 Super family Structures 
The size of the ENaC/DEG proteins ranges from ≈530 to ≈740 amino acids. The pore of 
ENaC has been the best characterized among the members of the ENaC/DEG channel 
family, and it is likely that the basic structural features of the channel pore are 
conserved within this family(Renard, Lingueglia et al. 1994). Regions of conserved 
amino acid sequences in ENaC/DEG family members are likely to represent structural 
elements important for channel function (Kellenberger, Gautschi et al. 1999) (Canessa, 
Schild et al. 1994; Rossier, Canessa et al. 1994).  
The conserved domains are located essentially in the transmembrane segments and 
their proximity, and in the extracellular loop. A few sequences are completely conserved 
among the ENaC/DEG family members; they include a HG motif located in the 
NH2-terminal cytoplasmic domain in close proximity to the M1 segment, a FPxxTxC 
sequence following M1 (post-M1) and completely conserved residues in the M2 
region(Canessa, Schild et al. 1994; Duc, Farman et al. 1994; Rossier, Canessa et al. 1994). 
The extracellular loop contains cysteine-rich domains (CRD) II and III(Firsov, 
Robert-Nicoud et al. 1999). The conserved Cysteine residues might be involved in the 
 8 
formation of disulfide bonds to maintain the tertiary structure of the large extracellular 
loop. Candidate cysteine residues in the extracellular loop of α-ENaC involved in 
disulfide bridges have been identified by tandem Cysteine mutations and functional 
analysis(Garcia-Anoveros, Ma et al. 1995). Other domains are conserved only within 
particular ENaC/DEG subfamilies. Two domains in the extracellular loop are conserved 
exclusively within the degenerin subfamily, the cysteine-rich domain CRDI and the 
extracellular regulatory domain ERD (Lingueglia, Renard et al. 1994; Renard, Lingueglia 
et al. 1994). ENaC subunits contain conserved proline-rich motifs in the cytoplasmic 
COOH terminus that are unique to the ENaC subfamily. These motifs have the 
consensus sequence PPPXYXXL and are involved in protein-protein interactions (Canessa, 
Schild et al. 1994; Duc, Farman et al. 1994; Garcia-Anoveros, Samad et al. 2001).  
1.3 ENaC Primary Structure and Membrane Topology 
The ENaC channel consists of three non-identical, but homologous subunits, α-, β-, and 
γ-ENaC. Each subunit can be defined in terms of four distinct domains: the cytoplasmic 
N-terminus, the large extracellular loop, the two short hydrophobic segments, and the 
cytoplasmic C-terminus (Canessa, Merillat et al. 1994; Canessa, Schild et al. 1994; 
Chassande, Renard et al. 1994; Renard, Lingueglia et al. 1994; Rossier, Canessa et al. 
1994).  
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Figure 1.1 ENaC subunits are composed of cytoplasmic N-terminus, the large 
extracellular loop, the two short hydrophobic segments, and the cytoplasmic 
C-terminus. 
1.3.1 The N-terminal 
1.3.1.1 The N-terminal is important in channel gating, assembly, delivery and 
expression 
There is considerable sequence homology in the cytoplasmic N-terminus of α-, β-, and 
γ-ENaC. The N-terminus has been suggested to participate in many key functions 
including subunit assembly, gating, and endocytic retrieval and degradation (Adams, 
Snyder et al. 1997; Grunder, Firsov et al. 1997; Horisberger 1998; Prince and Welsh 
1998). However, there are still controversies regarding the role of the N-terminus in 
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channel assembly, delivery and expression (Lingueglia, Voilley et al. 1993; Rossier, 
Canessa et al. 1994; Urzua, Sessler et al. 1994; Fyfe and Canessa 1998; Fyfe, Quinn et al. 
1998; Thomas, Auerbach et al. 1998). There are several amino acids that are highly 
conserved among ENaC subunits and species. These include lysine residues, which play 
roles in ubiquitination, endocytosis, and channel degradation. Deletion of the entire 
cytoplasmic N-terminus of α-, β-, and γ-ENaC completely eliminated Na+ current and the 
co-expression of wild type α-, β-, and γ-ENaC with N-terminal mutants of each rENaC 
subunit dramatically reduced Na+ current (Chalfant, Denton et al. 1999; Chalfant, 
Denton et al. 1999). These observations suggest that the N-terminus is essential for 
functional channel expression in oocytes and subunit assembly and delivery to the 
plasma membrane as seen in other multimeric ion channels such as the acetylcholine 
receptor and voltage gated K+ channels (Li, Jan et al. 1992; Verrall and Hall 1992; Shen 
and Pfaffinger 1995; Smith, Mackler et al. 1998) (Beguin, Hasler et al. 1998; Fyfe, Quinn 
et al. 1998; Snyder, Cheng et al. 1998). 
1.3.1.2 N-terminus in channel ubiquitination 
The N-terminus is important in channel ubiquitination. The cytoplasmic, N-terminus of 
α- and β-rENaC play an important role in determining the half life of the channel and 
thereby the number of channels in the plasma membrane. ENaC has a half life of ≈1 h 
and is ubiquitinated at key lysine residues in the N-terminus of the α- and β- subunit. 
Point substitutions of the lysine residues in γ-rENaC decreased channel ubiquitination 
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and degradation and increased the number of channels in the membrane and Na+ 
current(Hendron, Patel et al. 2002).  
A sequence residue KGDK (amino acids 47-50) in α-rENaC has been recently 
demonstrated as an endocytic motif which regulates the number of channels in the 
plasma membrane. The deletion of this amino acid sequence in α-rENaC has increased 
Na+ current ≈4 fold by increasing the number of channels in the plasma membrane 
without effect on the single channel conductance or on Po. Moreover, the increase in 
the number of channels in the membrane was due to a decrease in the endocytic 
retrieval of channels from the plasma membrane.  
1.3.2 The extracellular loop  
Nearly 70% of the constituent amino acids of each subunit of the Deg/ENaC superfamily 
lie in the extracellular compartment, which constantly exposed in the extracellular 
solution. There are a number of potential N-linked glycosylation sites on the 
extracellular loop domain of each subunit. The function of these glycosylation sites 
remains uncertain; the results from previous experiments suggested that glycosylation 
is not essential for efficient channel assembly and translocation to the plasma 
membrane and for its macroscopic conduction properties, at least in the case of the 
α-subunit (Canessa, Merillat et al. 1994; Canessa, Schild et al. 1994; Renard, Lingueglia 
et al. 1994; Snyder, McDonald et al. 1994). Coexpression of unglycosylated α-ENaC with 
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wild-type β-, and γ-ENaC did not exhibit differences in the magnitude of Na+ current and 
ion selectivity. The two cysteine-rich domains (CRD1 and CRD2) spanning nearly 50% of 
the extracellular loop, and they are highly conserved among all ENaC subunits. Each 
CRD domain contains 16 cysteines and all these cysteines are conserved among every 
ENaC subunit. Most of them are conserved among other branch members of ENaC/DEG 
super family (Take-Uchi, Kawakami et al. 1998; Firsov, Robert-Nicoud et al. 1999). Point 
mutation analysis revealed that these CRD domains are related to the surface 
expression of ENaCs mainly by affecting channel delivery without effects on channel 
assembly and degradation (Green and Wanamaker 1997; Firsov, Robert-Nicoud et al. 
1999; Green 1999).  
1.3.3 Transmembrane domain  
Topological analyses predicted that DEG/ENaC family contains two hydrophobic 
segments (Canessa, Merillat et al. 1994; Canessa, Schild et al. 1994; Rossier, Canessa et 
al. 1994). Both hydrophobic segments span the cell membrane (Coppola, Waldmann et 
al. 1994; Lingueglia, Renard et al. 1994; Voilley, Lingueglia et al. 1994). The first 
hydrophobic segments (H1M1) lie between the N-terminus and extracellular loop and is 
composed of the transmembrane domain preceding the short hydrophobic 
post-membrane-spanning region (H1). The second hydrophobic segments (M2) lie 
between the extracellular domain and the C-terminus and is composed of a short 
hydrophobic region (H2) preceding the transmembrane domain (M2) (Canessa, Merillat 
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et al. 1994). There is also evidence suggesting that the H2 domain is inserted into the 
membrane. Both H1M1 and H2M2 contain around 50 amino acids. The M1 domain is 
much less conserved among family members than the M2 region is. Mutational analysis 
demonstrated that both hydrophobic segments of α-rENaC affect the channel unitary 
conductance, channel dwell time and amiloride affinity, while a M2 mutation also 
reversed the cation selectivity (Langloh, Berdiev et al. 2000; Ji, Parker et al. 2001).  
1.3.4 Carboxyl terminal tails 
The hydrophobic carboxy-terminal lies in the cytoplasm and is important in channel 
regulation. The Carboxyl-terminus is the least conserved among family members, which 
may explain why ENaC channels expressed on different tissue or species respond 
differently to similar agonists or antagonists (Matalon, Benos et al. 1996; Zhu, Yue et al. 
1996; McNicholas and Canessa 1997). The carboxyl terminus closely regulates channel 
gating and internalization. It also is the phosphorylation target of protein kinase. The 
carboxyl terminus of each subunit conserves a proline-rich (PY) motif in spite of the fact 
that the C-terminus domain is the least conserved among subunits and subfamilies. The 
importance of this conserved sequence is underlined by studies of a human genetic 
hypertensive disease, Liddle’s syndrome (Hansson, Nelson-Williams et al. 1995; Hansson, 
Schild et al. 1995). In this disease, either mutations truncating part of the amino acids 
or point mutations within the C-terminus result in a gain of channel function such that 
sodium is re-absorbed with great avidity. 
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1.4 Distributions and physiology role 
The epithelial sodium channels are wildly distributed in different tissues in including: 
kidney, lung, gastrointestinal tract, and sweat glands. The regulatory responses of ENaC 
channels to similar agonists or antagonists vary from tissue to tissue and species to 
species. Same regulator may result in different effects on this channel. cAMP stimulates 
amiloride-sensitive sodium transport in airway and renal epithelia, but has no effect on 
ENaC channels in colon. Different proportions of subunits resulted in different channel 
composition and the presence or absence of intermediate effector or accessory 
proteins in different proteins. Malfunctions of ENaC results in deleterious consequences 
for the cell and tissue.  
1.4.1 Kidney 
In the kidney, ENaC is mostly expressed in the distal nephron where it is under strictly 
hormone control and constitutes the regulated, rate-limiting entry step in Na+ 
reabsorption (Schlatter and Schafer 1987; Farman 1988; Garty and Palmer 1997; Liang, 
Butterworth et al. 2008). Na+ reabsorption can be measured in in vitro microperfused 
tubules in the distal nephron, as a large amiloride-sensitive Na+ flux in sodium-deprived 
or aldosterone-treated animals. The first descriptions of the amiloridesensitive Na+ 
current at the single-channel level using the patch-clamp technique were obtained from 
principal cells of micro dissected cortical collecting ducts (CCDs) and from a cell line 
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derived from the distal nephron of amphibians that responds to aldosterone. 
Additionally, the most recent studies suggest that this hormone regulated, sodium 
channel mediated Na+ reabsorption of kidney nephrons extends at least into the outer 
medullary collecting duct. The presence of the amiloride-sensitive Na+ current 
correlates with the expression of ENaC both at the mRNA and protein levels in the distal 
convoluted tubule, the connecting tubule, the CCD, and the outer medullary collecting 
duct. There is a clear axial heterogeneity of ENaC expression along the distal nephron; 
expression of ENaC is higher in superficial cortical regions of the distal nephron such as 
the connecting tubule or the CCD than in the deeper medullary regions such as the 
inner medullary collecting duct. Western blot showed that all three ENaC subunits are 
expressed in cortex, outer medulla and the inner medulla of the kidney, and the Na+ 
current that detected by whole cell patch clamp confirmed ENaC’s functionality in this 
section. 
1.4.1.1 ENaCs expression and function on the cortical collecting duct 
The cortical collecting duct (CCD) is the most important expression site of the ENaC in 
kidney. Although the reabsorption of sodium largely takes place in the proximal tubule 
and Loop of Henle, the distal tubule and connecting duct are where this reabsorption is 
closely regulated according to the needs of the body.  The amilorde sensitive sodium 
channel plays an important role in both acid-base balance and water balance (Reif, 
Troutman et al. 1986; Frindt, Sackin et al. 1990).   
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In vitro microperfusion on cortical collecting duct demonstrated that the Na+ was 
transported in this section by an amiloride-sensitive mechanism (Barbry and Lazdunski 
1996) (O'Neil and Hayhurst 1985),  which was first described in the amphibian skin. 
like the Na+ transport mechanism of the amphibian skin (Koefoed-Johnsen and Ussing 
1958; Macrobbie and Ussing 1961; Rick, Dorge et al. 1980), the Na+ move into the 
epithelial cells through the sodium channels that only localized on the apical (outer) 
side of the cells, and is driven out by the Na+-K+ ATPase that is localized only on the 
basolateral (inner side) membrane (Koefoed-Johnsen and Ussing 1958; Dorge, Gehring 
et al. 1974; Rick, Dorge et al. 1981; Huf and Mikulecky 1983; DeLong and Civan 1984; 
Van Driessche and Zeiske 1985; Reif, Troutman et al. 1986; Frindt, Sackin et al. 1990; 
Hillyard, Viborg et al. 2007). Patch clamp experiments, which enabled the most direct 
observation of Na+ activity on the epithelial cells, confirmed that both cortical collecting 
tubule and amphibian skin transport Na+ in this amilorde-sensitive pathway (Palmer and 
Frindt 1986; Palmer and Frindt 1986; Hunter, Horisberger et al. 1987; Lazrak, Samanta 
et al. 2000). The abundance of expression and high Na+ activity along the CCD makes 
the regulation of the channels in this section very important in the overall Na+ balance 
(Kaissling 1985; Hamilton and Eaton 1986; Beck, Dorge et al. 1989; Wald, Scherzer et al. 
1989; Zeidel 1993; Kamel, Quaggin et al. 1994; Malnic, Fernandez et al. 1994; Watanabe, 
Matsushita et al. 1999). 
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1.4.1.2 ENaCs expression and function on the medullary duct  
The outer medullary collecting duct contributes to the renal Na+ reabsorption as well. 
The immunoblots experiments showed that all three ENaC subunits are expressed in 
both inner and outer medullary collecting tubule of the kidney. The channel activities 
have been recorded by whole cell patch clamp measurements (Vehaskari, Hempe et al. 
1998; MacDonald, MacKenzie et al. 2000; Kim, Wang et al. 2005).  Whole cell 
recording on outer medullary collecting duct indicated that the transepithelial Na+ 
current of the outer medullary collecting duct cell can reach to as high as that of the 
CCD cells cell. However the Na+ current was undetectable on the primary cells obtained 
from control rats (Frindt, Ergonul et al. 2007)   
This amiloride-sensitive Na+ reabsorption was also found in the inner medullary 
collecting duct (Sonnenberg, Honrath et al. 1987), but in a much lower exchange rate in 
compare to that of the CCD or outer medullary collecting duct (Diezi, Michoud et al. 
1973).  
1.4.1.3 ENaCs expression and function on the proximal tubule 
Although almost two-thirds of the Na+ is reabsorbed in the proximal tubule, the 
amiloride-sensitive sodium channel is not a major contributor to Na+ retention in this 
section. The Na+ entry into the epithelial cells in proximal tubule is mainly mediated by 
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active transport and facilitated diffusion. The uptake of Na+ is coupled with the uptake 
of organic solutes and ions such as H+. Furthermore, the sodium exchange in this part of 
the nephron tubule appears to be spontaneous rather than regulated by the needs of 
the sodium homeostasis (Edwards, Baer et al. 1973; Stein, Osgood et al. 1973; Chou, 
Porush et al. 1977; Ullrich, Fromter et al. 1977; Bagrov, Vasil'eva et al. 1979; Molitoris, 
Geerdes et al. 1991; Greger, Lohrmann et al. 1992; Larsen and Mobjerg 2006; Efendiev, 
Das-Panja et al. 2007; Girardi, Fukuda et al. 2008; Stevens, Saad et al. 2008; Kastner, 
Pohl et al. 2009; Segawa, Aranami et al. 2009; Verrey, Singer et al. 2009; Weinstein and 
Sontag 2009).  
However, Na+ selective, amiloride sensitive channels were detected by patch clamp 
technique in the luminal membrane of rabbit straight proximal tubule segments 
(Gogelein and Greger 1986; Duc, Farman et al. 1994). Their regulation mechanism and 
physiological functions remain to be determined. Functional epithelial sodium channels 
were detected on the epithelium of the urinary bladder of toad (Crabbe 1961) and 
rabbit(Lewis and Diamond 1976; Lewis, Eaton et al. 1976). The channels are tightly 
regulated by hormones (Bentley 1968; Spooner and Edelman 1976; Duc, Farman et al. 
1994).  
 
 19 
1.4.2 Lung 
Epithelial sodium channels in lung, unlike those in other parts of the body such as 
kidney, colon, and sweat and salivary ducts, do not participate in maintaining body 
sodium homeostasis and fluids balance. It is the mechanism by which the epithelium 
reabsorbs and secretes fluids in order to maintain an appropriate level of hydration 
(Durand 1988; Liu, Johnson et al. 2003). Fluid absorption is largely mediated by Na+ 
absorption, and Na+ enters the alveolar cells mainly through apical Na+ selective 
channels. Patch clamp experiment results demonstrated the presence of ENaCs on the 
apical membranes of fetal distal lung epithelial cells (FDLE) and alveolar type II cells 
(ATII)(Matalon, Kirk et al. 1992; Yue, Shoemaker et al. 1994) (Hamill, Marty et al. 1981), 
where they are regulated by various agents and second messengers. However, different 
types of Na+ channel are present in the apical membrane of alveolar cells, whose 
conductance ranges from 4-25pS. 
Na+ transport has been well studied in excised amphibian lung. The simple architecture 
of the amphibian lung makes it possible to directly study the ion movements in lung. An 
amiloride sensitive Na+ current was observed when the excised bullfrog lung was 
mounted in an Ussing chamber (Gatzy 1976). The excised lung exhibited a transmural 
electrical potential difference with the pleural surface positive and a high resistance. 
Later Xenopus lung epithelium experiments revealed that Na+ transport across the lung 
epithelium occurs in the same way as in the kidney and other tight epithelia (Fischer, 
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Van Driessche et al. 1989).  
The sodium channel has been also studied in the trachea. The results suggest that it is 
amiloride sensitive (Patton, Jenkins et al. 1982) and can be regulated by hormones. 
Additionally, this amiloride-sensitive sodium transport in the upper airway also 
mediates chloride secretion. 
The ability of fluid secretion and absorption of airway epithelium is regulated by the 
movements of chloride and sodium ions. Thus a balance between these two systems is 
crucial in maintaining a proper level of hydration of the fluid layer lining the inner 
surface of the airway epithelium (Bijman and Quinton 1984; Frizzell, Halm et al. 1986; 
Quinton 1986). According to a previous studies on the trachea epithelium of dog, 
human and rabbit, the Na+ transport mediated by epithelial sodium channels are closely 
coupled with the Cl- activities (Al-Bazzaz and Al-Awqati 1979; Welsh and Widdicombe 
1980; Liu, Luo et al. 2007). However, this active sodium transport regulates the Cl- 
secretion but the Cl- secretion did not appear to have any influence on the Na+ 
transport (Al-Bazzaz and Al-Awqati 1979) Thus the appropriate function of epithelial 
sodium channel is important in maintaining the thickness and viscosity of the fluid layer 
lining the cells; disruptions of its functions could cause serious consequences as seen in 
Cystic Fibrosis(Reddy and Quinton 1989; Hartmann and Verkman 1990; Welsh 1990).  
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1.4.3 Mechanical sensory cells  
Epithelial sodium channel subfamily members have long been implicated in the 
mechano-sensation and transduction processes in mechanical sensory cells. The 
epithelial sodium channel has been linked to mechanical sensation by genetic studies in 
Caenorhabditis elegans that revealed the homology between the rENaC channels and 
the genes involved in neurodegeneration and mechanical-stimulus transduction in 
C.elegans (Corey and Garcia-Anoveros 1996; Chelur, Ernstrom et al. 2002; Bianchi 2007). 
This similarity brought the speculation that the members of the same channel family 
might be involved in mechanosensory functions in vertebrates (Chalfie, Driscoll et al. 
1993; Hamill and McBride 1996; Adams, Anderson et al. 1998; Chelur, Ernstrom et al. 
2002). C.elegans degenerins are implicated in touch sensation and proprioception. 
Based on the genetic analysis of C.elegans mutants with impaired touch and stretch 
sensation, a model of the touch-transducing complex was proposed in which the 
degenerins MEC-4 and MEC-10 constitute the channel core of the mechanosensory 
transduction complex (Huang and Chalfie 1994; Gu, Caldwell et al. 1996). MEC-4 and 
MEC-10 subunits are coexpressed in touch receptor neurons (Tavernarakis and Driscoll 
1997; Duggan, Garcia-Anoveros et al. 2000). The similarity between the subfamily 
members of epithelial sodium channel and the channels involved in mechanotransducer 
channel on C. elegans brought the speculation that the members of the same channel 
family might be involved in mechanosensory functions in vertebrates(Chalfie, Driscoll et 
al. 1993; Hamill and McBride 1996; Adams, Anderson et al. 1998; Price, Lewin et al. 
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2000; Chelur, Ernstrom et al. 2002) 
The Epithelial sodium channel contributes to arterial baroreceptor 
mechano-transduction (Drummond, Price et al. 1998; Bianchi 2007). The gamma 
subunit of ENaC localizes to the site of mechano-transduction in baroreceptor nerve 
terminals innervating the aortic arch and carotid sinus. The b baroreceptor activity and 
control of blood pressure were abolished by an amiloride analog that inhibits ENaC 
channels (Drummond, Price et al. 1998). Further study in the topic revealed that ENaC 
transcripts and proteins are expressed in mechanosensory neurons and at the putative 
sites of mechano-transduction in baroreceptor sensory-nerve terminals. The potent 
ENaC channel blockers amiloride and benzamil disrupted mechanical transduction in 
arterial baroreceptor neurons(Drummond, Welsh et al. 2001), which indicated that the 
sodium channels had a functional role in transducing mechanical stimuli into neuronal 
responses. In addition to its mechanosensitivity in sensory neurons, ENaCs are also 
participated in the vessel responses to pressure. RT-PCR, immunoblotting and 
immunolocalization experiments confirmed that ENaCs are expressed in isolated blood 
vessels and vascular smooth muscle cells. The inhibition of ENaC with amiloride and 
benzamil which blocked myogenic constriction in isolated rat cerebral arteries proved 
the ENaC’s functionality (Drummond, Gebremedhin et al. 2004).  
The response of epithelial sodium channels to mechanical forces such as stretch and 
shear force granted its role in vascular epithelial cells sensing and responding to 
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changes in blood flow status. This topic will be discussed further in my thesis.  
1.5 Regulation of ENaC 
1.5.1 Aldosterone Regulations of the epithelial sodium channel  
The mineralocorticoid aldosterone is the primary hormone regulating the Na+ transport 
across the distal renal and gastrointestinal epithelium and responsible for maintaining 
electrolyte homeostasis and blood pressure in all terrestrial vertebrates. It is considered 
the most potent modulator stimulating Na+ reabsorption (Palmer LG 1986; Kemendy, 
Kleyman et al. 1992; Eaton, Becchetti et al. 1995; Rozansky 2006). In addition, 
aldosterone-induced Na+ influx alters the electrochemical gradient in these epithelial 
cells which in turn regulates the activities of other ions such as K+ and H+ secretion 
(Paillard 1977; de Wardener 1978; Rozansky 2006). Aldosterone’s effects on Na+ 
transport have been intensively studied on a variety of native and cultured epithelia 
from amphibian, avian, and mammalian sources. These studies involved short circuit 
measurement, current fluctuation analysis, microelectrode impalements, patch clamp 
recording and many molecular biology experimental techniques. The fundamental 
features of the aldosterone-induced increase in Na+ transport elucidated by all the 
previous studies can be summarized as(Lipton and Edelman 1971; Spooner and 
Edelman 1975; Geering, Girardet et al. 1982; Geering, Girardet et al. 1982; Palmer, Li et 
al. 1982; Garty 1986; Rozansky 2006).  
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a), the aldosterone induced increase in transepithelial Na+ transport is mainly mediated 
by apical epithelial sodium channel and partially by basolateral Na+-K+-ATPase, which 
facilitates the extrusion of Na+ from the cell.   
b), aldosterone’s effects can be divided into three phases according to different cellular 
events: 1 The latent phase, during which protein synthesis is initiated without significant 
change in Na+ transport; 2 The early phase, starts from 1-3 hours, during which an 
increase in Na+ reabsorption but no significant increase in ENaC mRNA are detected; 3 
The late phase, initiates from 6-24 hours and can persist up to several days, during 
which newly synthesized ENaC subunits and Na+-K+-ATPase are observed. 
c), in all the time domains of the response to aldosterone, Na+ transport increase is 
mediated by steroid receptors and is dependent on transcription and translation. This 
has been proved by the observation that the aldosterone-induced apical Na+ actions 
were fully abolished by the inhibitors of transcription and translation. 
d), the aldosterone stimulates Na+ absorption by increasing the expression of epithelial 
sodium channel on the apical cell membranes and may have additional effects on the 
channel kinetic characteristics (open probability). Furthermore, aldosterone enhances 
the expression level and activity of the basolateral Na+-K+-ATPase.   
Long term aldosterone’s action is characterized by the observation that the increase in 
apical Na+ transport begins before the significant elevation in ENaC subunit mRNA level 
are detected. Although ENaC mRNA remains stable during this period, the increase in 
Na+ transport was fully blocked by applying inhibitors of translation and transcription, 
 25 
which indicated that aldosterone stimulates protein synthesis of other ENaC modulator 
rather than the channel itself (Lipton and Edelman 1971; Rozansky 2006). 
1.5.2 Regulation by SGK1  
1.5.2.1 SGK  
Serum glucocorticoid induced kinase (SGK), is an aldosterone induced protein in the 
distal nephron and colon epithelial cells. SGK1 was originally identified through its 
glucocorticoid regulated mRNA in mammary epithelial cells and termed SGK to reflect 
its regulation at the transcriptional level by serum and glucocorticoids (Alliston, Maiyar 
et al. 1997; Waldegger, Barth et al. 1997). It was subsequently cloned and its expression 
level was found to be regulated by a variety of hormonal and non-hormonal stimuli, 
including serum, follicle stimulating hormone (FSH), osmotic shock and 
mineralocorticoids (Chen, Bhargava et al. 1999; Shigaev, Asher et al. 2000). It has the 
characteristic motifs of a serine/threonine kinase and kinase activity has been 
demonstrated in vitro (Kobayashi, Kitano et al. 1999; Kobayashi and Cohen 1999; Park, 
Leong et al. 1999; Brunet, Park et al. 2001). SGK1 is found in most vertebrate tissues, 
although at variable levels, and its expression pattern within tissues shows considerable 
heterogeneity with respect to both basal and stimulated levels of expression.  
In kidney CD, basal levels of SGK1 are low and are strongly induced by 
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mineralocorticoids, whereas in proximal tubule, expression is undetectable (by in situ 
hybridization) in the absence or presence of mineralocorticoids or glucocorticoids. 
Moreover, although SGK was initially discovered as a mRNA induced by glucocorticoids, 
as in this case in distal nephron and colon epithelial cells, where both mineralocorticoid 
receptor and glucocorticoid receptor are expressed, and both receptors mediate a 
similar, if not identical physiological effects in gene transcription, SGK can be induced by 
mineralocorticoid aldosterone and glucocorticoids such as dexamethasone (Shigaev, 
Asher et al. 2000; Wagner, Ott et al. 2001; Friedrich, Feng et al. 2003). Experiments in 
Xenopus cortical collecting duct cell line, rabbit cortical collecting duct cell and rat 
cortical collecting duct cell demonstrated that aldosterone increased the SGK mRNA 
level within 0.5 hour and protein abundance rapidly, with maximal induction at 
approximate 6h. And both SGK mRNA and protein level started to drop within 24h, in 
some cases, the mRNA and protein level decreased to near baseline by 24h. This time 
course and dose response of SGK to aldosterone expression is consistent with that of 
the early increase in Na+ transport(Loffing, Zecevic et al. 2001; Faletti, Perrotti et al. 
2002; Asher, Sinha et al. 2003; Rauh, Dinudom et al. 2006).  
1.5.2.2 SGK stimulates the ENaC-mediated apical Na+ transport 
The early phase of the stimulatory effect of aldosterone on sodium reabsorption in 
renal epithelia is thought to involve the increase of apical sodium channel activity by 
SGK. Since aldosterone’s action clearly requires changes in gene transcription, these 
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observations suggested the hypothesis that a key mineralocorticoid-regulated gene (or 
genes) encoded a regulatory protein that increases the plasma membrane localization 
and/or activity of already synthesized ENaC subunits (Palmer, Li et al. 1982; 
Naray-Fejes-Toth and Fejes-Toth 2000; Rozansky 2006). Nevertheless, regulation of 
α-subunit biosynthesis might be important for the late effects of aldosterone. However, 
in most cases, the ENaC mediated early effect of aldosterone accounts for more than 60% 
of the total increase in Na+ current and, importantly, occurs without changes in ENaC 
gene transcription or mRNA levels (Kemendy, Kleyman et al. 1992; Kleyman, 
Coupaye-Gerard et al. 1992; Eaton, Becchetti et al. 1995; Ling, Zuckerman et al. 1997). 
Thus, it has been suggested that mineralocorticoids stimulate electrogenic Na+ 
transport in tight epithelia by altering the transcription of the SGK gene rather than 
stimulating the expression of channel gene. In other words, the earliest 
mineralocorticoid effect is to increase the activity of the epithelial sodium channel 
(ENaC), ENaC mRNA and protein levels do not change. Instead, physiologic observations 
suggest that a mineralocorticoid target gene(s) encodes an ENaC regulator(s)  (Chen, 
Bhargava et al. 1999; Naray-Fejes-Toth, Canessa et al. 1999; Al-Baldawi, Stockand et al. 
2000; Naray-Fejes-Toth and Fejes-Toth 2000). To begin to identify and characterize 
mineralocorticoid-regulated target genes, suppression-subtractive hybridization was 
utilized to generate a cDNA library from A6 cells, a stable cell line of Xenopus laevis of 
distal nephron origin. SGK was identified from this screen. Sequence comparison 
revealed that frog, rat, and human SGK are 92% identical and 96% similar at the amino 
acid level. SGK mRNA was confirmed by Northern blot to be strongly and rapidly 
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corticosteroid stimulated in A6 cells (Becchetti, Kemendy et al. 2000). In situ 
hybridization revealed that SGK was strongly stimulated by aldosterone in rat collecting 
duct but not proximal tubule cells (Naray-Fejes-Toth, Canessa et al. 1999). Low levels of 
SGK were present in rat glomeruli, but SGK was unregulated in this structure. Finally, 
SGK stimulated ENaC activity approximately sevenfold when coexpressed in Xenopus 
laevis oocytes (Chen, Bhargava et al. 1999; Naray-Fejes-Toth and Fejes-Toth 2000). 
These data suggest that SGK is an important mediator of aldosterone effects on Na+ 
transport in tight epithelia. In addition, in view of the existence of SGK homologues in 
invertebrates, it is interesting to speculate that SGK is an ancient kinase that was 
adapted to the control of epithelial Na+ transport by early vertebrates as they made the 
transition from a marine to a freshwater environment. To test that whether increased 
SGK mediates the early response to aldosterone, SGK was co-expressed with ENaC in 
Xenopus oocytes, and this co-expression increased the Na+ current 7-fold in comparison 
to control, and this is mainly a result of an increase in the number of ENaC channels at 
the cell surface (Chen, Bhargava et al. 1999; Naray-Fejes-Toth and Fejes-Toth 2000). The 
co-expression of SGK and renal outer medullary potassium channel (ROMK), a principal 
potassium channel found in collecting duct apical membrane, under the same 
conditions produced no effect. This further confirmed the view that changes in K+ 
transport depend on the alterations in the electrochemical gradient established by Na+ 
(Shigaev, Asher et al. 2000; Loffing, Zecevic et al. 2001; Faletti, Perrotti et al. 2002; Rauh, 
Dinudom et al. 2006). 
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1.5.2.3 Possible SGK regulation pathway  
SGK1 stimulation of ENaC-mediated Na+ transport has been demonstrated to involve its 
kinase activity. However, phosphorylation of ENaC subunits by SGK1 has not been 
demonstrated. Moreover, SGK1 and probably SGK2 and SGK3 increase ENaC localization 
to the plasma membrane but an effect on channel open probability has not been ruled 
out. Hence, it seems likely that the target proteins of the SGKs are involved in ENaC 
translocation to the plasma membrane, its removal, or both. In conclusion, the most 
efficient way to achieve the rapid and potent effects that SGK1 on ENaC is to alter both 
insertion and removal of channels. The possible regulation pathways of SGK over ENaC 
are described as follow; 
1.5.2.3.1 SGK stimulate ENaC activity by phosphorylation 
 The fact that SGK has sequence similarity to serine-threonine kinase and a kinase-dead 
mutant of SGK did not stimulated ENaC activity suggested that SGK might increase ENaC 
surface expression by protein phosphorylation (Rauh, Dinudom et al. 2006). However, 
the target substrate of the SGK phosphorylation is unknown. It is possible that SGK 
phosphorylates ENaC directly. Consistent with such a direct mechanism, aldosterone 
has been reported to phosphorylate the C terminus of the β- and-ENaC, while the 
physiological consequences of this phosphorylation remain undetermined (Chen, 
Bhargava et al. 1999). However, an indirect mechanism has been proposed based on the 
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observations which demonstrated that ENaC is not phosphorylated by SGK. In this 
indirect mechanism, SGK may phosphorylate one or more proteins involved in 
regulating the expression of ENaC at the cell surface (Alvarez de la Rosa, Zhang et al. 
1999; Wang, Barbry et al. 2001; Faletti, Perrotti et al. 2002; Snyder, Olson et al. 2004; 
Zhou and Snyder 2005). 
1.5.2.3.2 SGK increases Na+ transport by facilitating the ENaC insertion 
The means by which SGK increases the ENaC surface expression is also unknown. One 
possible explanation is that SGK helps channel trafficking to the cell surface. This 
statement is because SGK is thought to be a member of the PKB/Akt family of 
serine/threonine kinases, a kinase family involved in the insulin-induced exocytosis of a 
glucose transporter, and parallels between the glucose transporter (GLUT4) mediated 
glucose transport and ENaC-mediated Na+ transport. This similarity perhaps reflects the 
common themes that underlie the hormonal control of protein trafficking and led to the 
speculation that SGK might regulate ENaC trafficking through a similar mechanism 
(Naray-Fejes-Toth and Fejes-Toth 2000; Pearce, Verrey et al. 2000; Kanelis, Rotin et al. 
2001; Asher, Sinha et al. 2003; Friedrich, Feng et al. 2003; Dieter, Palmada et al. 2004; 
Snyder, Olson et al. 2004; Zhou and Snyder 2005; Zhou, Patel et al. 2007).  
 
1.5.2.3.3 SGK increase Na+ transport by reducing the ENaC removal 
Several studies reported the interactions between SGK and Nedd4, ubiquitin-ligase that 
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reduce ENaC surface expression by initiating channel internalization. Nedd4 is 
considered a modulator that suppresses ENaC cell surface expression and activity (Chen, 
Bhargava et al. 1999; Shigaev, Asher et al. 2000; Chigaev, Lu et al. 2001; Kanelis, Rotin et 
al. 2001; Snyder, Olson et al. 2002; Pearce 2003; Dieter, Palmada et al. 2004; Snyder, 
Olson et al. 2004; Li, Koshy et al. 2009). This suppression effect is vitally important in 
mediating Na+ homeostasis and the malfunction of this interaction can cause serious 
pathological conditions such as Liddle’s syndrome (Schild 1996; Schild, Lu et al. 1996; 
Tamura, Schild et al. 1996; Staub, Gautschi et al. 1997; Kellenberger, Gautschi et al. 
1998; Dahlmann, Pradervand et al. 2003; Pradervand, Vandewalle et al. 2003; Zhou, 
Patel et al. 2007; Rotin 2008).  
 
1.5.2.3.3.1 PY motif and channel internalization 
ENaC was found to be composed of three non-identical but homologous subunits, each 
containing two transmembrane domains, a large extracellular loop, and short 
intracellular NH2 and COOH termini. Other domains involve an NH2-terminal gating 
domain, an extracellular cysteine-rich region important for channel expression at the 
cell surface, and a pre-M2 shown to contain the ion-selectivity filter and the amiloride 
binding site. All three ENaC subunits have conserved proline-rich regions conforming to 
the consensus of PY motifs in their COOH-terminal end, namely xPPxY, where P is 
proline, Y is tyrosine, and x is any amino acid. Such motifs have been shown to act as 
ligands for WW domains. These motifs have gained considerable interest with the 
mapping of Liddle’s syndrome to mutations in the genes encoding either the β- or the 
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γ-subunit (Kellenberger, Gautschi et al. 1998). It has been demonstrated that the 
SGK-induced phosphorylation of Nedd4 inhibits the interaction with ENaC subunits 
(Chen and Sudol 1995). This syndrome is a rare hereditary disorder in which the kidneys 
excrete K+ but retain too much Na+ and water, leading to high blood pressure (Hansson, 
Nelson-Williams et al. 1995). It was described as an autosomal dominant syndrome 
associated with early onset of severe hypertension, variable degrees of low serum K+ 
level and elevated blood pH, and suppressed plasma renin activity and aldosterone 
levels. In all cases of Liddle’s syndrome mapped until now, mutations are located at the 
COOH terminus of either β- or the γ- ENaC and cause either the deletion or the 
modification of the corresponding PY motif (Canessa, Horisberger et al. 1995; Hansson, 
Nelson-Williams et al. 1995; Puoti, May et al. 1995; Schild, Canessa et al. 1995; 
Dinudom, Harvey et al. 1998; Debonneville, Flores et al. 2001). To date, a total of 12 
mutations have been identified in the COOH-terminal domains of β- and γ-subunits. 
Previous studies have shown that the expression of Liddle’s channels yield higher 
channel activity compared with wild-type channels (Dinudom, Harvey et al. 1998; 
Debonneville, Flores et al. 2001). This increase was attributed to elevated channel 
numbers at the cell surface, as determined by transient expression in Madin-Darby 
canine kidney (MDCK) cells. There are also other reports provided evidence that both 
cell channel number and open probability were increased by expressing extracellularly 
FLAG-tagged ENaC constructs in X. laevis oocytes. Two mechanisms have been 
proposed to be perturbed and to be responsible for the observed increase in channel 
density: endocytosis or ubiquitination. The first proposal involves a defective 
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tyrosine-based endocytosis signal (YXXθ, where Y is tyrosine, X is any amino acid, and θ 
is hydrophobic amino acid), which overlaps with the above-mentioned PY motif. It was 
shown that mutation of the leucine after the PY motif in β-ENaC (PPPNYDSL; the 
tyrosine motif is underlined) caused increased amiloride-sensitive Na+ currents 
(McDonald, Price et al. 1995; Schild, Canessa et al. 1995; Snyder, Price et al. 1995). 
Moreover, this leucine is also involved in interaction with the WW domain of Nedd4, as 
recently demonstrated by resolving the structure of a complex between the third Nedd4 
WW domain and a β--ENaC PY peptide (McDonald, Price et al. 1995; Schild, Canessa et 
al. 1995; Dinudom, Harvey et al. 1998; Debonneville, Flores et al. 2001). Hence, 
mutation of this leucine may also affect the interaction with Nedd4. Further support for 
the endocytosis model came from experiments in X. laevis oocytes co-overexpressing 
ENaC with dominant-negative dynamin, a protein known to inhibit clathrin-mediated 
endocytosis (Puoti, May et al. 1995). This caused an increase in ENaC activity, 
suggesting that ENaC is internalized via such a mechanism. 
 
1.5.2.3.3.2 The ENaC cell surface expression and activity are regulated by 
ubiquitination 
The notion that ENaC may be regulated by ubiquitination first came from a two-hybrid 
screen using the COOH terminus of β-ENaC (including the PY motif) as bait. In this 
screen, Nedd4 was identified as a binding partner for the PY motifs in ENaC (Staub, Dho 
et al. 1996). Nedd4 was originally identified in a subtractive screen between mouse 
embryonic and adult brain (Kumar, Tomooka et al. 1992). It is part of a protein family, 
 34 
which comprises 12–13 human proteins, the Nedd4/Nedd4-like family of 
ubiquitin-protein ligases (Harvey, Dinudom et al. 1999; Harvey and Kumar 1999; Rotin, 
Staub et al. 2000; Staub, Abriel et al. 2000). These proteins are composed of one to four 
WW domains (serving protein-protein interaction), a domain homologous to the 
E6-AP-COOH terminal domain (HECT), the catalytic portion of these proteins, and most 
contain an NH2-terminal C2 (Ca2+-dependent lipid binding) domain (Andre and 
Springael 1994; Chen and Sudol 1995; Hofmann and Bucher 1995; Sudol, Chen et al. 
1995). Two closely related Nedd4 isoforms (or paralogues) exist: Nedd4–1 (also named 
Nedd4, KIAA0093, or RPF1) and Nedd4–2 (also known as KIAA0439, LdI-1, Nedd4La, 
Nedd18, or Nedd4-L). Nedd4–1 is composed of one C2 domain, a HECT domain, and 
three to four WW domains (Huibregtse, Scheffner et al. 1995; Scheffner, Nuber et al. 
1995). The rat and mouse species contain three WW domains, whereas in humans there 
are four WW domains (Debonneville, Flores et al. 2001; Kamynina, Debonneville et al. 
2001; Kamynina, Debonneville et al. 2001). The difference in the number of WW 
domains may be due to alternative splicing, as there is evidence for multiple transcripts 
in human Nedd4–1. Nedd4–2 contains four WW domains and a HECT domain 
(Debonneville, Flores et al. 2001; Kamynina, Debonneville et al. 2001; Kamynina, 
Debonneville et al. 2001; Kamynina, Tauxe et al. 2001). Only human and X. laevis 
Nedd4–2 comprise a C2 domain, whereas such a domain appears to be lacking in mouse 
Nedd4–2 (Chen and Sudol 1995; Huibregtse, Scheffner et al. 1995; Kamynina, 
Debonneville et al. 2001). However, there is evidence for alternative splicing of this 
isoform as well, and there may be isoforms that contain, and others that do not contain, 
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a C2 domain. 
 
The finding that ENaC interacts with Nedd4 suggested that ubiquitination plays a role in 
the regulation of ENaC. A model has been proposed in which Nedd4 interacts with the 
channel via its WW domains to the ENaC PY motifs and ubiquitinates one or several 
ENaC subunits (Staub, Dho et al. 1996). Such ubiquitination would cause a decrease in 
ENaC at the cell surface, likely by enhanced endocytosis. This proposed model also 
accounts for the hyper-active channel seen in Liddle’s syndrome, where one of the PY 
motifs (and hence a binding site for Nedd4) is missing, proper binding (and, 
consequently, ubiquitination) of Nedd4 would be impaired, leading to increased Na+ 
channel density (Staub, Gautschi et al. 1997).  
 
The regulation of ENaC by ubiquitination has been well demostrated by studies of 
Liddle’s syndrome (Schild, Canessa et al. 1995; Snyder, Price et al. 1995). Previouse 
invistigations have shown that the expression of Liddle’s channels yield higher channel 
activity compared with wild-type channels. This increase was attributed to an elevated 
channel numbers at the cell surface, as determined by transient expression in 
Madin-Darby canine kidney (MDCK) cells (Staub, Gautschi et al. 1997). There are also 
other reports suggesting that both increase in channel number and open probability 
were increased by expressing extracellularly FLAG-tagged ENaC constructs in X. laevis 
oocytes (Damke, Baba et al. 1994; Kellenberger, Gautschi et al. 1999; Kellenberger, 
Hoffmann-Pochon et al. 1999). Two mechanisms have been proposed to be perturbed 
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and to be responsible for the observed increase in channel density: endocytosis or 
ubiquitination. The first proposal involves a defective tyrosine-based endocytosis signal 
(YXXθ, where Y is tyrosine, X is any amino acid, and θ is hydrophobic amino acid), which 
overlaps with the above-mentioned PY motif. It was shown that mutation of the leucine 
after the PY motif in β-ENaC (PPPNYDSL; the tyrosine motif is underlined) caused 
increased amiloride-sensitive Na+ currents (Awayda, Ismailov et al. 1996; Bubien, 
Ismailov et al. 1996; Ismailov, Berdiev et al. 1996; Ismailov, Shlyonsky et al. 1999; Ji, 
Fuller et al. 1999). Moreover, this leucine also interacts with the WW domain of Nedd4, 
as recently demonstrated by resolving the structure of a complex between the third 
Nedd4 WW domain and a β--ENaC PY peptide (Kanelis, Rotin et al. 2001; Rotin, Kanelis 
et al. 2001). Hence, mutation of this leucine may also affect its interaction with Nedd4. 
Further support for the endocytosis model came from experiments in X. laevis oocytes 
co-overexpressing ENaC with dominant-negative dynamin, a protein known to inhibit 
clathrin-mediated endocytosis (Damke, Baba et al. 1994; Kellenberger, Gautschi et al. 
1999; Kellenberger, Hoffmann-Pochon et al. 1999). This caused an increase in ENaC 
activity, suggesting that ENaC is internalized via such a mechanism.  
 
1.5.2.3.3.2 SGK increase the channel activity by deactivating the ubiquitination 
protein, Nedd4 
 
SGK1 phosphorylates Nedd4 and interferes with Nedd4-ENaC interaction. The 
observation that both Sgk1 and Nedd4–2 are able to control ENaC density at the cell 
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surface suggested that the two proteins may act on the same regulatory pathway. The 
recent identification of the consensus phosphorylation motif for Sgk1 [RXRXX(S/T)] 
(Kobayashi and Cohen 1999; Kobayashi, Deak et al. 1999; Polo, Sigismund et al. 2002) 
and the presence of a conserved PY motif (hence a putative binding site for the WW 
domains of Nedd4–2) on Sgk1 prompted the research for Sgk1 phosphorylation sites on 
Nedd4–2. Two motifs were subsequently identified (Debonneville, Flores et al. 2001), 
and a third, present only on certain spliced forms of human Nedd4–2, was described 
(McDonald, Western et al. 2002; Snyder, Olson et al. 2002). Nedd4-2 but not Nedd4-1 
which does not contain such consensus sites in X. laevis oocytes was phosphorylated by 
Sgk1 and that this phosphorylation is impaired when the Sgk1 PY motif is mutated. In 
addition,, the mutation of the Nedd4–2 phosphorylation sites impairs the ability of Sgk1 
to increase ENaC activity at the cell surface and provided evidence that Sgk1-dependent 
phosphorylation of Nedd4–2 reduces its ability to interact with ENaC (Debonneville, 
Flores et al. 2001). Subsequent studies demonstrated that in vitro translated Sgk 1 can 
interact with Nedd4–2 in a PY motif-dependent manner (Snyder, Cheng et al. 1998). 
However, there is some controversy over the involvement of the ENaC PY motifs in 
Sgk1-dependent regulation of ENaC.  
Hence, on the basis these data, the model for ENaC activity regulation, involving 
Nedd4–2, Sgk1, aldosterone, was proposed. ENaC cell surface expression is routinely 
regulated by the balance between the insertion of more channels from vesicular stocks 
and their retrieval via Nedd4–2- mediated ubiquitination. Aldosterone, on binding to 
the mineralocorticoid and glucocorticoid receptors and translocation into the nucleus, 
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induces the expression of Sgk1 (and a number of other genes). Sgk1 will bind via its PY 
motif to a WW domain of Nedd4–2 and initiate the phosphorylation. Such 
phosphorylation weakens the interaction between ENaC and Nedd4–2 and reduces 
ENaC ubiquitination, resulting in the accumulation of ENaC at the cell surface and 
increased Na+ reabsorption (Schild, Lu et al. 1996; Kanelis, Rotin et al. 2001; Lu, Pribanic 
et al. 2007).  
 
1.5.3.1 AA regulation over ENaCs 
Arachidonic acid (AA) is a polyunsaturated fatty acid that is present in the phospholipids 
of membranes of the body's cells. The chemical structure of arachidonic acid is a 
carboxylic acid with a 20-carbon chain and four cis double bonds. AA is involved in 
cellular signaling, mediating inflammation and helping to maintain the mammalian cell 
membrane correct fluidity at physiological temperatures. Arachidonic acid is found in 
the sn-2 position of membrane phospholipids, where it can potentially be liberated by 
the deacylating action of different lipases (Bonventre 1999). Arachidonic acid and its 
metabolites have been implicated in the regulation of a number of important 
physiologic processes in the kidney, including water and Na+ reabsorption and K+ 
secretion. Phospholipase A2 (PLA2) is the principal enzyme responsible for arachidonic 
acid production in most mammalian cells (Balsinde, Balboa et al. 1999; Kudo and 
Murakami 2002). After its liberation, AA is metabolized into a wide range of products by 
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three types of oxygenase: cyclooxygenases (COX) (Bonvalet, Pradelles et al. 1987; Smith 
1992; Kuwamoto, Inoue et al. 1997; Jakobsson, Thoren et al. 1999), lipoxygenase 
(LOX)(Werz and Steinhilber 2006; Mahipal, Subhashini et al. 2007) (Samuelsson, Dahlen 
et al. 1987; Schweiger, Furstenberger et al. 2007) and cytochrome P450(Capdevila, 
Chacos et al. 1981; Schwartzman, Ferreri et al. 1985; Nelson, Koymans et al. 1996). Both 
the product of AA and AA itself have well-substantiated bioactivities. Its metabolites 
perform a diverse range of physiological and pathological roles in the cardiovascular 
system (Lee, Lu et al. 1999; Node, Huo et al. 1999; Roman 2002) and kidney (Breyer, 
Jacobson et al. 1996; Breyer 1998; Breyer, Zhang et al. 1998; Breyer and Breyer 2000; 
Breyer and Breyer 2000; Zhang, Guan et al. 2000). Among the wide range of AA 
metabolites, the prostaglandin via cyclooxygenases (COX) path way has been well 
studied for its role in water and Na+ homeostasis in the kidney; the 
Hydroxyeicosatetraenoic acids (HETEs) formed through hydroxylase pathway are 
involved in cell proliferation and migration of vascular smooth muscle cells, suggesting 
contribution to atherosclerosis and may cause vasoconstriction, increased myogenic 
mechanism sensitivity in renal and cerebral arteries; the epoxyeicosatrienoic acids (EETs) 
formed by CYP epoxygenase path way are believed to participate in modulating ion 
transport, gene expression, producing vasorelaxation factors and anti-inflammatory 
effects in cardiovascular system and kidney (Harrison and Cai 2003; Pratt, Medhora et al. 
2004; Imig 2005; Fleming 2007; Gauthier, Yang et al. 2007; Saltin 2007; Spector and 
Norris 2007; Kaspera and Totah 2009; Spector 2009).  
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1.5.3.2 AA metabolites regulate ENaCs 
1.5.3.2.1 Prostaglandins regulate ENaC  
1.5.3.2.1.1 Prostaglandins  
Prostaglandins comprise a diverse family of autocoids derived from 
cyclooxygenases-mediated metabolism of AA to prostaglandin H2, generating five 
primary bioactive prostanoids: PGE2, PGF2α, PGD2, PGI2 and thromboxane A2 (Breyer, 
Bagdassarian et al. 2001; Helliwell, Adams et al. 2004). Each of these prostanoids 
interacts with a unique G protein-coupled receptor (GPCR) (Breyer, Davis et al. 1996). 
The importance of these autacoids to systemic blood pressure and volume control is 
highlighted by the deleterious side effects of cyclooxygenase inhibitors nonsteroidal 
anti-inflammatory drugs (NSAIDs), which may induce hypertension, Na+ retention, and 
oedema, suggesting an antihypertensive role for endogenous prostaglandins (Radi and 
Ostroski 2007). Among the prostanoids that have been well described, PGE2 is the major 
prostaglandin produced along the collecting duct and potently regulates the Na+ and 
water homeostasis in kidney (Machida, Ueda et al. 1988; Teraoka, Takahashi et al. 1989; 
Taub, Wang et al. 1992; Breyer and Breyer 2000; Hebert, Carmosino et al. 2005). The 
maintenance of normal renal blood flow and function during physiological stress is 
especially dependent on endogenous prostaglandin synthesis. Prostaglandins effectively 
buffer the vasoconstrictor effects in kidney to preserving normal renal blood flow, 
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glomerular filtration rate and salt excretion. PGE2 not only dilates the glomerular 
microcirculation, supplying the renal medulla but also modulates salt and water 
transport in the distal tubule. 
1.5.3.2.1.2 PGs regulation through PG receptors 
PGs have multiple effects on epithelial solute and water transport in kidney by 
interaction with the prostaglandin receptors on the cell surface along the nephron; it 
may either stimulate or inhibit solute and water transport. Three distinct effects of 
basolateral PGs on transport have been described(Pitts, Dominguez et al. 1984; 
Boumendil-Podevin and Podevin 1985; Jabs, Zeidel et al. 1989; Ardaillou, Nivez et al. 
1990; Lear, Silva et al. 1990; Hebert, Jacobson et al. 1991; Shimizu, Nakamura et al. 
1993; Kokko, Matsumoto et al. 1994; Kaji, Chase et al. 1996; Guan, Zhang et al. 1998; 
Natochin, Bogolepova et al. 2000; Wegmann and Nusing 2003; Nusing, Treude et al. 
2005): stimulation of basal water absorption; inhibition of vasopressin-stimulated water 
absorption; and inhibition of Na+ absorption. Numerous studies have demonstrated 
that PGE2 directly inhibits solute absorption in in vitro microperfused thick ascending 
limbs, as well as water and solute absorption in the collecting duct. These findings 
provide a cellular basis for the well-described natriuresis and diuresis after acute renal 
PGE2 infusions in intact animals. Tubule microperfusion studies also demonstrate a 
more complex picture, because PGE2 can either increase or decrease water absorption. 
When added to vasopressin-prestimulated collecting ducts, PGE2 potently inhibits 
 42 
water absorption, consistent with the aforementioned in vivo diuretic effects of PGE2 
infusion. However, observations of PGE2 increases osmotic water and Na
+ absorption 
have been reported as well; infusion of PGE2 in glomerular renal filtrate increases Na
+ 
transport and PGE2 augment Na
+ transport in frog skin and in MDCK cells 
(Boumendil-Podevin and Podevin 1985; Jabs, Zeidel et al. 1989; Lear, Silva et al. 1990; 
Kaji, Chase et al. 1996). The controversial effects are generally considered the results of 
the diverse signaling pathways initiated by distinct EP receptors.  
In contrast to classic circulating hormones such as insulin and vasopressin, prostanoids 
act locally on the tissues in which they are synthesized or on the tissues adjacent to 
those in which they are synthesized. Prostaglandin synthesis occurs in all cells and 
tissues, the kidney is a particularly rich source where PGE2 is the major renal metabolite 
and urinary PGE2 concentrations are typically higher than that of the circulating PGE2. 
Thus the kidney is an important biologic target of PGE2 due to its autocrine and 
paracrine action. Nevertheless, PGE2 has multiple effects and under certain 
circumstances, P opposing functional effects on a given target tissue, such as seen in its 
vasodilator and vasoconstrictor effects on different vascular beds. The underlying 
explanation for such controversial PGE2 effects are accounted for by multiple receptor 
subtypes for individual prostaglandins; there are at least three types of EP prostaglandin 
receptors expressed in the kidney. Each receptor has a distinct distribution and appears 
to modulate distinct renal actions.  
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However, another possible explanation is that PGE2 as well as other prostanoids which 
are membrane permeable, may directly cause cellular event without interaction with 
their receptors; for instance, PGs may directly bind to ion channels to alter their 
activities which in turn initiate different cellular responses. In regard of PGs regulating 
water and Na+ reabsorption, epithelial sodium channel may be one of their direct 
targets. The investigation of effects of PGs on ENaC channel could help to understand 
different signaling pathway of prostanoids action. 
1.5.3.2.2 EET may directly regulate ENaC channels 
1.5.3.2.2.1 EETs  
Epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids are formed by CYP 
pathways. Early studies indicated that the EETs produce important biological effects, 
particularly in the vascular and renal systems. EETs are synthesized in the endothelium 
and are believed to function as an endothelium-dependent hyperpolarizing factor 
(EDHF) under certain circumstances. The EDHF effects mediated by EETs are considered 
the result of their abilities to modulate ion channels. EETs are demonstrated to directly 
regulate ion transport by interactions with ion channels. The involvement of EETs in ion 
homeostasis was best demonstrated by their ability to release Ca2+ from aortic smooth 
muscle microsomes. EETs were found to transiently increase intracellular Ca2+ 
concentration in this type of cells by stimulating Ca2+ influx through L-type Ca2+ channels. 
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11,12-EET particularly increase Ca2+ in pig ventricular myocytes. EETs also mediate Ca2+ 
release from intracellular stores in glomerular mesangial cells. Ca2+ mobilization from 
both intracellular store or influx from extracellular fluid has been shown repeatedly to 
occur concurrently with EET-stimulated biological responses, indicating that an increase 
in the cytoplasmic Ca2+ concentration may be a central component of the cellular 
response to EETs. The intracellular Ca2+ elevation mediated by EETs is believed to be the 
basis for their action as an endothelial-derived hyperpolarization factor. EETs mediate 
smooth muscle cell hyperpolarization and vasorelaxation by increasing the open 
probability of large conductance Ca2+ dependent K+ channel (BKCa). This EET-induced 
BKCa activation is thought to be triggered by an EET-mediated increase in intracellular 
Ca2+. The further investigations of interactions between EETs and ion channels revealed 
that EETs may have the potential to mediate the activation of BKCa by directly 
interactions with the channel itself. Patch clamp results demonstrated that EETs were 
able to activate the BKCa channels in cell-free patch clamps, where the Ca
2+ 
concentration is held constant. Therefore, the activation of BKCa under such 
circumstance is not dependent on intracellular Ca2+ or other messengers and cellular 
regulators. However, this elevation could also be caused by the interactions between 
EETs and the channel associated proteins or the cell membrane lipid domains that 
surrounds the channels.  
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1.5.3.2.2.2 EETs and renal Na+ transport  
EETs have been shown to inhibit the amiloride-sensitive ion transport in renal epithelial 
cells and modulate Na+ transport in kidney by regulating the function of 
membrane-bound transport proteins (Escalante, Staudinger et al. 1995; Sakairi, 
Jacobson et al. 1995; Yu, Xu et al. 2000; Wei, Lin et al. 2004; Wei, Sun et al. 2006). 
14,15-EET stimulate Na+/H+ exchanger activity in glomerular messangial cells by 
approximately 40%-60% (Staudinger, Escalante et al. 1994; Escalante, Staudinger et al. 
1995) whereas 5,6-EET inhibits Na+ reabsorption in renal CCD cells. EET inhibits the 
open probability of Na+ channels in rat ventricular myocardium cells by 70%. However, 
in neither case is there enough evidence presented to provide a mechanism by which 
EETs affect Na+ transport. Nevertheless, the observation that the stimulation effects of 
EETs on Na+ transport in rabbit CCD cells pretreated with cyclooxygenase inhibitors were 
completely abolished has led to the speculation that EETs modulate Na+ transport by 
interacting with other factors such as the prostaglandin synthesis pathway (Sakairi, 
Jacobson et al. 1995). The understanding of the effects of EETs on Na+ movement and 
Na+ channel has not been well established.  
The previous studies on EETs regulation over K+, Cl- and Ca2+ channels lead to the 
hypothesis that the overall effects of EETs on Na+ movement in the renal and vascular 
system are partially contributed by the direct interactions between EETs and ENaCs. In 
addition, ENaCs are expressed in vascular endothelium, where EETs are synthesized 
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(Revtyak, Hughes et al. 1988; Carroll, Balazy et al. 1993; Fang, VanRollins et al. 1995; 
Rosolowsky and Campbell 1996) and exert their EDHF actions (Campbell, Gebremedhin 
et al. 1996; Quilley, Fulton et al. 1997; Hoebel, Steyrer et al. 1998; Edwards, Thollon et 
al. 2000; Campbell, Falck et al. 2001; Snyder, Krishna et al. 2002; Archer, Gragasin et al. 
2003; Dhanasekaran, Al-Saghir et al. 2006). The cellular targets of the EDHF effects of 
EETs have been previously summarized as Ca2+ channels and K+ channels; the activation 
of these channels lead to hyperpolarization of smooth muscle cells (Baron, Frieden et al. 
1997; Hayabuchi, Nakaya et al. 1998; Benoit, Renaudon et al. 2001; Ungvari and Koller 
2001; Fleming, Rueben et al. 2007). Nevertheless, the ENaC channel is likely to be 
another cellular target of EETs in vascular endothelium. Thus, the understanding of the 
effects of EETs on ENaC channels will contribute to explain EET action in both the renal 
and vascular system. Furthermore, previous studies indicated that deletion of soluble 
epoxide hydrolase (sEH), the enzyme that converts EETs to dihydroxyeicosatrienoic acids, 
decreased blood pressure in male mice; sEH inhibitors decreased blood pressure in 
hypertensive rats (Yu, Xu et al. 2000; Imig, Zhao et al. 2002; Keseru, Barbosa-Sicard et al. 
2008; Hercule, Schunck et al. 2009). These results suggested a role of EETs in the blood 
pressure control. And it is reasonable to speculate that the overall effects of EETs on 
blood pressure is contributed by not only their known EDHF function, but also their 
regulation over Na+ movement both in kidney and vascular endothelium. 
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1.5.4 Vasopressin regulation of ENaC 
1.5.4.1 Vasopressin is an important regulator of ENaC  
Anti-diuretic hormone (ADH), also known as Vasopressin, is an important regulator of 
Na+ reabsorption, which causes rapid Na+ influx increase in Na+ reabsorbing epithelia. It 
acts by stimulating the apical sodium channels and this action is one important 
constituent of Na+ homeostasis. Vasopressin and its analogues can induce a 2- to 5-fold 
increase in Na+ channel activity within 5-20 minutes. Its effect on Na+ transport is 
similar to that of the aldosterone but happens more rapidly, as the most immediate 
cellular response to vasopressin does not involve transcriptional effects on ENaC 
channel or channel regulatory proteins. The vasopressin effects can also be divided into 
different stages based on the different cellular events; the rapid effect and long-term 
effect. Previous studies indicated that the acute vasopressin-induced Na+ transport 
increase mainly results from accelerated Na+ channel insertion whereas the long-term 
effects mainly depend on increased ENaC channel synthesis, both of which lead to an 
increased ENaC surface expression. The rapid vasopressin effect, which occurs within 
5-20 minutes, does not involve protein transcription and translation, whereas long 
treatment of vasopressin has been reported to markedly increase the expression of β- 
and γ-ENaC and other regulatory protein and mRNA.  In addition, there are also 
reports indicating that vasopressin may enhance ENaC open probability by direct 
phosphorylation of channel proteins.  
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1.5.4.2 The acute vasopressin effects is mediated by cAMP 
Vasopressin binds to basolateral V2 receptor, which activates adenylate cyclase, 
resulting in an increased cellular cAMP, and which in turn accelerates ENaC trafficking 
from intracellular pool to the cell surface, and probably also enhances the channel open 
probability. V2 receptors are found expressed in both the collecting duct and connecting 
tubule of rat, mouse and human. 
Numerous previous studies have clearly demonstrated that vasopressin effects on Na+ 
can be reproduced by membrane permeable cAMP analogues, inhibitors of 
phosphodiesterase and other activators of adenylate cyclase such as forskolin. All these 
observations proved that vasopressin effects are mediated by cAMP. Although 
uncertaintys remain, the mechanism by which cAMP increases ENaC mediated Na+ 
current can be summarized as: cAMP increase the ENaC surface expression by 
facilitating channel trafficking/insertion to cell surface which is responsible for the rapid 
vasopressin effects. In addition cAMP may also enhance ENaC channel open probability, 
which is observed in purified channels such as in lipid bilayers.   
1.5.4.3 The rapid vasopressin effects, cAMP increases ENaC channel trafficking 
The rapid vasopressin induced Na+ transport increase results from an increased ENaC 
surface expression contributed by a cAMP mediated increase in channel 
trafficking/insertion rate.  
Functional studies on Xenopus laevis kidney A6 cells demonstrated that the acute 
activation of Na+ channels by vasopressin depends on intact microtubules and Golgi 
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apparatus. This observation suggests that the vasopressin-induced activation of ENaC is 
caused by enhanced trafficking of channels from an intra-cellular pool to the apical 
plasma membrane. On a coexpression of α-, β-, and γ-ENaC in Fischer rat thyroid 
epithelial cell, cAMP-mediated stimulation of ENaC has been investigated by channel 
modification, protein labeling and electrophysiology measurements; a covalent 
modification of cysteines was introduced into ENaC, which can almost completely and 
irreversibly block the ENaCs that are already inserted in the cell surface without effects 
on the intracellular channels. The rate of the increase in transepithelial current of 
cAMP-treated cells and control cells were measured by a short circuit current technique. 
As all pre-existing ENaC channels were blocked by the modification, the increased 
current was contributed by the newly inserted unmodified ENaC channels at the cell 
surface. The cAMP treated cells clearly displayed a higher rate of current increase 
compared to that of the control cells, which indicates a higher rate of channel insertion 
induced by cAMP. The protein labeling method also confirmed the same conclusion. 
More direct evidence was provided by a combination of antibody detection of ENaC and 
short circuit current measurements on MDCK cells expressed with ENaC; the increase in 
transepithelial current is proportional to the increase in surface density of ENaC 
induced cAMP. Cell surface biotinylation of endogenous ENaC on mpkCCD cells further 
confirmed the model in which the acute ENaC stimulation by cAMP results from an 
accelerated ENaC insertion from intracellular pool. However, despite all in vitro 
evidence, evidence that vasopressin increase the ENaC surface abundance in vivo is still 
lacking.    
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1.5.4.4 Long-term vasopressin effects 
The long-term vasopressin effect is distinguished by its transcriptional effects on ENaC 
and ENaC regulatory proteins. Long-treatment with vasopressin or its analogue 
markedly increased the expression of β-, and γ-ENaC in a rat cortical colleting duct cell 
line and in rat kidneys. This effect is thought to account for the increase of Na+ transport 
occurring in these cells since the enhanced trafficking of channel molecules to the cell 
surface does not appear to be related to the long-term vasopressin stimulation; in 
DDAVP (a synthetic vasopressin analogue) treated connecting tubule and collecting duct 
cells, immunohistochemistry revealed that the induction of β-, and γ-ENaC led to an 
intracellular accumulation of the channel subunits without detectable change in the cell 
surface abundance of ENaC subunits. However, the role of enhanced channel trafficking 
in long-term vasopressin effects remains uncertain. 
1.5.4.5 Overview of the vasopressin effects 
The vasopressin effect is similar to that of the aldosterone, but occurs much more 
rapidly, which indicates that it may compose the most immediate step in the renal 
regulation over Na+ reabsorption.  
 
1.5.5 Regulation of ENaC by insulin 
The stimulating effect of insulin on ENaC-mediated renal Na+ reabsorption exhibits a 
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high similarity to that of the aldosterone. In cultured renal epithelial cells, both 
aldosterone and insulin have been shown to increase the phosphorylation of the COOH 
terminal ends of all the ENaC subunits. The aldosterone induced protein SGK is thought 
to be the integrator of the aldosterone and insulin stimulation effect. In this 
hypothesized mechanism, aldosterone regulates the SGK abundance; insulin regulates 
the SGK activity. 
 
As described in the section on aldosterone’s action, one of the transcriptional effects of 
aldosterone is the increase of SGK expression. Subsequently, SGK decreases the removal 
of ENaC channel from cell surface by phosphorylating the Nedd4, which acts as a 
channel ubiquitin ligase. Importantly, SGK must be phosphorylated at two residues to 
have its kinase activity. This phosphorylation occurs through the PI3K pathway; 
inhibitors of the PI3K pathway prevented SGK from phosphrylating a peptide substrate 
thus abolishing the aldosterone-induced increase in Na current in A6 cells. In distal 
nephron epithelial cells, PI3K pathway can be activated by insulin receptors. Thus it has 
been proposed that SGK might integrate signals from aldosterone and insulin to 
regulate epithelial Na+ absorption. 
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1.5.6 Regulation of ENaC by proteases 
1.5.6.1 Proteases are involved in the activation of ENaC 
Proteases are involved in the processing and activation of ENaC. Current evidence 
indicates that proteases contribute to ENaC regulation by cleaving specific sites in the 
channel subunits both along their biosynthetic pathway and at the cell surface. The 
regulation of ENaC by proteolytic processing is an important and complex mechanism. 
1.5.6.2 Extracellular channel activating-proteases  
Membrane-anchored channel-activating proteases (CAPs) with extracellular proteolytic 
activity were first identified using the Xenopus laevis oocytes expression system and 
were shown to activate ENaC when coexpressed with the channel. Electrophysiological 
studies in the Xenopus laevis oocytes expression system clearly demonstrated a large 
and rapid stimulatory effect of extracellularly applied trypsin and chymotrypsin on ENaC 
activity. Various membrane-bound or secreted proteases such as CAPs are likely to exist 
in ENaC-expressing epithelia and are thought to act on the extracellular domain of the 
channel after its surface insertion or act on the channel regulatory proteins.  
There are many candidates of endogenous ENaC-activating protease in ENaC regulation 
in mammals. One attractive candidate, prostasin, the mammalian homologue of 
Xenopus CAP1, is expressed in the kidney and cultured collecting duct cells and its 
expression appears to be regulated by aldosterone. However, the prostasin is practically 
inactive due to the urine pH and may act indirectly by altering the activity of 
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downstream proteases. Another candidate is tissue kallikrein which recently has been 
reported to be involved in ENaC processing in the kidney. Tissue kallikrein is synthesized 
in large amounts in the connecting tubule and released into the urine, and act on ENAC 
either directly on the extracellular channel domain or indirectly by activating other 
proteases. Also, tissue kallikrein synthesis and release in connecting tubule is subject to 
aldosterone regulation. However, tissue kallikrein failed to activate ENaC heterologously 
expressed in Xenopus laevis oocytes and renal ENaC cleavage is preserved in a 
kallikrein-deficient mice. Extracellularly applied trypsin demonstrated a markedly 
stimulating effect on ENaC probability as well. In addition, trypsin also has been 
reported to indirectly stimulate ENaC channel by activating G-proteins. These findings 
all suggest that ENaC regulation by proteases is complex. 
1.5.6.3 Intracellular channel-activating proteases 
Candidates for intracellular ENaC activating proteases include furin and other 
Golgi-associated convertases, the proteolytic cleavage by which is thought to be 
important in the maturation of ENaC in the biosynthetic pathway. Western bolt analysis 
of a range of ENaC expressing cells and tissues has revealed the presence of distinct 
ENaC cleavage products in particular of the α- and γ- subunit. However, the presence of 
uncleaved ENaC subunits in the plasma membrane suggests that this cleavage is not a 
prerequisite for channel synthesis and trafficking.  
 54 
1.5.6.4 Overview of ENaC regulation by proteases 
Although the precise molecular mechanism of proteolytic channel activation remains 
unclear, the overall result of proteases action can by summarized as, proteolytic 
cleavage may cause a conformational change of the channel favoring its open-state.  
1.6 ENaCs is suggested to be mechano-sensitive 
1.6.1 Machano-sensitivity of ENaC implied by the homology between DEG subunits 
and ENaC subunits  
Specific members of the degenerin/epithelial Na+ channel (DEG/ENaC) family of ion 
channels are activated by mechanical stimuli. DEG subunits MEC-4 and MEC-10 form 
the core of MEC channel complex, which is believed to be the machano-transducer ion 
channel in C. elegans touch receptor neurons (Barr and Sternberg 1999; Barr, 
DeModena et al. 2001; Yoder, Hou et al. 2002; Nauli, Alenghat et al. 2003). Genetic and 
molecular data support a model of the mechano transducer in C. elegans in which DEG 
subunits MEC-4 and MEC-10 compose the core of the channel complex. The most direct 
evidence that the MEC channel is gated by mechanical forces has come from studies 
employing intracellular Ca2+ concentration measurements (Suzuki, Kerr et al. 2003). This 
set of experiments clearly demonstrated that the MEC channel is specifically required 
for responses to gentle touch and not for general function of touch neurons. A transient 
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rise in intracellular Ca2+ concentration is observed in touch neurons of C. elegans that 
are mechanically stimulated, whereas this Ca2+ rise is absent in Mec-4 and Mec-2 
mutants, suggesting that the MEC channel is indeed needed for cellular responses to 
gentle touch. Although DEG and ENaC channels participate in strikingly diverse 
biological processes and are activated in response to markedly distinct stimuli the 
overall secondary structure of channel subunits encoded by this gene superfamily is 
highly conserved. DEG and ENaC subunits range from about 500 to 1,000 amino acids in 
length and share several distinguishing blocks of sequence similarity (Canessa, Schild et 
al. 1994; Adams, Snyder et al. 1997; Firsov, Gautschi et al. 1998; Eskandari, Snyder et al. 
1999). Their subunit topology is invariable: all members of the DEG and ENaC subfamily 
have two membrane-spanning domains with Cysteine-rich domains (CRDs, the most 
conserved is designated CRD3) situated between the transmembrane segments. N- and 
C-termini project into the intracellular cytoplasm, whereas most of the protein, 
including the CRDs, is extracellular. Based on the homology of the members of the 
DEG/ENaC family, it has been suggested that ENaC is also a mechano-sensitive channel. 
1.6.2 Machano-sensitivity of ENaC implied by reconstitution in bilayers and 
expression system  
1.6.2.1 Reconstituted ENaC in bilayers 
Initial reports regarding the role of ENaC in mechanosensation is from reconstitution of 
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the ENaCs in planar lipid bilayers. ENaC subunits (α-, β-, and γ-ENaCs) have been cloned 
from bovine renal epithelial channel and reconstituted to form the core conductive unit 
of Na+-selective, amiloride-sensitive channels in planar lipid bilayers. The re-built 
channel displayed voltage-independence and amiloride-sensitivity consistent with the 
biophysical characterizations of ENaCs and exhibited mechano-sensitivity in which the 
single-channel open probability was maximally activated with a hydrostatic pressure 
gradient (Awayda, Ismailov et al. 1995; Ismailov, Berdiev et al. 1997; Jovov, Tousson et al. 
1999; Berdiev and Benos 2006). With the use of a rabbit nuclease-treated in vitro 
translation system, mRNA coding for α-ENaC was translated and the polypeptide 
products were reconstituted into liposomes. On incorporation into planar lipid bilayers, 
in vitro-translated α-ENaC protein 1) displayed voltage-independent Na+ channel 
activity with a single-channel conductance of 40 pS, 2) exhibited mechano-sensitivity in 
that the single-channel open probability was maximally activated with a hydrostatic 
pressure gradient of 0.26 mmHg across the bilayers, 3) was blocked by low 
concentrations of amiloride. This observation of stretch activation of alpha-ENaC was 
confirmed in dual electrode recordings of heterologously expressed α-ENaC whole cell 
currents in Xenopus oocytes swelled by the injection of 15nl of a 100mM KCl solution. 
Another set of experiments of reconstituted ENaC channel in lipid bilayers also 
displayed mechano-sensitivity. Hydrostatic pressure gradient across bilayers increased 
channel open probability by five-fold without effects on channel unitary conductance 
(Ismailov, Berdiev et al. 1997).  
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1.6.2.2 ENaC in cell expression system 
ENaC subunit (α-rENaC) has been cloned and transfected into LM cells, a null cell for 
stretch-activated channels. The ENaCs expressed in LM cells exhibited stretch-activation 
(Kizer, Guo et al. 1997).  A cDNA clone was obtained of the entire coding region of rat 
α-rENaC (α-rENaC). The α-rENaC cDNA was cloned into an expression plasmid and 
transfected into LM (TK2) cells, a null cell for SA-CAT activity. The channel is only 
activated when negative pressure is applied during cell-attached patches, cell swelling, 
or patch excision. The open probability (Po) of the reconstituted channels was increased 
in a graded manner with increased negative pressure on the pipette. Po was increased 
by a maximum of 0.39 at 280 mmHg. After observing stretch-activated ion channels in a 
cell attached patch, the patch was excised to the inside-out configuration and subjected 
to asymmetrical solutions so current–voltage (I–V) plots could be constructed to 
determine the ion selectivity of the channels. Expressed α-rENaC channels had a 
conductance of approximate 24.2pS when activated in symmetrical NaCl Ringer’s 
solutions. These results provided evidence that ENaC is mechano-sensitive and implied 
the potential role of ENaC channels in mechano-signal transduction (Kizer, Guo et al. 
1997). 
ENaC has also clearly demonstrated its mechano-activation in Xenopus Oocytes 
(Awayda, Ismailov et al. 1995). Xenopus laevis oocytes injected with α-, β-, and 
γ-mENaCs cRNA were examined by using a two-electrode voltage clamp and was 
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measured by whole-cell as well as single-channel recordings. The application of 
physiologically relevant ranges of laminar shear stress produced a significant increase in 
channel open probability without effects on channel conductance and channel density 
on the membrane surface. Flow activated whole cell Na+ currents in oocytes expressing 
α-, β-, and γ--mENaC. In the absence of perfusion, the whole cell Na+ current was 
10.0µA. Initiating bath flow from 0 (no flow) to the range of 4–6 ml/min led to a 
increase in amiloride-sensitive Na+ current. Amiloride-sensitive Na+ currents were not 
observed in water-injected oocytes either in the absence or presence of flow. However, 
it was difficult to establish a dose-response relationship (flow rate vs. flow-induced 
current) with the oocytes expression system due to the fact that the maximal increase 
in Na+ current in response to flow was quite variable. Flow-mediated increases in Na+ 
current were observed within 1 min after initiation of oocytes perfusion and reached a 
plateau within 3–5 min. Flow activation of the sodium current was reversible, as current 
fell when the flow was stopped. Flow activation of Na+ current was not associated with 
a significant change in the resting membrane potential of the oocyte(Satlin, Sheng et al. 
2001). Cells are potentially exposed to a variety of mechanical forces including 
indentations, circumferential stretch, high frequency vibrations, osmotic pressure 
gradients, hydrostatic pressure, and fluid shear stress.  
1.6.3 Mechano-sensitivity of ENaC implied by Native ENaC in distal nephron 
Similar to vascular endothelial cells, epithelial cells in the distal nephron are also 
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exposed to a variety of mechanical forces including indentations, circumferential stretch, 
osmotic pressure gradients, hydrostatic pressure and fluid shear stress (Hamill and 
Martinac 2001). In the kidney, frictional forces of the ultra-filtrate flowing through 
tubules regulate the vectorial transport of glucose (Garvin 1990), chloride (Garvin 1990) 
magnesium (Wong, Berry et al. 1995), K+ (Giebisch 1998) (Kunau, Webb et al. 1974; 
Woda, Bragin et al. 2001), Na+ (Grantham, Kurg et al. 1970; Stoner, Burg et al. 1974; 
Engbretson and Stoner 1987; Satlin, Sheng et al. 2001), the organization of the 
cytoskeleton, the synthesis of matrix proteases, and the activity of specific transcription 
factors(Essig and Friedlander 2003). 
ENaCs expressed in distal nephron segments are subjected to physiological variations in 
tubular flow rate. Increasing the rate of perfusion of isolated rabbit CCDs within a 
physiologically relevant range increased net Na reabsorption via an amiloride-sensitive 
pathway, suggesting that ENaCs within the CCD are activated in response to increases in 
tubular flow rates (Engbretson and Stoner 1987; Satlin, Sheng et al. 2001; Woda, Leite 
et al. 2002; Woda, Miyawaki et al. 2003).  
The Na+ transport in rabbit cortical collecting duct were examined to verify the effects 
of flow on Na+ channels flow (Satlin, Sheng et al. 2001; Morimoto, Liu et al. 2006). 
Single cortical collecting duct was perfused by increasing flow rates and the rates of net 
Na+ absorption were measured. The rate of net Na+ absorption increased significantly as 
flow rate was increased. 0.1mM amiloride added to the luminal perfusate significantly 
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inhibited net Na+ absorption compared with transport rates measured at comparable 
flow rates in the absence of the inhibitor. In addition, net Na+ absorption in the CCD 
reflects the sum of opposing processes of Na+ absorption and secretion. To determine 
whether a flow-induced reduction in bath-to-lumen Na+ backflow into the lumen could 
account for the flow stimulation of net Na+ absorption, net Na+ transport was measured 
in a group of CCDs perfused with a slightly hypotonic 0-Na+ perfusate containing 
amiloride and bathed in Burg’s solution. These selected conditions were used to inhibit 
lumen-to-bath and maximize bath-to-lumen transepithelial Na+ transport. However, an 
increase in flow rate under this condition led to no significant change (Morimoto, Liu et 
al. 2006). 
 
1.7 The potential role of endothelial ENaCs 
1.7.1 Endothelial cells, shear force and mechano-sensitive channels 
Endothelial cells are constantly exposed to a variety of mechanical forces such as 
pressure created by the hydrostatic forces of blood within the blood vessel, which is 
applied perpendicularly against the endothelial cells; circumferential stretch or tension, 
created as a result of defined intercellular connections between the endothelial cells 
that exert longitudinal forces on the cell during vasomotion; and shear stress, the 
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dragging frictional force produced by blood flow, which is applied tangential to the 
apical membrane of endothelial cells. Shear stress has been demonstrated to play 
important roles in physiological processes such as cell growth, differentiation, 
remodeling, metabolism, morphology, and gene expression. The blood pressure has 
also been implicated to cause both endothelium-derived vasoconstriction and 
vasodilatation. Numerous studies suggest that endothelial cells can detect these 
mechanical forces produced by blood flow and consequently modulate the tone of 
vascular smooth muscle cells, which in turn controls blood pressure and blood flow by 
adjusting the caliber of arteries and arterioles.  
Endothelial mechano-sensitive ion channels represent one of the earliest responses in 
mechanical signal transduction. Mechano-sensitive ion channels function as 
transducers that respond to mechanical stimuli by changing the permeability of the 
membrane to specific ions. Mechano-sensitive ion channels in endothelial cells 
represent the most immediate cellular response to fluid flow and these responses 
happen in seconds and minutes (Olesen, Clapham et al. 1988; Barakat, Leaver et al. 
1999; Nakao, Ono et al. 1999; Marchenko and Sage 2000). In other words, the virtually 
immediate endothelial response to shear stress is the activation of flow-sensitive ion 
channels. Therefore, mechano-sensitive ion channels in endothelial cells are 
hypothesized to play a role in shear stress sensing and transduction. Several types of ion 
channels have been suggested to mediate the initial shear force signaling events, 
including stretch-activated cation channels, P2X4, TRPM7, TRPV, TRPC, K+ channels, Ca2+ 
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activated Cl- channels and volume-regulated anion channels (VRACs) (Olesen, Clapham 
et al. 1988; Olesen, Davies et al. 1988; Rossitti, Frangos et al. 1995; Nilius, Viana et al. 
1997; Traub and Berk 1998; Nakao, Ono et al. 1999; Marchenko and Sage 2000; Nilius 
and Droogmans 2001). The activations of shear force sensitive ion channels eventually 
lead to alterations of membrane potential with or without [Ca2+]i elevation(Folgering, 
Sharif-Naeini et al. 2008). 
1.7.2 ENaC is a potential candidate of mechano-sensitive ion channels 
ENaC are expressed in ECs.  
ENaC mRNA and proteins have been recently identified in vascular endothelial cells 
including the human vascular endothelial cell line (ECV) (Golestaneh, Klein et al. 2001), 
human umbilical vein endothelial cells (Kusche-Vihrog, Sobczak et al. 2008) and bovine 
aortic endothelial cell line (BAEC). PCR analysis followed by sequence alignment 
demonstrated that both the mineralocorticoid receptor (MCR) and the epithelial 
sodium channel (ENaC) genes are expressed in the human vascular endothelial cell line 
(ECV). The growth and multiplication of the ECV in culture were influenced by both 
aldosterone and the MCR-specific antagonist ZK 91587. The PCR analysis of the total 
RNA from exponential HBMEC cultures was used to screen for the possible expression 
of ENaC at the level of mRNA. ENaC also has been described in the human bone marrow 
endothelial cells (HBMEC) (Chen, Valamanesh et al. 2004). The PCR analysis of the total 
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RNA from exponential HBMEC cultures revealed that ENaC mRNA and DNA are 
expressed in this type of cells. In addition, ENaC has been recently identified in human 
umbilical vein endothelial cells (Kusche-Vihrog, Sobczak et al. 2008). However, their 
function and regulation in vascular endothelial cells are poorly understood. 
Recent reports suggest that ENaC are required for myogenic vasoconstriction.  
Myogenic vasoconstriction is an intrinsic property of most resistance vessels 
characterized by a decrease in luminal diameter in response to an increase in 
intraluminal pressure. The response is important in establishing basal vascular tone and 
maintaining blood flow autoregulation. And ENaCs are required for myogenic 
vasoconstriction in mouse interlobar arteries (Jernigan and Drummond 2005), thus 
ENaC proteins may be components of mechano-sensitive complexes in the vascular 
system including both endothelial cells and smooth muscle cells. Selective DEG/ENaC 
inhibition by low doses of amiloride and benzamil abolishes pressure-induced vessel 
constriction and increases cytosolic Ca2+ and Na+ without diminishing agonist-induced 
responses in isolated mouse interlobar arteries. Under control conditions, mouse 
interlobar arteries constricted in response to an increase in intraluminal pressure in a 
pressure-dependent manner, whereas both low dose amiloride and benzamil inhibited 
the development of myogenic tone by preventing active vaso-constriction. Resistance 
vessels crossing many vascular beds respond to increases in blood pressure by 
vaso-constriction, a mechanism important for maintaining blood flow autoregulation. 
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This response is initiated by conversion of a mechanical stimulus into a cellular event 
such as membrane potential depolarization and is independent of neural, metabolic, 
and hormonal vasoactive factors. This observation that ENaC are required for myogenic 
vasoconstriction in mouse interlobar arteries has further permited the speculation that 
ENaC may function as mechano-sensitive ion channels in the vascular system, which 
initiates pressure induced contraction by depolarizing the cell membrane potential, 
which in turn activates voltage-gated Ca2+ channels. 
1.8 Other important cellular pahways  
1.8.1 Na+ /Ca2+ exchanger (NCX) 
The NCX family belongs to the super family of membrane proteins, which exchanges 
three Na+ ions for one Ca2+ ion or four Na+ ions for one Ca2+ ion depending on 
intracellular Na+ concentrations ([Na+]i) and intracellular Ca
2+ concentrations ([Ca2+]i) 
(DiPolo, 1979; Hilgemann et al., 1992). In resting excitable cells, when [Ca2+]i rise and 
the cells require the return of [Ca2+]i to resting levels (Salvaterra et al., 1989), this 
exchange transport mechanism couples the uphill extrusion of Ca2+ to the influx of Na+ 
ions into the cells down their electrochemical gradient. This mode of operation, defined 
as forward mode (Wang et al., 2000), which keeps the 104-fold difference in Ca2+ 
concentrations across the cell membrane. In contrast, in other physiological 
circumstances, when [Na+]i rise or membrane depolarization occurs, thus reducing the 
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trans-membrane Na+ electrochemical gradient, the NCX mediates the extrusion of [Na+]i 
and the influx of Ca2+ ions. This mode of operation is defined as reverse mode (Wang et 
al., 2000). Furthermore, submicromolar concentrations (0.1–0.3 µM) of intracellular 
Ca2+ could activate the antiporter (Robertson et al., 2000b). This regulatory function of 
low micromolar Ca2+ is more evident when the NCX is working in the reverse mode. 
1.8.2 Ca2+-activated K+ channel 
K+ channels can be activated by several factors. One such class of K+ channels is 
Ca2+-activated K+ channels, whose gating is mediated by the rise of intracellular 
concentration of free Ca2+ ions. Three broad categories of Ca2+-activated K+ channels 
have been identified and classified according to their conductance and are called 
large-conductance, 100–300 pS (BKCa) (Marty 1981), intermediate-conductance, 25–100 
pS (IKCa) (Ishii, Silvia et al. 1997; Logsdon, Kang et al. 1997), and small-conductance, 
2–25 pS (SKCa) Ca
2+-activated K+ channels (Blatz and Magleby 1986). Among them, BKCa 
channels were first studied in smooth muscle cells where they are the key players in 
setting the contractile tone. 
BKCa channels from vascular smooth muscle are multimeric complexes, which consist of 
2 distinct subunits: pore-forming subunit α and regulatory subunit β, which are 
arranged in a 1:1 stoichiometry (Knaus, Folander et al. 1994; Knaus, McManus et al. 
1994; Toro, Wallner et al. 1998). Each channel exists as a tetramer, composed of 4 
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α-subunits either alone or in association with β-subunit pairs, which could change 
physiological properties of the channel (Garcia-Calvo, Knaus et al. 1994; Shen, Lagrutta 
et al. 1994; McManus, Helms et al. 1995); for example, α –subunit splice variants and 
association with β1 subunit give rise to diverse electrophysiological phenotypes of the 
channel.  
BK channel activity is highly regulated by its molecular composition. The α-subunit 
consists of 7 trans-membrane spanning domains (S0–S6) at the N-terminus, the P-loop 
(or the pore-forming loop) between the S5 and S6 domains, the four hydrophobic 
segments (S7–S10) at the large intracellular carboxyl (C) terminus. Acidic residues in the 
S2 domain (Seoh, Sigg et al. 1996) and S3 domain (Papazian, Shao et al. 1995) along 
with basic residues (Arg) at every third position in the S4 domain (Papazian, Timpe et al. 
1991) confer voltage sensitivity to the channel (act as voltage sensor). Ca2+ regulatory 
domain(s) are complex and not simple linear structures. Although the hypothesis has 
been formed from the results of gene mutation, for example, when the regulator of 
conductance for the K+ domain (RCK) (Jiang, Lee et al. 2002; Xia, Zeng et al. 2002) 
mutated together with mutation of the Ca2+ bowl, which located just before S10, 
practically abolish BKCa physiological regulation by Ca
2+; recent evidence suggests that 
neither the Ca2+ bowl nor the RCK domain is necessary for Ca2+ activation of BKCa 
channels (Piskorowski and Aldrich 2002). At this point, I can only state that BKCa 
channels probably have several Ca2+-binding sites with complex 3D structure that 
regulate channel activity. Nonetheless, they are activated both by elevated cytosolic 
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Ca2+ levels and by membrane depolarization. Quite surprisingly, these channels can 
open even in the absence of Ca2+ or voltage activation (voltage less than -80mV) 
(Horrigan and Aldrich 2002) and it is thought that the Ca2+ and membrane potential 
dependence of the channels are independent of each other, both of which can enhance 
the channels’ open probability (Pallotta 1985). 
1.8.3 Heme oxygenase and oxygen metabolic pathway 
1.8.3.1 Heme oxygenase 
Heme 0xygenase (HO) activity serves an essential metabolic function as the rate-limiting 
step in heme degradation (Tenhunen, Marver et al. 1969; Tenhunen, Marver et al. 1969; 
Tenhunen, Marver et al. 1970; Tenhunen, Ross et al. 1970). The diverse physiological 
roles of HO have been invistigated in basic research fields including molecular cell 
biology, genetics and pharmacology and also in clinical sciences such as pulmonology 
(Lee, Alam et al. 1996; Mumby, Upton et al. 2004; Hoetzel, Leitz et al. 2006; Hoetzel, 
Dolinay et al. 2008), cardiology(Vulapalli, Chen et al. 2002; Liu, Pachori et al. 2006), 
exercise physiology (Sato, Balla et al. 2001; Thompson, Basu-Modak et al. 2005), and 
transplant immunology (Sato, Balla et al. 2001; Akamatsu, Haga et al. 2004). There are 
three isoforms of HO: HO-1, HO-2 and HO3, among which the HO-2 is constantly 
produced and HO-1 is highly inducible as a stress response protein and critical mediator 
of cellular homeostasis (Applegate, Luscher et al. 1991; Vulapalli, Chen et al. 2002). 
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HO-1 and HO-2 catalyze heme degradation by cleaving heme-b at the α-methene bridge 
carbon, to generate carbon monoxide (CO), biliverdin, and ferrous iron (Tenhunen, 
Marver et al. 1969; Tenhunen, Marver et al. 1969). The reaction requires molecular 
oxygen as well as reducing equivalents from NADPH cytochrome p450 reductase. The 
expression of HO-1 occurs at low levels in most tissues under physiologic conditions 
except in the spleen, the site of erythrocyte hemoglobin turnover. HO-2 is constitutively 
expressed under basal conditions in most tissues. 
1.8.3.2 The physiology role of HO-1 
HO-1 has been suggested to play a very important role in homeostasis and tissue 
protection. The central role of HO-1 in vascular and tissue homeostasis is exemplified by 
HO-1 deficiency in both human (Kawashima, Oda et al. 2002) and experiment animals. 
Analysis of HO-1 gene deleted mice indicated that HO-1 is an important molecule in 
systemic responses to stress and iron homeostasis (Poss and Tonegawa 1997; Poss and 
Tonegawa 1997; Zakhary, Poss et al. 1997). The protective role of HO-1 in injury and 
disease is suggested by the phenotypic studies of HO-1 deletion mice since endothelial 
cells derived from HO-1 deficient mice are more susceptible to cytotoxicity induced by 
pro-oxidant stimuli, such as heme or hydrogen peroxide, and produce more intracellular 
reactive oxygen species (ROS) when challenged with such stimuli(Poss and Tonegawa 
1997).  Furthermore, the HO-1 deficiency mice also displayed increased mortality 
during pulmonary(Fujita, Toda et al. 2001) and renal ischemia/reperfusion (I/R) injury, 
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suggesting the protection role of HO-1 against oxidative stress (Zhang, Bedard et al. 
2002; Shen, Ke et al. 2003; Di Filippo, Marfella et al. 2005; Tsuchihashi, Zhai et al. 2005; 
Feitoza, Goncalves et al. 2007).  
1.8.3.3 CO 
CO, the byproduct of heme degradation, has been demonstrated to have many 
important physiological roles including anti-apoptosis, anti-inflammation and 
anti-proliferation. When applied at low concentrations, CO can influence a number of 
signaling pathways in cultured cells, including those regulated by soluble guanylate 
cyclase and Mitogen-activated protein kinases (MAPK). At a cellular level, CO can 
stimulate guanylate cyclase to increase the production of cGMP, which has been 
demonstrated in vascular smooth muscle cells (Morita, Perrella et al. 1995). CO 
treatment can modulate the activation of MAPK pathways that are critical for cellular 
signal transduction in response to stress and inflammation. The MAPK signaling 
pathway has been implicated in the anti-inflammatory, anti-apoptosis and 
anti-proliferation. 
Accumulating experimental evidences suggest that CO confers tissue protection in 
preclinical animal models of injury and disease. These models include acute lung injury, 
vascular injury, pulmonary hypertension, liver injury, organ I/R injury, organ 
transplantation, and numerous others. In specialized applications, CO inhibited the 
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tissue injury during mechanical ventilation in mice, by reducing inflammation and 
preventing alveolo-capillary barrier dysfunction (Dolinay, Szilasi et al. 2004; Hoetzel, 
Dolinay et al. 2008; Hoetzel, Schmidt et al. 2009). Low concentration CO can reverse 
established pulmonary hypertension in rats, induced by chronic hypoxia or 
monocrotaline administration. All these previous results suggest CO as potential 
therapies for human disease. 
1.9 Hypothesis and aims 
1.9.1 Hypotheses 
We hypothesized that AA and its metabolites, namely EETs and PGs, in addition to their 
regulation of Na+ reabsorption through cellular receptors, may direct affect channel 
activity.  
We also aimed to identify the possible oxygen regulation pathway. In this study, we 
propose that HO mediated heme degeneration reaction, in which the HO-1 acts as 
oxygen sensor may serve as one of the oxygen regulation mechanism.  
We hypothesized that ENaCs are mechano-sensitive and endothelial-expressed ENaCs 
may serve as mechano-transducing ion channels.  
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1.9.2 Specific aims 
To verify the proposed hypotheses, the flowing specific objects were investigated 
1.9.2.1 Determine the direct effects of AA on ENaC activity 
The results of this investigation were demonstrated and discussed in chapter 3 with 
more detailed discussions in chapter 7. 
1.9.2.2 Determine the direct effects of prostaglandins on ENaC activity 
The results of this investigation were demonstrated and discussed in chapter 3 with 
more detailed discussions in chapter 7. 
1.9.2.3 Determine the direct effects of EETs on ENaC activity  
The results of this investigation were demonstrated and discussed in chapter 3 with 
more detailed discussions in chapter 7. 
1.9.2.4 Verify the possible oxygen sensitive regulation pathway of ENaCs that 
underlines the impact of hypoxia on renal Na+ transport 
The results of this investigation were demonstrated and discussed in chapter 4 and 
chapter 6 with more detailed discussions in chapter 7. 
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1.9.2.5 Determine whether ENaCs are able to sense machano-stimulation 
The results of this investigation were demonstrated and discussed in chapter 6 with 
more detailed discussions in chapter 7. 
1.9.2.6 Determine the ENaC expression in vascular ECs  
The results of this investigation were demonstrated and discussed in chapter 5 and 
chapter 6 with more detailed discussions in chapter 7. 
1.9.2.7 Determine whether ENaCs expressed in vascular ECs are functional 
The results of this investigation were demonstrated and discussed in chapter 5 and 
chapter 6 with more detailed discussions in chapter 7. 
1.9.2.8 Investigate the characterizations of endothelial expressed ENaC and potential 
regulation mechanisms 
The results of this investigation were demonstrated and discussed in chapter 5 and 
chapter 6 with more detailed discussions in chapter 7. 
1.9.2.9 Determine the effects of proposed intracellular inhibitory molecules on ENaC 
in ECs in vitro 
The results of this investigation were demonstrated and discussed in chapter 4, chapter 
5 and chapter 6 with more detailed discussions in chapter 7. 
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1.9.2.10 verify the hypothesis that removing or neutralizing the intracellular inhibitors 
restores ENaC activity 
The results of this investigation were demonstrated and discussed chapter 6 with more 
detailed discussions in chapter 7. 
1.9.2.11 Verify the hypothesis that after channel activity is restored, ENaC is able to 
mediate cellular response to mechano-stimulation such as shear force 
The results of this investigation were demonstrated and discussed in chapter 6 with 
more detailed discussions in chapter 7. 
1.9.2.12 Identify the possible endogenous factors that are able to remove or 
neutralize the intracellular inhibitory factors 
The results of this investigation were demonstrated and discussed in chapter 6 and 
chapter 7 with more detailed discussions in chapter 7. 
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Chapter 2 
 
General Materials and Methods 
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2.1. Cell culture 
2.1.1 M1 cells  
Mouse kidney cortical collecting duct cells (M1) were purchased from the European 
Collection of Cell Cultures. Cells were grown in a medium containing DMEM: Ham’s F12 
medium (1;1) (Sigma), 2 mM glutamine (Gibco), 5 µM dexamethasone (Sigma) and 5% 
FBS (Sigma) in a 5% CO2 and 37ºC incubator. M1 cells were maintained as follows: the 
Culture medium was changed to freshly supplemented Medium every 4-5 days until the 
cells were approximately 80% confluent. Subcultures were performed when the cells 
reached 80% confluence. 1.5 µM aldosterone (Sigma) was added into the culture 
medium 24 hours before the experiments to stimulate cells. When cells reached 70% 
confluence, cells were seeded in a low density approximately 40%-60% to either the 
coverslip or the culture inserts (BD).  
2.1.2 HMEC cells 
Human dermal microvascular endothelial cells (HMEC) and primary cultured human 
dermal microvascular endothelial cells (pHMEC) were kindly provided by Prof A Ahmed 
(University of Birmingham, UK). pHMECs were used within five passages.  The culture 
medium contains both basal culture midia and supplement.  
Subculture: Subcultures were performed when the cells reached 80% confluence. 
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Remove all of the old culture medium from the flask. Add 3ml of PBS solution and 
incubate for 2 minutes. After remove the PBS, add 2-3ml trypsin/EDTA solution to the 
flask and make sure the entire bottom surface is covered. Trypsin incubation should not 
last longer than 3 minutes. When 90% of the cells are rounded up, rap the flask very 
gently to dislodge cells from the surface of the flask. Add culture medium to the flask at 
a ratio of 2:1 (culture medium/trypsin) to neutralize the trypsin. Harvest the mixture 
and centrifuge at 200g for 5 minutes to pellet the cells. Remove the supernatant from 
the tube and then re-suspend cell. The cell pellet is diluted and seeded on coverslips or 
culture flasks. The density of seeding on coverslips varies depend on experimental need 
but for culture purpose, 2500-5000 cell per cm2 is desired.  
Maintainece: the Culture medium was changed to freshly supplemented Medium every 
48 to 72 hours until the HMEC cells were approximately 80% confluent. The fresh 
culture medium is required to be warmed to 37oC before replacing the old medium. 
2.1.3 HUVEC  
Primary cultured HUVEC cells, culture media and stimulatory supplement were 
purchased from Lonza and Promocell.  
Subculture: The cells were seeded at a density of 2500 to 5000 cells/cm2. The mixture 
of culture media was added into culture flask at a rate of 1mL/5cm2. Minimum of 30 
minutes equilibrium time of the culture media in 5% CO2 humidified incubator was 
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required.  
Subculture was immediately performed when the cell confluence reached to 80%. For 
each 25cm2 of cells to be subcultured, 5ml of PBS buffer solution, 3ml of EDTA, and 2ml 
of EDTA/trypsin solution were applied. After incubation with PBS and EDTA solution, 
cells were covered by 2ml of trypsin/EDTA solution in the 25cm2 flask for not longer 2 
minutes. When 90% of the cells were rounded up, a gentle shock is required to apply to 
the bottom of the flask to release the majority of cells from the culture surface. A 
seconde shock was applied after 30 seconds If only a few cells were detached. I 
neutralize the trypsin by culture media at a ratio of 2:1 (culture media/trypsin) and then 
transfer the mixture to a sterile 15ml centrifuge tube. The mixture was centrifuged at 
220g for 5 minutes to pellet the cells. The cell pellet was then diluted and seeded on 
coverslips or culture flasks. The density of seeding on coverslips varies depend on 
experimental need.   
Maintenance: I change the growth medium the day after seeding and every 48 hours 
thereafter. The fresh culture medium is required to be warmed to 37oC before replacing 
the old medium.  
2.1.4 HEK cell culture 
Human human embryonic kidney epithelial cells (HEK 293) cells were cultured in the 
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DMEM medium containing 10% FCS under standard condition of 5% CO2 and 37oC.  
Subculture: HEK Cells were split every 2–4 days as they reach 70–80% confluence. As a 
general rule, HEK 293 cells should not be confluent nor should they be seeded too 
sparsely. Therefore the cells were seeded approximately at a density of 15% confluence 
when splitting. Experiments were not performed until cells reached 40% confluence. 
The cells were split according to the following protocol; culturing medium was removed 
and cells were washed once with pre-warmed sterile PBS (containing no Ca2+ or Mg2+). 
Cells were detached by EGTA-trypsin incubation for 2 minutes. Afterwards, 5-10 ml of 
growth medium was added into the mixture of trypsin-EDTA and cells to stop the 
trypsinization. The cell pellet was collected after 5minutes centrifuge at the speed of 
1000rpm. The cells were then resuspended gently but thoroughly and appropriate 
amount cell suspension was aliquot into culture flasks and plates. 
2.2. Patch clamp protocal 
2.2.1 Single channel recording  
The single-channel patch clamp is one type of the voltage-clamp technique. This 
technique permits the direct measurement of the dynamic activity of individual 
membrane-bound channel proteins. In this recording configuration, a blunt pipette is 
sealed onto a patch of membrane and the membrane at the tip of the pipette is 
preserved rather than ruptured as seen in whole cell recording configuration. The 
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current recorded is only the current that flows through the membrane at the tip of the 
pipette. Since this membrane area is very small, there is likely just one or a few ion 
channels are located in the patched membrane. Therefor, individual ion-channel 
currents can be recorded. Previously, the only way to estimate kinetics or conductance 
of these channels was the technique of “noise” or “fluctuation” analysis. Noise analysis 
yields an estimate of the mean lifetimes of the channels and the mean amplitudes, but 
no information about actual opening and closing transitions nor about the shape of the 
conductance changes.  
In single-channel recording, a good seal is vitally important to avoid voltage error and 
guarantee the accuracy of the results of the experiments. A high seal resistance is a 
prerequisite of low-noise recordings. The recording pipette must be engaged with the 
cell membrane properly to ensure that the interior of the pipette is isolated from the 
extracellular solution. The quality of the seal is judged by the resistance, i.e. if the 
resistance of the seal is infinite, in most cases a few giga ohms, the seal is then 
considered good and no current can leak across it.  The reason why the success of 
single channel recording is highly dependent on seal quality is because; firstly, 
depending on the size of the seal resistance, a fraction of the current passing through 
the membrane patch will leak out through the seal and will not be measured i.e. the 
lower the seal resistance the larger the fraction of undetected current. Secondly, 
thermal movement of the charges in the conducting pathways of the seal will 
constitutes a major source of noise in the recording unless the seal resistance is very 
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high. High-resistance seals, often called “gigaseals,” require that very clean pipettes be 
used and that they only be used once. If this is the case, gigaseals will routinely form 
after the application of gentle suction. When good gigaseals are formed, the noise due 
to the leakage current is virtually eliminated and other sources of noise remain the 
dominant limitations in the resolution of the recording technique. A competent 
amplifier is able to minimize such noises.   
2.2.1.1 Equipment 
2.2.1.1.1 Amplifier 
The patch amplifier employed in the project is Axon 1D from Axon Instruments. 
Appropriate choice of patch amplifier is the prerequisite of a success patch-clamp 
recording since after a good gigaseal is formed the noise resulted from the leakage 
current is virtually eliminated whereas other noise sources become the main body of 
the noise in the recording. These noise sources include the noise of the electronics, 
the pipette glass, the input capacitance and the feedback resistor. We use this type of 
amplifier because it is able to minimize the noise of the electronics and the feedback 
element in the headstage. 
2.2.1.1.2 Micromanipulator 
The micromanipulator MP285 from Sutter instruments was utilized to control the 
movements of the headstage (recording pipette).  
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2.2.1.1.3 Patch pipette 
Patch pipettes were fabricated from selected glass tubing. We use glass tubing with 
walls of 0.3 mm thick because thick wall generates lower electrical noise and increases 
bluntness at the tip, which preventing penetration into the cell during seal formation. 
The outside diameter of the glass tubing is 1.5 mm and the inside diameter is 1.2 mm.  
The physical characters of patching pipette varied in different cell types. For example, 
the optimum pipette is range from 1.5µm to 2.0µm in M1 cell experiments, whereas 
this size is less than 1.5µm in HUVEC experiments. Currents were recorded at 20 kHz 
sample acquisition and filtered by a 5 kHz low-pass filter.  
2.2.1.2 Data analysis 
2.2.1.2.1 Filtering 
A filter is a circuit that removes selected frequencies from the signal. Filtering is most 
often performed to remove unwanted signals and noise from the data. The filter 
method is particularly important in measuring currents from single-ion channels. The 
most common form of filtering in single channel recroding is a low-pass filter, which 
limits the bandwidth of the data by eliminating signals and noise above the corner 
frequency of the filter. We use digital low-pass filters that are implemented in the 
recording software (clampfit from Axon instruments) which consist of a series of 
mathematical calculations that process digitized data. All recordings were filtered by the 
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Gaussian Low-pass filter in clampfit 9.0 at the parameters of 15 coefficients (200Hz 
cut-off).   
2.2.1.2.2 Single channel current detection 
Open probability analysis: The channel open probabilities were analyzed by the 
single-channel search function of pclampfit 9.0. A 50% threshold crossmethod was 
utilized to determine valid channel openings. When multiple channel events were 
observed in a patch, the total number of functional channels (N) in the patch was 
determined by observing the number of peaks detected on all-point amplitude 
histograms. NPo, the product of the number of channels and the open probability, or 
the open probability (Po) itself, was used to measure the channel activity within a 
patch.  
2.2.2 Whole-cell recordings 
The whole-cell patch clamp is voltage-clamp technique. This technique permits the 
measurement of the activity of all the membrane-bound channel proteins on the cell. 
Similar to the single-channel protocol, a blunt pipette with low-resistance is sealed by 
suction onto the surface of the membrane to achieve the giga-seal. In contrast to the 
single channel recording, the patch of membrane enclosed within the tip of the pipette 
is ruptured by applying a gentle negative pressure or a short voltage pulse known as zap. 
The electrolyte solution in the pipette then forms an electrical continuity with the 
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interior of the cell. It is equivalent to an extremely low resistance intracellular 
micropipette. The voltage at the top of the pipette is controlled by a voltage-clamp 
circuit. 
2.2.2.1 Equipments  
2.2.2.1.1 Amplifier 
The patch amplifier employed for the whole cell recordings is as described in 2.2.1.1.1 
2.2.2.1.2 Micromanipulator 
The micromanipulator is as described in 2.2.1.1.2 
2.2.2.1.3 Patch pipette 
The properties of pipettes used for whole-cell recordings are similar to that of the 
single-channel recording. However, reducing the noise of the pipette is much more 
crucial in single-channel recording than in whole-cell recording since the dominant 
noise source in whole-cell recording is the pipette resistance that is in series with the 
capacitance of the entire cell. Hence, the noise contribution of the pipette is not as 
important. In order to provide sufficient bandwidth for whole-cell current recording and 
to limit command voltage errors, the resistance of a pipette used in wholecell recording 
is slightly bigger than that used in single-channel recordings. In both single-channel and 
whole-cell recording, capacitance currents following voltage steps must be sufficiently 
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small and simple in time course to allow compensation by circuitry in the patch-clamp 
amplifier.  
Physical character of patching pipette: the size of the pipette for whole cell recording is 
generally smaller than that used in single channel recordings; usually range from 1µm to 
1.5µm. This size is chosen because it optimizes the seal performance in whole cell 
configuration. Large tips may potentiate the negative suction effects which make it 
easier to break the membrane clamped in the pipette, but this advantage is 
compensated by the high leakage current after whole cell formation. For example, In 
HUVEC whole cell recordings, due to the cell biophysical characterization, small tip 
pipettes maintain good quality recordings, although it was difficult to break the cell 
membrane. Currents were recorded at 20kHz sample acquisition and filtered by a 5kHz 
low-pass filter.  
2.2.2.2 Data analysis:  
Filtering: all recordings were filtered by clampfit 9.0 (purchased from Axon instruments) 
under the parameters; The Gaussian Low-pass filter, 15 coefficients (6000Hz cut-off).  
This filter was selected because it can effectively remove high frequency noise from 
single channel recordings without interfering with whole cell currents. Current-Voltage 
relationship analysis: whole cell currents were analyzed by clampfit 9.0.  
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2.2.2.3 Perforated-patch recording method 
 Perforated-patch recording techniques measure whole-cell currents and 
transmembrane voltages much less invasively than standard patch-clamp or 
microelectrodes do. Unlike the conventional whole cell patch configuration where the 
entire cell membrane within the tip of recording pipette is broken, the perforated-patch 
only drills micro-holes in the cell membrane and these micro-holes are impermeable to 
molecules as large as or larger than glucose. Because perforated-patch does not 
permeate pipette solution into cells, the intracellular solution can be preserved and the 
mechanisms important to cell signalling and channel regulation remain operative.  
After giga omh seal was achieved, amphotericin B was utilized to gain electrical access 
to the cell’s interior. These polyene antibiotics form pores in cholesterol- or 
ergosterol-containing cell membranes, which allows the measurements of 
electrophysiology activity of whole-cell without changing the intracellular environments. 
Because of their limited water solubility, amphotericin stock solutions of 15 mg/mL are 
prepared in DMSO. These stock solutions lose activity upon prolonged storage and 
freezing and the perforating activity of this compound begins to decrease about 3 hours 
after preparing. The stock solution, therefore, is best to prepare them freshly before use 
and use within 2 hour. My approach is to aliquot the antibiotic powder into centrifuge 
tubes and to store them indefinitely in the freezer without loss of activity. At the time of 
use, the appropriate amount of powder was solubilized by fresh DMSO. Solubilization is 
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enhanced by sonication or vortex mixing. Stock solution can be added directly to the 
pipette filling solution to achieve a desirable final concentration. It is not clear if higher 
concentrations offer any advantage. Vortex mixing for a few seconds or sonication for a 
minute is recommended for maximum solubilization of the antibiotic in the pipette 
filling solution. When the antibiotic is in excess, some of it settles out of solution and 
adheres quite well to the wall of a plastic tube or syringe. Therefore, the saturated 
solution can be used without adding much particulate matter to the pipette interior. 
The filling solution can be filtered after adding the antibiotics, but care must be taken 
since some filters might inactivate these compounds. The final solution is yellow in color 
and slightly turbid. After filtration with either a 0.22 or 0.45 micron filter, the final 
solution is perfectly clear. With nystatin, it is possible to make up larger volumes of the 
stock solution and adjust the pH to neutrality before use.  In my experience, 
amphotericin B seems to interfere with seal formation. Although it is possible to seal 
some cells when either compound is present in the pipette filling solution, the success 
rate is lower than when an antibiotic-free filling solution is used with the same cells. In 
the first set of experiments of Perforated-patch (more than 500 attempts); the gig-seal 
formation is achieved normally as seen in antibiotic-free backfill solution condition, but 
immediately after seal formation, the resistance started to drop until it reached to less 
than 200 mega-ohm, which result in an unacceptable leakage current in whole cell 
recording. Therefore, it is best to fill the tip of the pipette with an antibiotic-free 
solution and then to backfill with the antibiotic-containing solution. The tip-filling 
process can be accomplished by simply dipping the tip into the desired solution. 
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However, the distance of antibiotic-free solution from the tip is critical in determining 
the time length of whole cell formation; the time required for the diffusion of the 
antibiotic from the backfilling solution to the tip determine how long it requires for the 
antibiotic to partition the cell membrane. For example, if the pipette is filled up to 1.0 
mm from the tip with an antibiotic-free solution, more than an hour will be required for 
the antibiotic to reach a tip-concentration comparable to that in the backfilling solution. 
Ideally, the tip should be filled to a distance that allows the antibiotic to reach the tip 
within a few seconds following a gig-ohm seal formation.  Since the time required for 
seal formation depends on the cells and the setup, tip filling distances should be 
optimized by each investigator. My approach is to overfill the tip with amphotericin B 
and then force the excess solution out by applying positive pressure to the back of the 
pipette while observing it under a dissecting microscope in the first few attempts, after I 
acquired more experience without microscope observation. When the antibiotic-free 
solution is approximately 0.5mm from pipette tip, the time required for whole-cell 
formation after gig-ohm seal is less than 90 seconds. However, the quality of the seal of 
whole-cell is not stable until the partition effects of amphotericin B stops, thus 
sometimes a waiting period of 10 minutes is necessary. I monitor the whole-cell forming 
process by cell membrane capacitance and access resistance, and start the formal 
current recordings only after these two indicators remain stable.  
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2.3 Western blot  
1. Cultured cells were homogenized with CelLytic M lysis/extraction reagent (Sigma: 
c2978) containing Protease Inhibitor cocktail (Sigma: P8340).  
 
2. The standard concentration curve was drawed using readouts of a serial diluted 
standard concentration protein mixed with Bradford reagent via a spectrophotometer 
(read outs against concentrations). Concentrations of same proteins were determined 
by their Bradford Assay readout using standard curve. 
 
3. Equal amounts of total protein were loaded into the SDS-PAGE gel wells, the 
amount of protein was calculated as following: the volume that needed for each sample 
= [the lowest protein concentration of all samples x volume of the well (30µl)]/ 
concentration of the sample that is going to be loaded. β-actin was used as the inner 
marker to calibrate the protein quantity. Samples were prepared with 5x loading buffer 
(for 10ml buffer: 1.25ml of Tris-HCl pH6.8; 2 ml of 20% SDS; 2 ml of glycerol; 0.02g of 
bromophenol  blue; 0.469g of DL-Dithiothreitol, add water up to 10 ml), heat at 94°C 
for 5 min. 
 
4. Separated protein samples on 10% SDS-PAGE gels (for 15ml separating gel: 5ml of 
30% acrylamide/bisacrylamide; 3.75ml of 1.5M Tris-HCl solution pH 8.8; 0.075ml of 20% 
SDS; 0.2ml of 10% Ammonium persulfate; 6ml of distilled water; 10µl of N,N,N′,N′
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-Tetramethylethylenediamine; For 6.5 ml stacking gel: 640µl of 30% 
acrylamide/bisacrylamide; 780µl of 1M Tris-HCl pH6.8; 36µl of 20% SDS; 62µl of 10% 
Ammonium persulfate; 5ml of distilled water; 4µl of N,N,N ′ ,N ′
-Tetramethylethylenediamine) under voltage 120 V for 90min and then transferred to 
PVDF membranes under voltage 100 V for 1h.  
 
5.  The membranes were rinsed with Tris-Buffered Saline Tween-20 (TBS-T) and then 
blocked in TBS-T containing 5% milk for 1 hour (at room temperature). The membrane 
was incubated with the first antibody, overnight at 4°C, followed by washes in TBS-T and 
incubation with the secondary antibody for 1 hour at room temperature.  
 
6. Membranes were washed with TBS-T and blots were detected by Pico 
chemiluminescent substrate (Pierce: 34080). A negative control was performed without 
incubation of either primary antibody or secondary antibody. 
2.4 Isolation of caveolae compartment from HUVEC cells 
HUVEC were grown to confluence in 75ml culture flasks as described in 2.1.3, and used 
for fractionation. The homogenates in MBS (25 mM 2-(N-morpholino)-ethanesulfonic 
acid (MES), pH 6.5, 0.15 M NaCl) containing 1% Triton X-100 were adjusted to 40% 
sucrose by the addition of 2 ml of 80% sucrose prepared in MBS and placed at the 
bottom of an ultracentrifuge tube. A 5–30% discontinuous sucrose gradient was formed 
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above (4 ml of 5% sucrose/4 ml of 30% sucrose, both in MBS lacking detergent) and 
centrifuged at 39,000 rpm for 18 h in an SW41 rotor (Beckman Instruments, Palo Alto, 
CA, USA). A light-scattering band at the 5–30% sucrose interface was collected or 
fractionated into 12 subfractions. A 100 µl aliquot of each fraction was used to measure 
alkaline phosphatase activity. After direct addition of substrate solution (p-nitro-phenyl 
phosphate, R&D systems, Minneapolis, MN, USA), the absorbance at 405 nm was 
measured. 
2.5 Mechano-stimulation application 
2.5.1 Flow application method 
To apply laminar solution flow, an Open Diamond Bath recording chamber (RC-26, 
purchased from Warner instruments) was utilized. The diamond shaped geometry 
facilitates laminar solution flow throughout the bath area evenly to reproduce the most 
physiological shear force. The flow speed was controlled by gravity and measured by 
the ratio of volume against time. The shear force was therefore calculated accordingly.  
2.5.2 Membrane stretch application method 
Membrane stretch was produced by applying a positive pressure or a negative pressure 
to the rear of the patch pipette. However, the positive pressure seems to be more 
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important since it simulate the effect of blood pressure. Channel activity measured as 
the probability of channel being open which is dependent on the degree of membrane 
stretch. A pressure gauge was introduced in the pressure application system to measure 
the exact amplitude of the pressure.   
2.6 Calcium imaging  
Fura-2: The growth medium was removed and cells were rinsed once in Earl’s Balanced 
Salt Solution (EBSS). To prepare stock solution, 50 µg Fura-2 AM (F1221, Molecular 
Probe, Ltd.) was dissolved in 20 µl of 20% pluronic acid (0.01g in 50 µl Dimethyl 
sulfoxide (DMSO)). Prior to the experiment, a mixture of 1 µl stock dye with 200 µl EBSS 
was loaded onto the cells and incubated for at least 30-40 minutes. Prior to placing the 
coverslips into the recording chamber, cells were rinsed in modified thyroid medium 
(mM): NaCl 115, KCl 3, NaH2PO4 1.25, MgCl2 1.3, NaHCO3 24, CaCl2 2 and d-glucose 11, 
at pH 7.4 to remove residual dye. Data acquisition and analysis were performed by 
Wasabi programming (Hamamatsu, Ltd.). A CCD camera (C9102, Hamamatsu, Ltd.) was 
used to capture the fluorescent image. Images were collected in a format of 1344 x 
1024 pixels. Fluorescent changes in Fura-2 were measured with double wavelength 
excitation at 340 and 380 nm, and emission at 510 nm. Absolute Ca2+ was calibrated by 
using Fura-2 calcium imaging calibration kit (Invitrogen F6774). Changes in Ca2+ 
concentration in the region of interest were calculated according to a ratio of 340/380. 
Time lapse recording initially captured the images at 2s intervals. In order to minimize 
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cell photo bleaching in the long experimental protocol, 3 or 5 s intervals were applied in 
the experiments. Most data presented in the figures were acquired at 3 s intervals. The 
hypoxic medium was made of modified tyrode buffer bubbled with 95% N2 and 5% CO2. 
The O2 level in the recording chamber was measured by using an OCM-2 amplifier 
(Cameron Instrument Company) and a mini Clark-style O2 electrode (Diamond General 
Development Corp). The EGTA solution for calcium imaging recording contained (mM) 
NaCl 117, KCl 4.46, NaHCO3 24, d-glucose 11 and EGTA 0.2. The high K
+ bath solution 
contained (mM) NaCl 66.3, KCl 45.3, MgCl2 1, CaCl2 1.8, NaHCO3 23 and d-glucose 11, at 
pH 7.4. 
Post-hoc analysis was carried out using Wasabi programe. Individual cells or groups of 
cells were outlined and analyzed. Data from one coverslip were averaged and presented 
in the figures. The same experiments were repeated on different coverslips, the number 
of total cells and batches were presented using n and N, respectively. Data are 
presented as means ± S.E.M., and statistical differences were compared using a 
Student’s paired t test, taking P <0.05 being significant *. 
2.7 Perfusion system for exchange of the gas bubbled media 
The media were bubbled in para-film sealed bottles. Each bottle was connected to two 
TYGON tubes; a 1.6 mm ID tube carried the medium out of the bottle, and a 0.8 mm ID 
tube returned the medium to the bottle. The bubbled medium circulated in the system 
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constructing of the medium bottle and two tubes, and was driven by a peristaltic pump 
(Gilson minipuls 3 with four pumping heads). A tri-connector was placed very close to 
the electric valve and the recording chamber. This connector linked the delivery and 
return tubes, and another tube to the recording chamber (chamber tube). The chamber 
tube passed an electrical valve (Automation 8) and reached the recording chamber. The 
media flowed into recording chamber (RG 26, Warner) if the valve was open; otherwise 
they continually circulated to reduce dead space. The flow rate was 5 ml/min. After the 
coverslip was loaded into the recording chamber, a glass cover-slide (20 x 60 mm) was 
placed on top of the recording chamber to reduce gas exchange. An oxygen electrode 
was placed into the recording chamber to detect the O2 level in the medium. According 
to the calibration, the O2 level of the hypoxia medium in the recording chamber was 
around 20 mmHg. 
2.8 Hypoxic protocol  
Hypoxic challenges were performed in HUVEC and HEK experiments. 
HUVEC and HEK cells were exposed to a hypoxic solution containing (mM): NaCl, 42; 
NaHCO3, 24; MgSO4, 1; NaH2PO4, 0.435; glucose, 5.56; CaCl2, 1.8; KCl, 80, with 2min 
duration and 10min interval. ~5μM of PGF2α (higher concentration may be required 
when certain chemical was used, which will be specified in the following chapters) was 
added to the solution to achieve a pretone equivalent to ~15% of control. When the 
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pretone was stable, cells were exposure to continuously gas of 95%  N2/5% CO2 for 40 
min, then wash with bath and return to normoxia condition. Oxygen level was 
monitored using a dissolved oxygen meter in all experiments: at hypoxia condition, ~2% 
and normoxia, ~19%. Reproducible results were obtained after 60-90min recovery time 
after exposure to hypoxia, so a standard 80min recovery was observed between control 
and testing experiments. 
2.9 Gene modification 
2.9. 1 Interference RNA (RNAi)  
1. HMECs: One day before transfection, plate cells on coverslips in a 24 well pate format 
with 500 μl of growth medium without antibiotics, so that cells will be 90-95% 
confluent at the time of transfection. 
2. For each coverslip, oligomer-Lipofectamine™ 2000 complexes were prepared as 
follows: 
a. Dilute 20 pmol siRNA oligomer in 50 μl Opti-MEM® I Reduced Serum Medium 
without serum (final concentration of RNA when added to the cells is 33 nM) and then 
mix them gently. 
b. Lipofectamine™ 2000 was mixed gently before use, then dilute 1 μl in 50 μl Opti- 
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MEM® I Reduced Serum Medium. Mix gently and incubate for 5 minutes at room 
temperature.  
c. After the 5-minute incubation, combine the diluted oligomer with the diluted 
Lipofectamine™ 2000. Mix gently and incubate for 20 minutes at room temperature. 
3. Add the oligomer-Lipofectamine™ 2000 complexes to each well containing cells and 
medium. Mix gently by rocking the plate back and forth. 
4. Incubate the cells at 37°C in a CO2 incubator. The cell will be suitable for experiments 
in a period of 48-96h.  
The materials used are list as following: 500 µl Opti-MEM (Invitrogen); on-Targetplus 
siRNA (smart pool ENaC channel, catalogue no. L-006504-00 from Thermo Fisher 
Scientific); lipofectamine 2000 (Invitrogen catalogue no.:11668). Negative controls were 
employed by using anegative control siRNA (nontargeting pool, Dharmacon). 
Knockdown effects were examined by RT-PCR and western blot analysis after 24 and 48 
hours. 
2.9.2 Over-expression  
1. HUVECs: One day before transfection, plate cells on coverslips in a 24 well pate 
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format with 500 μl of growth medium without antibiotics, so that cells will be 90-95% 
confluent at the time of transfection. 
2. For each coverslip, prepare complexes as follows: 
a. Dilute 0.8µg of plasmid in 50 μl of Opti-MEM® I Reduced Serum Medium without 
serum (or other medium without serum). Mix gently. 
b. Mix Lipofectamine™ 2000 gently before use, then dilute 2µl in 50 μl of Opti-MEM® I 
Medium. Incubate for 5 minutes at room temperature.  
c. After the 5 minute incubation, combine the diluted plasmid with diluted 
Lipofectamine™ 2000 (total volume = 100 μl). Mix gently and incubate for 20 minutes at 
room temperature.  
3. Add the 100 μl of complexes to each well containing cells and medium. Mix gently by 
rocking the plate back and forth. 
4. Incubate cells at 37°C in a CO2 incubator for 48 hours prior to testing for transgene 
expression.  
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2.10 Statistical method 
I used a t-test to analyze my data. My results usually consisted of two groups of data, 
where each group represents one cellular response to a certain stimulation or a 
matching control. I need to compare each stimulation group with its control, comparing 
the difference of the two means in relation to the variation in the data. The t-test is one 
type of parametric statistic that fits this purpose. As the t-test assumes normality, I 
needed to do a normality test to check whether the individual groups were normally 
distributed. I used graphical methods and Kolmogorov–Smirnov tests to check the 
normality of my data. The results of both tests indicate that my data is normally 
distributed. Thus it is safe and appropriate to use the t-test to analyze my experimental 
data. 
2.11 Solutions and chemicals 
Chemicals dissolved in water: suramin (Sigma-Aldrich), D609 (Sigma-Aldrich), AICAR 
(Calbiochem), sulfaphenazole (Sigma-Aldrich), carboxyheptyl PGI2Na (Sigma-Aldrich), 
L-NAME (Torcis), acetylcholine (Sigma-Aldrich), sodium nitroprusside (Sigma-Aldrich); 
Chemicals dissolved in ethanol: nifedipine (Sigma-Aldrich), 2APB (Calbiochem), OAG 
(Sigma-Aldrich), AA (Alexis), ETYA (Alexis), indomethacin (Alexis), isotetrandrine 
(Sigma-Aldrich),  forskolin (Sigma-Aldrich), AH6908 (Biomol), NS398 (Sigma-Aldrich), 
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EETs (Biomol), PPOH (Cayman), DDMS (Cayman), Cabacyclin PGI2 (Biomol), 15-HPETE 
(Biomol), SKF525A (Biomol), picotamide (Cayman), PGE2 (Biomol), PGF2α(Biomol); 
Chemicals dissolved in DMSO:  amiloride (Sigma-Aldrich), CO donor (Sigma-Aldrich), 
amphotericinB (Sigma-Aldrich), U73122 (Calbiochem), KBR7943 (Calbiochem), 
compound C (Calbiochem), RHC20267 (Sigma-Aldrich); 
All solutions were made on the day of the experiments. The 1000 times stock solution 
were made of chemicals that dissolved in ethanol/DMSO/water. The solvent, 
ethanol/DMSO at the same vehicle concentration, was tested alone on the controls and 
had no effect. Light or temperature sensitive chemicals like ATP and arachidonic acid 
(AA) were kept on ice and in the dark. Drugs were added into a syringe or bottle which 
led to the recording chamber as necessary, at room temperature or at 37◦C respectively. 
The activities of chemicals, e.g. suramin, U73122, 2APB, and nifedipine, from the same 
stock solutions as used in these experiments, were also examined in other cell lines, 
including human kidney epithelial tubules cells and PC12 cells to assess their efficacy. In 
these cells, these drugs all produce results as expected, either inducing or preventing 
[Ca2+]i elevation. 
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Chapter 3 
 
Effects of lipids on ENaC activity in cultured mouse cortical collecting duct 
cells 
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3.1 Introduction  
Epithelial Na+ channels (ENaC) expressed on the apical membrane of distal renal tubules 
and collecting ducts are responsible for hormone-regulated Na+ reabsorption. Two basic 
steps compose this Na+ reabsorption: Na+ enters into the cells via ENaC on the apical 
membrane following the Na+ gradient and it is then extruded to the interstitial fluid by 
basolateral Na+-K+-ATPase. The rate of Na+ uptake is determined by the number of 
channels (channel density) and channel activity. Although the direct activation 
mechanism of ENaC remains unclear, protein kinase A (PKA), the small G protein K-Ras 
(Eaton, Malik et al. 2001; Staruschenko, Nichols et al. 2004; Staruschenko, Patel et al. 
2004), serum glucocorticoid-induced kinase (SGK) (Chen, Bhargava et al. 1999; Friedrich, 
Feng et al. 2003) and the channel activated protease (CAP1) (Vallet, Chraibi et al. 1997) 
have been demonstrated to increase ENaC activity. Whereas protein kinase C, [Na+]i 
(Anantharam, Tian et al. 2006), arachidonic acid (AA) (Worrell, Bao et al. 2001), the 
products of cytochrome P450 (CYP), e.g. 11,12 epoxyeicosatrienoic acid (EET) (Wei, Lin 
et al. 2004), and the reduction of PIP2 (Ma, Saxena et al. 2002; Yue, Malik et al. 2002) 
have been shown to decrease ENaC activities.  
Arachidonic acid (AA), a precursor of eicosanoids, exists primarily in esterified form as a 
glycerophospholipid in the cell membrane. Under normal conditions, non-esterified, 
free arachidonic acid is virtually undetectable. Arachidonic acid is found in the sn-2 
position of membrane phospholipids and can be liberated primarily by phospholipase 
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(PLA). Upon release, AA may initiate signalling or can be metabolized into a wide range 
of products via cyclooxygenases (COX), lipoxygenase (LOX) and cytochrome P450 
(CYP450). AA and its metabolites act in a diverse range of physiological and pathological 
roles in water and Na+ homeostasis in the kidney (Breyer, Jacobson et al. 1996; Breyer, 
Zhang et al. 1998; Breyer and Breyer 2000). In addition to interactions with specific 
receptors (Breyer, Kennedy et al. 2000), lipids can also directly bind to ion channels to 
alter their activities, resulting in either inhibition (Oliver, Lien et al. 2004) or stimulation 
(Chyb, Raghu et al. 1999). By using trans-epithelial electric resistance (TEER) methods, a 
previous study has shown that the decrease of apical AA by a cPLA antagonist 
significantly increases trans-epithelial Na+ current whereas the decrease of basolateral 
AA reduces Na+ transport, suggesting that AA can lead to inhibition of ENaC activity 
(Worrell, Bao et al. 2001). In the oocyte expression system, AA, as well as its analogue 
ETYA, moderately decreases ENaC whole cell currents by inhibiting ENaC exocytosis and 
increasing ENaC endocytosis (Carattino, Hill et al. 2003). However, AA fails to reduce 
ENaC activity when CYP-epoxygenase is blocked, suggesting that 11,12-EET as a 
metabolite of AA inhibits ENaC activity (Wei, Lin et al. 2004). It still remains unclear 
whether ENaC activity, including conductance and open probability, is altered by lipids 
regardless of the channel density and other second messengers. To prevent the 
interference of second messengers, single channel recording was employed in this study 
to clarify the direct effects of the lipids on ENaC channels. 
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3.2 Specified protocols 
3.2.1 Patch clamping recording protocols 
Single channel recordings were performed as previously described (Gorelik, Gu et al. 
2002). Briefly, a coverslip or insert containing grown M1 cells was transferred into a 
recording chamber mounted on a Nikon inverted microscope (Nikon TE 2000U). A patch 
pipette with a resistance of 7 MΩ was fabricated from a borosilicate glass capillary (1.5 
od, 0.86 id) (Warner) on a Sutter Puller (P97). Bath solutions contained (in mM): 110 
NaCl, 4.5 KCl, 1 MgCl2, 1 CaCl2, 5 HEPEs, 5 Na-HEPEs, pH 7.2. Pipette solution contained 
(in mM): 110 NaCl, 4.5 KCl, 0.1 EGTA, 5 HEPEs, 5 Na-HEPEs, pH 7.2. Currents were 
recorded with an Axon 1D amplifier and Axon clampex 9.0. The data were acquired at 
20 KHz and filtered by a 1 kHz low pass filter. The channel events were analyzed by 
pclampfit 9.0 (single channel search in analyze function). Data were further filtered at 
200 Hz before data analysis. A 50% threshold cross method was utilized to determine 
valid channel openings.  When multiple channel events were observed in each patch, 
the total number of functional channels (N) in the patch was determined by observing 
the number of peaks detected on all point amplitude histograms. NPo, the product of 
the number of channels and the open probability, or the open probability (Po) itself was 
used to measure the channel activity within a patch. The NPo was calculated according 
to previous descriptions (Yue, Malik et al. 2002). Because the recording membrane 
patch usually contained multiple channels, in most cases the changes in the NPo (not Po) 
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were directly observed and compared.   Due to the variance of the channel open 
probability, 2-5 minutes of single channel recording prior to lipid application was 
normally used as the control. The open probability of the channel during the application 
of lipids (whole duration excluding the noise) was directly compared with that of the 
control.  This ratio was employed to determine the effects of lipids on ENaC activity. In 
some cases, the NPo of ENaC during the application of lipids was compared to that of 
ENaC in medium after the lipids were washed away. The data were utilized to confirm 
the observations. The data are presented as the mean ± S.E.M., and the statistical 
differences were compared using Student’s paired t test, taking P < 0.05 as significant 
and represented as *. 
There is an inevitable fluid turbulence during bath medium exchange, for example 
during valve opening and closing, and this will cause a transient noise which is 
composed of an initial spike and a base line sine wave.  The noise component of the 
currents was excluded from the NPo analysis. Control experiments have been 
performed by switching perfusion with normal bath medium and the NPo of the 
currents was not significant altered.  
3.2.2 Chemicals  
The following chemicals were used: arachidonic acid (AA) (Alexis), linoleic acid (LA) 
(Alexis), ETYA (Alexis), stearic acid (Sigma), 11-12 EET (Biomol), 20 HETE (Biomol), PPOH 
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(Cayman), DDMS (Cayman), AH6809 (Biomol), SC51322 (Biomol), PGE2 (Biomol) and 
PGF2α (Biomol).  Most chemicals were dissolved in ethanol and made up as 1000 to 
5000 times stock. All recording solutions were made on the day of experiments. The 
solvent at the same dilution was tested alone in controls and had no effect on the 
results. 
3.3 Results 
3.3.1 Functional ENaC channels expressed in M1 cells 
Single channel recording was utilized to characterize the ENaC channels in M1 cells. In a 
cell-attached recording, an inward current was detected when the pipette voltage was 
held at +20 mV and +60 mV. These inward currents exhibited a slope conductance of 5.1 
± 0.25 pS (n=15) between the command voltages (20 and 60 mV, hyperpolarization). 
The cell membrane under a patching pipette was excised from the cell to form either 
the inside-out or the outside-out recording configuration. In an outside-out recording, 
the currents with a slope conductance of 5.15 ± 0.15 pS (n=15) are shown in figure 3.1a. 
A bath application of 0.5 µM amiloride significantly reduced the channel open 
probability, shown as the currents flickered and the major open state stepped toward 
the closing level. A high concentration of amiloride (5 µM) then almost abolished this 
current (Fig. 1a).  Currents with the same conductance were also observed in the 
inside-out recordings (n=60) (Fig. 1b). The summary of the excised membrane 
recordings was plotted as shown in figure 3.1c. The data above suggested that these 
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currents were carried out by ENaC channels.  In addition, previous reports have also 
shown that the rundown of ENaC currents in the inside-out recording are due to the 
lack of PIP2 (Yue, Malik et al. 2002). In M1 cells, significant current rundown of ENaC 
was not normally observed within 10 minutes of the formation of the inside-out 
recording configuration (figure 3.2). The selected NPo values of ENaC in M1 cells (seven 
individual cells), which cover the range of NPo values observed in M1 cells, were 
presented in the lower panel of figure 3.2d.   
3.3.2. Effects of AA and other fatty acids on ENaC activity from the extracellular side  
Within 10 minutes, the bath application of AA at 10 µM significantly reduced the ENaC 
NPo to 0.08 ± 0.05% of the control (n=5), as shown in figure 3.2a (P<0.005), while the 
cell-attached recording was performed. Incubating cells with AA for a longer period did 
not enhance the inhibition effect as described previously (Carattino, Hill et al. 2003).  
ETYA, an analogue of AA but resistant to AA degenerative enzymes, was used to 
determine whether the inhibitory effect of AA is a result of the metabolites of AA. The 
NPo of the ENaC channel was slightly reduced to 85.1 ± 9.1% (n=6) of the control by 
ETYA (Fig. 2b) (P<0.05). In addition, extracellular application of LA also reduced the NPo 
of ENaC to 89.1 ± 8.2% (n=5) of the control (figure 3.2c) (P<0.05). In an outside-out 
recording, a bath application of AA reduced the NPo of ENaC to 77.5 ± 6.1% of the 
control (n=5). These results indicate that the lipid can alter the membrane’s physical 
properties, resulting in a slight change in channel kinetics. However, the major 
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inhibition effect of AA on ENaC is accounted for by the metabolites of AA but not via a 
non-specific effect of the lipid. 
3.3.3 Effects of AA and other lipids on ENaC activity from the cytoplasmic side  
In most of the inside-out recordings, cells were held by a pipette voltage of either 60 
mV or 100 mV. In the inside-out recordings, lipids can directly interact with the 
cytoplasmic membrane and the effects of lipids on ENaC should be instantaneous. 
Therefore, our standard protocol was to incubate the patch of the membrane with the 
lipids for up to 5 minutes. Some experiments with longer incubation times, exceeding 9 
minutes, were also performed and no further effects on ENaC activity due to the lipids 
were observed. Application of 10 µM AA only induced a small reduction of the ENaC 
NPo, to 86.1 ± 4.2% (n=10) of the control (figure 3.3a) (P<0.05).  Similar effects were 
observed by application of EYTA (n=9), LA (n=8) or stearic acid (n=6) on the cytoplasmic 
membrane (Fig. 3). These observations suggested that a significant inhibition effect of 
AA on the ENaC NPo resulted from the AA metabolites but not from AA itself.  
3.3.4 Inhibition effect of 11, 12-EET on ENaC channels 
11, 12 EET as a metabolite of AA via the epoxygenase pathway, exerted a significant 
inhibition on the ENaC NPo when it was applied directly to the cytoplasmic membrane. 
In an inside-out recording, the NPo of ENaC was reduced to 5.3 ± 2.1% (n=12) of the 
control by a bath application of 250 nM of 11, 12 EET and 7.4 ± 2.5% (n=11) of the 
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control by 100 nM of 11, 12 EET (figure 3.4).  The other products, e.g. 20-HETE, as 
metabolites of AA via the CYP-dependent ω-hydroxylation pathway, slightly altered the 
NPo of ENaC as did ETYA (not shown).  In the outside-out recordings, a bath 
application of 250 nM of 11, 12 EET inhibited ENaC activity to 8.3 ± 3.1% (n=5) of the 
control, which is similar to the results obtained from cytoplasmic application of 
11,12-EET （P>0.05）.  In a cell-atteched recording, a bath application of 10 µM AA 
reduced the NPo of ENaC to 55.1 ± 8 .9% (n=5) of the control when cells were 
pre-incubated with PPOH (15 µM), which is significantly different to AA effects on cells 
without treatment (P<0.05) (figure 3.2c).  
3.3.5. Effects of PGE and PGF on ENaC activity 
PGF2 and PGE, the major metabolites of AA via the cyclooxygenase (COX) pathway, are 
abundant in CCD cells. They are generated in the cellular plasma and diffuse out of the 
cell.  In an inside-out recording, the application of PGE enhanced the NPo of ENaC to 
135.1 ± 14.2% (n=12) (figure 3.5a) of the control (P<0.05) and addition of PGF2 to the 
cytoplasmic membrane enhanced the NPo of ENaC to 167.3 ± 15.1% (n=11) (figure 3.5b) 
of the control (P<0.05). Changes in the conductance of the ENaC channels were not 
observed with the application of either PGF2 or PGE.  In addition, PGE2, at a 
physiological concentration of 2 µM (Els and Helman 1997), also enhanced the NPo of 
ENaC to 153.1 ± 111.3% (n=4).  Furthermore, EP receptor antagonists, e.g. SC-51322 (2 
µM) and AH6809 (5 µM), have been included in the pipette during some inside-out 
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recording (n=20), no significant effects were observed on the augmented effects of PG 
on the ENaC NPo. 
In conclusion, cytoplasmic AA, EYTA, LA and SA slightly reduced the NPo of ENaC, 
whereas 11,12 EET almost abolished ENaC activity. Cytoplasmic PGE and PGF both 
significantly enhanced the NPo of ENaC (figure 3.6).  
3.4 Discussion  
The data presented demonstrated that AA inhibits ENaC activity in M1 cells. This 
inhibition effect is mediated by 11,12-EET, a metabolite of AA via CYP epoxygenase, but 
not via AA per se.  The unsaturated fatty acids from either the extracellular or 
intercellular side of the cell membranes slightly reduced the ENaC channel open 
probability, whereas both PGF2 and PGE, the major metabolites of AA via COX, 
significantly enhanced the ENaC channel open probability. Since the lipids and their 
metabolites are constantly present in the cellular cytoplasm, their direct interaction 
with ENaC channels might serve as a mechanism in the regulation of ENaC activity and 
subsequently determine Na+ reabsorption.  
The previous studies have shown that ETYA, at high concentrations of 40 µM (Worrell, 
Bao et al. 2001) and 50 µM (Carattino, Hill et al. 2003), inhibits ENaC activity in Xenopus 
oocytes. Due to the similar effects of ETYA and AA, AA was considered a direct regulator 
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of ENaC. Controversially, ETYA has also been shown to exert no effect on ENaC activity 
from rat CCD cells (Wei, Lin et al. 2004), resulting in a conclusion that metabolites of AA, 
rather than AA itself, inhibit ENaC activity. We found there is a small inhibition of ENaC 
activity caused by ETYA, and this small inhibition is due to non-specific effects of fatty 
acids. Application of LA, ETYA and stearic acid from either the extracellular or 
intracellular side exerts similar slight inhibitions of ENaC.  However, differences in AA’s 
inhibitory effect on ENaC by cytoplasmic application revealed that metabolites of AA, 
rather than AA itself, primarily inhibit ENaC. This is consistent with previous work (11, 
12-EET) (Wei, Lin et al. 2004).  
In the toad bladder, an increase of Na+ reabsorption is associated with an increased 
turnover of phospholipids (Goodman, Wong et al. 1975), which implicates the 
involvement of PLA (Yorio and Bentley 1978). Inhibition of PLA2 by aristolochic acid 
significantly increases the Na+ conductance in A6 cells, suggesting that cPLA2 is tonically 
active in A6 cells (Worrell, Bao et al. 2001).  The cPLA2 constantly liberates free AA 
from the sn-2 position of the membrane lipids.  The free AA is the substrate for a 
number of enzymes, e.g. COX, CYP epoxygenase and CYP hydroxylase, and it can 
degenerate to a number of metabolites, e.g. PGE2, PGF2, EET, HETE. Either free AA or its 
metabolites on the cytoplasmic side may act as signalling molecules to directly regulate 
ion channels.  Previous studies have demonstrated that polyunsaturated fatty acids 
including AA and LA could directly mediate the activities of ion channels including TRP 
(Chyb, Raghu et al. 1999), BK (Denson, Wang et al. 2000), K+ channels (Kim and Clapham 
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1989; Ordway, Walsh et al. 1989; Oliver, Lien et al. 2004), and this regulation is not due 
to alterations in the membrane fluidity by PUFA. In this study, we found that fatty acids, 
including saturated fatty acids, could slightly inhibit ENaC activity in a non-specific way. 
Unlike other channels, ENaC possesses only two transmembrane domains and 
cytoplasmic C- and N- terminals. Other evidence suggested that ENaC may associate 
with the cholesterol enriched microdomains (Hill, An et al. 2002), which are detergent 
insoluble.  The fatty acids may interact with either a subunit of the ENaC channel 
(Carattino, Hill et al. 2003) or these lipids may form rafts to alter the physical proximity, 
resulting in changes in channel activity.  
Prostaglandins comprise a diverse family including PGE2, PGF2α, PGD2, PGI2 and 
thromboxane A2 (TXA2) (Breyer and Breyer 2001; Breyer, Kennedy et al. 2002; Sugimoto 
and Narumiya 2007). These prostanoids are abundantly produced in the kidney (Farman, 
Pradelles et al. 1986; Bonvalet, Pradelles et al. 1987; Smith, Marnett et al. 1991; Smith 
1992; Hebert, Carmosino et al. 2005), where they act locally via eight specific 
transmembrane G protein-coupled receptors (GPCR) designated EP 1-4 (for 
E-prostanoid receptor), FP, DP, IP and TP (Breyer, Kennedy et al. 2002; Nusing and 
Seyberth 2004; Wu and Liou 2005; Sugimoto 2006), respectively.  PGE2 is the major 
prostaglandin produced along the collecting duct (Hebert, Breyer et al. 1995), where it 
potently regulates solute and water transport (Breyer, Jacobson et al. 1996; Breyer and 
Breyer 2000). It is well established that PGE2 exerts its effects by either stimulating or 
inhibiting salt and water reabsorption through its interaction with the cell surface EP 
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receptors in an autocrine or paracrine fashion (Narumiya 1994). The controversial 
effects are generally considered to be due to the diverse signalling pathways initiated by 
distinct EP receptors (Guan, Zhang et al. 1998).  However, as we demonstrated in this 
report, PGs can also directly affect ENaC without EP receptors, because they lack a 
cellular mediator, e.g. Ca2+ or cAMP, to cope with the activation of GPCR in the 
inside-out recordings. Cytoplasmic prostaglandins directly enhance the NPo of ENaC. 
Due to their membrane permeability, luminal PGs might also stimulate ENaC after they 
enter into the cytoplasm. Many observations may be consistent with this direct 
activation. For example, infusion of renal filtrates contacting PGs increases Na+ 
reabsorption (Hornych, Bedrossian et al. 1975; Lazzeri, Barbanti et al. 1995; Breyer and 
Harris 2001). PGE2 augments amiloride-sensitive Na+ transport in frog skin (Kokko, 
Matsumoto et al. 1994; Matsumoto, Mo et al. 1997), MDCK (Wegmann and Nusing 
2003) and A6 cells  (Nielsen 1990).   
Our results are in disagreement with the observations of Els and Helman, who found 
that PGE2 decreases the NPo of Na+ channels by unknown mechanisms (Els and Helman 
1997).  Several explanations of this discrepancy are possible. Most obviously, there 
could be a species difference, since frog skin was investigated in the previous study 
whereas our study was performed on mouse kidney cells. Second, there could be 
time-dependent differences. In the tissue study of frog skin, changes in short circuit 
currents happen over minutes.  In patch clamping experiments, the exposure of the 
inner surface of the membrane is fairly brief.   Effects of PG on ENaC are 
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instantaneous and occur within seconds. Finally, the interference of second messengers 
should be seriously considered when the study is performed on a tissue level. Within 
minutes, application of PGE could stimulate a variety of signalling pathways via EP 
receptors (Breyer and Breyer 2001). Results would therefore be profound. In this study, 
we provided a simple and clear conclusion which excludes effects of second 
messengers.  
Consistent with the previous studies, 11, 12-EET, but not HETE, plays a primary role in 
inhibiting ENaC activity. This effect is due to the direct interaction of 11, 12-EET with 
ENaC channels, although the interaction site remains unclear.  Accumulated evidence 
has suggested that 11,12-EET is the major signalling molecule inhibiting ENaC activity 
(Wei, Lin et al. 2004; Sun, Lin et al. 2006; Wei, Sun et al. 2006).  The expression of CYP 
epoxygenase, which mediates the product of 11,12-EET from AA, could be regulated by 
the diet of Na+ uptake (Sun, Lin et al. 2006). It partly explains the observation that 
removal of an epoxygenase inhibitor decreases the blood pressure in rats maintained on 
a high Na+ diet (Makita, Takahashi et al. 1994). However, some studies reported there is 
either lack of epoxygenase or deficient of epoxygenase activity in cultured cells 
(Michaelis, Fisslthaler et al. 2005). Our results in this study confirm that 11, 12-EET 
strongly inhibits ENaC by direct interaction. 
There are opposite regulations in ENaC channel activity by different AA metabolites. 
Products of epoxygenase inhibit ENaC channels whereas products of COX augment 
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ENaC activity.  According to our experiments, lipids are strongly suggested to directly 
interact with the ENaC channels via the binding sites in the ENaC molecular structure. 
The defined ENaC activity will be determined by lipid affinity to ENaCs and spatial 
distribution of different AA metabolism enzymes.  In A6 cells, application of 
aristolochic acid from the apical membrane increases trans-epithelial Na+ current 
whereas application from the basolateral side reduces Na+ transport (Worrell, Bao et al. 
2001).  Basolateral application of ibuprofen mimics the effects of inhibition of cPLA via 
basolateral application of aristolochic acid, suggesting that the distribution of COX in A6 
is likely close to the basolateral membrane.  
This study provides direct evidence to reveal the direct effects of common cytoplasmic 
lipids on ENaC activity, because membrane patches in inside-out recordings containing 
channels are physically isolated from the rest of the cell and cytoplasmic factors are 
absent. This evidence will be conducive in understanding the regulation mechanisms of 
ENaC by lipids, though many issues remain to be resolved.  
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Fig. 3.1 The single channel currents of ENaC in M1 cells. 
 a. In an outside-out recording, the currents were monitored when the pipette voltage 
was held at -100 mV. The bath application of 0.5 µM amiloride significantly reduced the 
ENaC open probability and 5 µM amiloride almost abolished the ENaC currents.  b. In 
an inside-out recording, single channel currents were detected when the pipette 
voltage was held at +100 mV and +60 mV. c. Currents corresponding to the voltages 
from inside-out (n=60) and outside-out recordings (n=15) were plotted. The points were 
fitted by a line (γ2=0.99).  
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Fig.3.2. The effects of PUFA on ENaC activity in cell-attached recordings.  
a. In a cell-attached recording, the bath application of 10 µM AA significantly reduced 
the ENaC NPo. b. In a cell-attached recording, the bath application of 10 µM ETYA 
slightly reduced the ENaC NPo. c. The bar figure shows the effects of extracellular PUFA 
on ENaC NPo. d. A trace of single channel current from an inside-out recording. 
Summary plots of the NPo from seven individual cells along 10 minutes after the 
formation of the inside-out configuration. 
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Fig 3.3 
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Fig.3.3. The effects of AA and ETYA on ENaC activity in inside-out recordings.  
a. In an inside-out recording, the bath application of 10 µM AA slightly reduced the 
ENaC open probability and this effect of AA was reversed when AA was washed away. b. 
In an inside-out recording, the bath application of 10 µM ETYA slightly reduced the 
ENaC open probability and this effect was reversed when ETYA was washed away.   
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Fig.3.4 
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Fig.3.4. The effects of 11, 12-EET from the cytoplasmic side on ENaC activity.  
In an inside-out recording, 11, 12-EET at 100 nM significantly reduced the ENaC open 
probabilities. This effect was reversed when the 11, 12-EET was washed away. The 
arrow bar indicates the noise induced by the fluid turbulence in the recording bath.  
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Fig.3.5. The effects of PGE2 and PGF2α from the cytoplasmic side on ENaC activity.  
a. In an inside-out recording, the bath application of 20 µM PGE2 enhanced the ENaC 
open probability. b. In an inside-out recording, 20 µM PGF2α slightly enhanced the 
ENaC open probability. This effect was reversed when PGE2 was washed away. 
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Fig 3.6 
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Fig.3.6. The effects of lipids from the cytoplasmic side on ENaC activity.  
This figure shows the analyzed results about the effects of the lipids on ENaC NPo. Data 
were normalized to the control.  
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Chapter 4 
 
An oxygen-sensitive mechanism regulating of epithelial sodium channels 
(ENaCs) 
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4.1 Introduction 
In hypoxic conditions, such as following haemorrhage or in other circumstances in 
which effective circulating volume is decreased, the metabolic activity of many tissues is 
reduced. The kidneys, however, must restore the effective circulating volume, and 
hence have an increased oxygen requirement in order to increase Na+/K+ ATPase activity. 
This would appear to be a recipe for renal failure. A number of protective mechanisms 
enable the kidney to increase Na+/K+ ATPase activity, but limit the extent of the increase. 
Such mechanisms include increased PGE2 synthesis, and increased production of other 
arachidonate metabolites (Lote and Haylor 1989; Breyer and Breyer 2000). Alternatively, 
controlling the availability of Na+ at Na+/K+ ATPase sites in the distal nephron epithelial 
cells could provide the required regulation.  
Epithelial sodium channels (ENaCs), which are expressed primarily in the apical 
membranes of epithelia lining the distal nephron, lung airway, alveoli, and descending 
colon, mediate Na+ entry into the epithelial cell. These channels control Na+ absorption 
and play a critical role in maintenance of Na+ homeostasis, blood pressure and airway 
fluid volume. O2-sensitive regulation of ENaCs is thus potentially a key mechanism for 
regulation of epithelial Na+-transport during hypoxia. It has long been recognized that 
hypoxia may affect Na+ absorption in the distal nephron and lung epithelia (Cohen, 
Merkens et al. 1980; Durand, Durand-Arczynska et al. 1986; Durand, Durand-Arczynska 
et al. 1988; Planes, Blot-Chabaud et al. 2002; Thome, Davis et al. 2003; Jain and 
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Sznajder 2005) and that O2 -dependent epithelial Na
+ transport requires the presence of 
haem protein (Rafii, Coutinho et al. 2000). However, the mechanism underlying these 
important observations remains unclear.  
We employed the excised, inside-out configuration of the patch-clamp method to 
examine the significance of haem protein activity of ENaCs from mouse cortical 
collecting duct cells (M1) in which α, β and γ ENaC subunits are expressed (Chalfant, 
Peterson-Yantorno et al. 1996; Nakhoul, Hering-Smith et al. 1998).  In this 
configuration the channels are physically isolated from the rest of the cell and 
cytoplasmic factors are absent. We report that ENaC activity is sensitive to haem at 
physiological concentrations and that metabolism of haem by hemeoxygenase functions 
as an O2-sensitive mechanism for the regulation of ENaC activity. 
4.2 Specified materials and methods 
4.2.1 Single channel patch clamp recording  
Single channel recordings were performed as previously described. Briefly, a coverslip or 
insert on which M1 grown was transferred into a recording chamber mounted on a 
Nikon inverted microscope (Nikon TE 2000U). A Patch pipette with the resistance of 6 
MΩ was fabricated from a borosilicate glass capillary (1.5 mm od, 0.86 mm id) (Sutter) 
on a Sutter Puller (P97). Bath solutions contained (in mM): 110 NaCl, 4.5 KCl, 1 MgCl2, 1 
CaCl2, 5 HEPEs, 5 Na-HEPEs, pH 7.2. Pipette solution contained (in mM): 110 NaCl, 4.5 
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KCl, 0.1 EGTA, 5 HEPEs, 5 Na-HEPEs, pH 7.2. Single channel currents were recorded with 
an Axon 1D amplifier and Axon clampex 9.0. The data were acquired at 20 KHz and low 
pass filtered at 5 kHz. During post analysis, data were further filtered at 200 Hz. Single 
channel events were listed and analyzed by pclampfit 9.0 (single channel search in 
analyze function). 50% threshold cross method was utilized to determine valid channel 
openings.  When multiple channel events were observed in a patch the total number 
of functional channels (N) in the patch was determined by observing the number of 
peaks detected on all point amplitude histograms. NPo, the product of the number of 
channels and the open probability calculated as described previously (Yue, Malik et al. 
2002), or the open probability (Po) itself, was used to measure the channel activity 
within a patch.  Initial, 3-4 minute, single channel records were normally used as the 
control. The activity of ENaC during application of chemicals was normalised to activity 
during the control period to assess the effects of chemicals on ENaC activity. In some 
cases ENaC activity during application of chemicals was also compared to that of ENaC 
when chemicals were washed off. These data were used to confirm the effects of 
chemicals. Data are presented as means ± s.e.m.  and statistical differences were 
compared using Student’s paired t test, taking P < 0.05 as significant and represented as 
*.  
4.2.2 Chemicals and stock solutions 
Haem, PP9, MP11, FeSO4, NADPH and ZnPP9 were from Sigma-Aldrich. SnPP was from 
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Tocris. Biliverdin was from Frontier Scientific. Stock solutions (1 mM) of these reagents 
in 10 mM NaOH were made weekly and kept at -20 °C in aliquots. All the solutions were 
thawed and immediately before use. [ruthenium(CO)3Cl2]2  was freshly dissolved in 
DMSO on the day of experiments. Ruthenium (III) chloride hydrate and ruthenium 
(DMSO)4Cl
2
 were also freshly prepared accordingly. The medium containing certain 
concentration of CO donor is made of 30 minutes ahead of experiments. Partial 
pressures of medium O2 were measured and monitored by O2 meter (WPI ISO2). 
Hypoxic medium was obtained by N2 bubbling. 
4.2.3 Statistics 
Data are displayed as the mean ± s.e.m. Paired t-test was used to compare channel 
activity before (control) and after application of drugs.  Effects of different treatments 
were assessed by normalising activity (to pre-treatment levels) and comparing groups 
using one-way ANOVA (Orgin pro 7.5) and multiple comparisons. Dosage curve was 
fitted using Origin pro 7.5 (sigmoid fitting) according to equation 
Y=minimum+(maximum-minimum)/(1+(X/X0)^p).  
4.3 Results 
Currents mediated by ENaCs were identified by their unique conductance  (≈4.9 pS in 
both inside-out and outside-out recordings) ( 1, 7, 8) and their sensitivity to 1 µM 
amiloride (Gu 2008).  Application of haem (Fe3+ protoporphyrin IX chloride) at 
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nanomolar concentrations to the intracellular side of the channels (inside-out 
recordings) consistently and significantly reduced the open probability (NPo) of ENaC 
(figure 4.1a). Inhibition of ENaC by haem did not require any exogenously added 
enzyme or cofactor. Half-maximal inhibitory concentration (IC50) was 23.3 nM and IC80 
was 122 nM (fig 4.1b), considerably less than the equivalent  inhibitory concentrations 
on BK channels (Tang, Xu et al. 2003). No change of unitary current amplitude was 
observed. The inhibitory effect of haem occurred immediately and outlasted its period 
of application. Upon washout of haem, the reversal of inhibition was slow and 
sometimes partial (figure 4.1a), indicating there is a stable physical interaction between 
haem and its binding site. The inhibitory effect on ENaC was specific to free haem. 
FeSO4, haem precursor protoporphyrin IX (PP9) and the microperoxidase MP11 did not 
cause inhibition (figure 4.1c). Tin protoporphyrin IX (SnPP) caused a small but significant 
decrease in NPo of ENaC (figure 4.1c). Application of haem (up to 100 nM) to the 
extracellular face of the membrane (outside-out recordings) did not inhibit ENaC 
activity (figure 4.1c).  
NADPH, the reduced form of nicotinamide adenine dinucleotide phosphate (NADP+), 
provides the reducing equivalents for biosynthetic reactions and for oxidation-reduction. 
Application of 1µM NADPH alone had no effect on activity of ENaC. However, when 
haem was co-applied with NADPH (1 µM), the inhibitory effect of haem was reversed. 
Upon application of 1 nM haem with NADPH NPo was increased to 149 ± 27% (P<0.001) 
of that under control conditions (figure 4.2), unitary conductance remaining unchanged. 
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Modulation of ENaC activity by combined application of haem and NADPH was gradual. 
An increase in channel activity became apparent only 10-20 s after stimulation and 
recovery of activity to control levels after washout was similarly slow.  
In the presence of O2 and NADPH, hemeoxygenase converts haem to biliverdin, iron and 
CO (Williams, Wootton et al. 2004). To examine whether the effects of haem and 
NADPH might be due to activity of hemeoxygenase and consequent generation of CO, 
we investigated the effects on activity of ENaC of a CO donor ([ruthenium(CO)3Cl2]2). 
Upon application of the CO donor (100 nM), NPo was reversibly enhanced under both 
normoxic (pO2 ≈ 160 mm Hg) and hypoxic conditions (pO2 ≈ 15 mmHg) (figure 4.3). The 
increase in activity of ENaC occurred rapidly upon application of CO, developed 
progressively and reversed slowly upon washout, indicating a stable physical interaction 
between CO and its binding site. When the concentration of the CO donor exceeded 20 
µM the channel was held permanently open, an effect that was not reversed by 
washing.  Application of the control compounds ruthenium (III) chloride hydrate (5 µM) 
(Cudmore, Ahmad et al. 2007) or ruthenium (DMSO)4Cl
2
 (10 µM ) failed to evoke a 
significant enhancement of NPo.  
Modulation of the activity of ENaC by CO resembled that seen upon co-application of 
haem and NADPH, suggesting that the stimulatory effect of these agents might indeed 
reflect the generation of CO by hemeoxygenase. Further to investigate this, we 
examined the effects of co-application of haem (1 nM) and NADPH (1 µM) on the 
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activity of ENaC channels in patches maintained under hypoxic conditions (PO2≈15 mm 
Hg), which will inhibit action of hemeoxygenase.  In hypoxic medium, haem and 
NADPH induced a depression on ENaC activity resembling that seen upon application of 
haem alone (figure 4.4). This inhibitory effect was reversed to an enhancement of NPo 
(in the same patch) when oxygen tension was raised to normoxic levels, permitting 
activity of hemeoxygenase. Hypoxia alone had no effect on ENaC activity (figure 4.4a). 
Application of SnPP (50 nM; a blocker of hemeoxygenase) to patches containing ENaC 
channels caused only ≈ 8.7% inhibition of activity. However, when SnPP was present, 
application of 10 nM haem plus 1 µM NADPH exerted a significant inhibition on ENaC 
(resembling that seen with haem alone) even under normoxic conditions (figure 4.4c). 
Biliverdin (100 nM), which is also generated by activity of hemeoxygenase, did not 
affect ENaC activity (figure 4.4b). 
If the increase in NPo that occurs upon co-application of haem and NADPH under 
normoxic conditions reflects metabolism of haem by hemeoxygenase, application of a 
high concentration of haem may exceed the catalytic ability of the enzyme. Fig5 shows 
that this is indeed the case. Co-application of 1µM NADPH and 50 nM haem resulted in 
a 39%, reduction of NPo. The minimum concentration of haem necessary to inhibit 
channel activity under these conditions was ≈40 nM (figure 4.5b). These findings 
suggest that haem (a substrate of hemeoxygenase) and CO (a product of 
hemeoxygenase) act competitively in their effects on ENaC.  
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4.4 Discussion  
We have shown that ENaCs in M1 mouse cortical collecting duct cells were inhibited by 
application of nanomolar concentrations of haem to the cytoplasmic surface of the 
membrane. Previous studies on the usage of haem have employed 5 – 30 µM haem in 
extracellular medium (Kaasik and Lee 2004; Rajagopal, Rao et al. 2008) and 1 – 200 nM 
haem in cytoplasmic medium (Tang, Xu et al. 2003; Williams, Wootton et al. 2004; 
Jaggar, Li et al. 2005) to interact with ion channels. The half-maximal inhibitory 
concentration (IC50) of 23.3 nM reported here is consistent with these values and 
comparable to the dissociation constant values of other haemoproteins and 
haem-binding proteins (Taketani, Adachi et al. 1998; Hirotsu, Abe et al. 1999; Ponka 
1999; Tang, Xu et al. 2003). Thus inhibition of ENaC activity by haem will occur under 
conditions similar to those for other haem-protein interactions.  Interestingly, SnPP 
also caused a much smaller, but nevertheless significant decrease in ENaC NPo (fig 1c), 
suggesting that, for haem’s inhibitory effect on ENaC, other metals may be able partially 
to substitute for iron. 
Exact concentrations of haem in the cytoplasm are not known but the evidence 
suggests that cytoplasmic haem reaches levels more than sufficient to elicit the effects 
reported here. Haem is synthesized on the matrix side of the inner mitochondrial 
membrane (Rajagopal, Rao et al. 2008) and is exported to distinct intracellular 
compartments (Hamza 2006), most being used for the formation of hemoproteins 
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including haemoglobin, myoglobin, cytochromes and nitric oxide synthase (Ponka 1999). 
Haem is also liberated after cellular injury (hemolysis, trauma, and crush syndrome), 
hypoxia and/or stress (Dore 2002), leading to an elevation of cellular free haem that can 
be transported across the plasma membrane (Goldman, Beck et al. 1998; Worthington, 
Cohn et al. 2001). Intracellular haem may increase 10-fold when 30 µM haem is present 
in the extracellular medium (Kirschner-Zilber, Laufer et al. 1989). Reported values for 
total cellular haem vary considerably. For spleen cells the reported value is 13 nmol/mg  
protein (equivalent to ≈163 µM) whereas in olfactory receptor neurons  approximately 
1.5 nmol/mg protein (≈18.8 µM) (Ingi, Chiang et al. 1996) was reported and in K562 
cells the content was as low as 0.17 nmol/mg protein (≈2.1 µM) (Kirschner-Zilber, Laufer 
et al. 1989; Atamna and Frey 2004). Levels of free haem in the cell are controlled by a 
fine balance of biosynthesis and enzymatic catabolism (by hemeoxygenase) and are 
likely to be below micromolar (Kim and Dore 2005), consistent with the effective 
concentration reported here.   
Haem present in the cell might therefore be expected tonically to inhibit ENaC activity, 
as occurred in inside out patches (fig 1). However, when haem was co-applied with 
NADPH (permitting activity of hemeoxygenase) the effect on NPo was dependent upon 
oxygen tension. Activity of ENaC was stimulated under normoxic conditions (when 
hemeoxygenase would be active) but was inhibited under conditions of hypoxia. 
Furthermore, application of CO, a product of hemoxygenase activity, stimulated ENaC 
activity, mimicking the effects of haem when co-applied with NADPH under normoxic 
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conditions. It has been proposed that hemeoxygenase-2 functions as an oxygen sensor 
in the carotid body, regulating activity of high conductance Ca2+ activated K+ (BK) 
channels (Williams, Wootton et al. 2004). We conclude that modulation of 
hemoxygenase by O2 functions similarly, providing a novel, sensitive mechanism for 
regulation of ENaC.  
An important question is whether hemeoxygenase and ENaC are sufficiently closely 
associated in vivo for the interaction described here to occur in vivo.   ENaCs are 
known to co-localize with caveolin-1, a protein found in lipid rafts and caveolae, 
membrane pits of 60-80 nm diameter (Dupree, Parton et al. 1993; Parton and Simons 
2007). Recent findings have shown that ENaCs are concentrated in lipid rafts in A6 cells 
(Hill, An et al. 2002) and mouse cortical collecting duct cells (Hill, Butterworth et al. 
2007) and disruption of caveolae will reduce abundance of  ENaC by >70%.  Indeed 
the inducible form of hemeoxygenase (hemeoxygenase-1) has been shown to be 
present in plasma membrane caveolae and physically to interact with caveolin-1 (Kim, 
Wang et al. 2004). It is therefore probable that ENaC and hemeoxygenase are both 
present in caveolae and closely associated with caveolin. Thus there seems little doubt 
that close associated between these proteins occurs, sufficient to permit O2 sensitive 
regulation of ENaC by hemeoxygenase as described here.   
With regard to the site on ENaC through which effects of haem are exerted, the 
molecular structure of ENaCs contains two transmembrane domains and a large 
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extracellular loop with repeated cysteine and glycosylation sites (Benos 2004). Haem 
inhibits ENaC when it is applied to the cytoplasmic membrane face, suggesting that 
interaction with the channel involves the N- and/or C- termini. Histidine, methionine 
and cysteine residues are known to provide sites of interaction with haem iron. Previous 
work on BK (Slo) channels has demonstrated a conserved haem binding motif 
containing the amino acid sequence CXXCH (where X represents any amino acid) 
located between the two putative ‘regulator of K+ conductance’ domains (RCK) (Tang, 
Xu et al. 2003). However, this motif is not present in any subunits of ENaC so binding 
must involve a previously unknown haem-binding domain or possibly a site formed by 
the allosteric structure of the three ENaC subunits. In addition, other proteins (such as 
caveolin-1 and hemeoxygenase) which are spatially close to ENaC may provide a 
platform for haem binding which results in modification of ENaC gating. Similarly, haem 
may interact with the β and γ subunits of ENaCs in M1 cells which are not pore-forming 
but exert regulatory effects (Canessa, Schild et al. 1994).  Further systematic 
investigation by will require investigation of different combinations of ENaC subunits 
combined with truncation, replacement or mutation of regions within the subunits.  
Regulation of renal ENaC channels by O2-hemeoxygenase, as described here, may play a 
significant role in a number of processes. It is consistent with previous reports (Vivona, 
Matthay et al. 2001; Carpenter, Schomberg et al. 2003) that hypoxia reduces epithelial 
Na+ transport to compensate reduced Na+/K+ATPase during metabolic stress and it may 
also underlie the role of hemeoxygenase in ameliorating renal injury during ischemia 
 138 
followed by reperfusion of the rat kidney (Akagi, Takahashi et al. 2005). Furthermore, 
increased expression of hemeoxygenase provides a mechanism that modulates 
inflammation and promotes wound closure (Patil, Bellner et al. 2008). ENaCs are also of 
immense importance in functioning of the mammalian lung. Malfunction or impaired 
expression of ENaCs is implicated in a number of important and common pathologies 
including pulmonary edema (Jain and Sznajder 2005; Factor, Mutlu et al. 2007). Control 
of ENaC in the alveolar epithelium is particularly intriguing. Na+ flux through ENaC is 
crucial for clearance of alveolar edema (Factor, Mutlu et al. 2007) yet, apparently 
paradoxically, activity of channel is reduced under hypoxic conditions (Jain and Sznajder 
2005) . However, inhibition of ENaC under hypoxic conditions, leading to an increase in 
airway surface liquid may be beneficial for clearance of mucus (Taguchi, Niisato et al. 
2005; Mall 2008). Thus activity of ENaC, a channel pivotal to lung function, may be 
‘regulated’ by PO2 and hemeoxygenase, a process that may be crucial to survival of lung 
injury or infection.  In addition to the direct regulation of ENaC through haem and 
haem metabolism described here, other less direct effects may occur, such as  
activation soluble guanylate cyclase by CO (Rodgers 1999), regulating ENaC cycling and 
activity. More fundamental effects may also occur through effects of haem on 
processing of micro RNAs. Such effects can regulate expression of a large number of 
protein-coding genes (Faller, Matsunaga et al. 2007) and could modulate transcription 
of ENaC.  
In summary, I have shown a novel mechanism for regulation of ENaC by which the 
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O2-dependent activity of hemeoxygenase and the generation of CO controls channel 
activity. This novel mechanism provides a mechanistic explanation for previous 
observations and sheds new light on the role(s) and functioning of ENaCs, particularly in 
fluid clearance and functioning of renal and lung epithelium. 
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Fig.4.1. Haem inhibits the opening of ENaC.  
a: Inhibitory effect of 1 nM (upper panel), 10 nM (middle panel) and 100 mM (lower 
panel) haem on ENaC open probability (NPo). Traces were obtained in inside out 
configuration with a pipette voltage of +80 mV.  Application of haem is shown by the 
bold bar above the upper current trace in each panel. Selected parts of currents 
(marked by bars below the upper trace) are shown with an expanded time scale in the 
lower trace of each panel. Arrowhead and ‘c’ besides the current traces indicate the 
closed state of ENaC currents. b: Concentration dependent inhibition by haem of ENaC 
activity. Each point was averaged from 6-8 cells. Data were fitted with a sigmoidal 
dose-effect curve based on the equation: 
Y=minimum+(maximum-minimum)/(1+(X/X0)^p). IC50 = 23.3 nM and IC80 = 122 nM. Hill 
coefficient is 0.998.  c: Effects of haem related chemicals on ENaC activity. PP9 
represents protoporphyrin IX. Both PP9 and Zn PP9 had no effect on ENaC activity. 
Asterisk, P<0.05 versus control. Each column shows the mean (±SEM) of 5-6 cells, 
except ZnPP (9 cells) Asterisk indicates p<0.05 compared to paired control (before 
application of drug). Application of one-way ANOVA showed that the haem group and 
SnPP group were significant different from other groups(P<0.05) and haem group was 
different from SnPP group (P<0.05) stabilize  
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Fig 4.2 
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Fig.4.2. Haem and NADPH augment ENaC activity under normoxia (pO2 ≈ 160 mmHg).  
The augmented effect of haem and NADPH on ENaC was observed both with an 
inherent high (a) and low (b) ENaC activity. In both a: and b: application of 
haem+NADPH is shown by the bar above the upper current trace and selected parts of 
currents (marked by bars below the upper trace) are shown with an expanded time 
scale in the lower trace. c: The stimulatory effect of haem+NADPH and the inhibitory 
effect of haem alone during prolonged recording from a single patch. The 5 displayed 
traces were selected from 1 recording in the sequence shown by the arrows. d. 
summary of effects of haem and NADPH. Each column represented the mean (±SEM) of 
5-6 cells. Asterisk indicates p<0.05 compared to paired control (before application of 
drug). Application of one-way ANOVA and cross-group statistical comparison showed 
that there was a significant difference between the effects of 1 nM and 10 nM haem, 
both in the presence and absence of NADPH. 
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Fig.4.3 
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Fig.4.3. Stimulation of ENaC activity by CO.  
a: 100 nM CO donor significantly enhances ENaC activity. b: 20 µM CO donor holds 
ENaC constantly open. c: CO donor significantly enhances ENaC activity under both 
hypoxic and normoxic conditions. Each column shows mean (±SEM) of 6-8 cells. Asterisk 
indicates p<0.05 compared to paired control (before application of drug). Application of 
one-way ANOVA and cross-group statistical comparison showed that there were 
significant differences (P<0.05) between the CO control group, the 100 nM CO donor 
groups (which were not significantly different from each other) and the 1µM CO donor 
group.  
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Fig 4.4 
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Fig.4.4. O2 is required to maintain the stimulatory effect of haem (1 nM) and NADPH 
(1 µM).  
a: Upper panel shows reversible inhibitory effect of haem and NADPH applied under 
hypoxic conditions (pO2≈15 mmHg), 2
nd  panel shows inhibition by haem and NADPH 
under hypoxic conditions followed by stimulation of activity (in the same patch) when 
applied under normoxia (pO2 ≈ 160 mmHg). 3
rd panel shows stimulation by haem and 
NADPH under normoxic conditions followed by inhibition of activity (in the same patch) 
when applied under hypoxia. Bottom panel shows the lack of effect of hypoxia alone on 
ENaC activity. b: Effects of haem and NADPH on activity of ENaC.  Each column shows 
mean (±SEM) of 5-6 cells. Asterisk indicates p<0.05 compared to paired control (before 
application of drug). Application of one-way ANOVA showed that there was a significant 
difference between groups (P<0.05).  Cross-group statistical comparison showed that 
the haem + NADPH + normoxia group was significantly different from the other groups. 
There was no significant difference between effects of haem and haem with NADPH 
under hypoxia. c: Effect on ENaC activity of haem plus NADPH during inhibition of 
hemeoxygenase. Asterisk indicates p<0.05 compared to paired control (before 
application of drug). Application of one-way ANOVA showed that there was a significant 
difference between groups (P<0.05).  Cross-group statistical comparison showed 
significant differences between all three groups. Inset shows inhibitory effect of 10 nM 
haem plus NADPH on ENaC activity when applied in presence of 50 nM SnPP. 
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Fig.4.5. Concentration dependent effects of haem on ENaC activity when co=applied 
with NADPH. 
a: Effects of 10 nM (upper panel), 20 nM (middle panel) and 50 nM (lower panel) haem, 
co-applied with 1 M NADPH, on ENaC activity. In each panel an example trace is 
shown before (left) during (centre) and after (right) exposure. b: Data were fitted with a 
sigmoidal dose-effect curve. Hill coefficient is 1.0.  based on the equation: 
Y=minimum+(maximum-minimum)/(1+(X/X0)^p). Each point was averaged from 6-8 
cells. Dashed line represents effect of haem alone (from data shown in figure 1.). 
Minimum concentration of haem necessary to induce inhibition of NPo was ≈40 nM. 
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Chapter 5 
 
Functional ENaC channels expressed in endothelial cells: a new candidate 
for mediating shear force 
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5.1 Introduction 
The endothelium is a thin layer of cells lining the interior surface of all blood vessels, 
forming an interface between circulating blood in the lumen and the rest of the 
vessel wall.  Endothelial cells (ECs) are constantly exposed to blood flow and are 
capable of sensing the blood flow pattern and shear stress. The “immediate response” 
of ECs to alteration of blood flow occurs in a range of seconds and is mediated by a 
variety of ion channels. Several types of ion channels have been suggested to 
mediate the initial shear force signalling events, including stretch-activated cation 
channels (Popp, Hoyer et al. 1992; Hoyer, Kohler et al. 1997; Yao, Kwan et al. 2002), 
P2X4 (Yamamoto, Korenaga et al. 2000; Sim, Chaumont et al. 2006), TRPM7 (Oancea, 
Wolfe et al. 2006), TRPV (Nilius, Droogmans et al. 2003), TRPC (Nilius and Droogmans 
2001; Wei, Freichel et al. 2001), K+ channels (Hoger, Ilyin et al. 2002; Brakemeier, 
Kersten et al. 2003; Fang, Schram et al. 2005; Chatterjee, Levitan et al. 2006; Fang, 
Mohler et al. 2006), Ca2+-activated Cl- channels (Maertens, Wei et al. 2000; Hisadome, 
Koyama et al. 2002) and volume-regulated anion channels (VRAC) (Maertens, Wei et 
al. 1999; Vennekens, Trouet et al. 1999). The activations of shear force-sensitive ion 
channels eventually lead to alterations of membrane potential with or without [Ca2+]i 
elevation.  
Epithelial Na+ channels (ENaCs) were initially identified in the epithelium of the distal 
nephron, colon and lung, and are related to Na+ uptake and trans-epithelial water 
movement. They contain only two trans-membrane domains and a large extracellular 
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region with cysteine-rich domains and glycosylation sites.  The ENaC superfamily 
has been demonstrated to be able to sense mechanical stress (Adams, Anderson et al. 
1998; Hong, Mano et al. 2000) and transduce the stress into electrical events, 
resulting in membrane depolarization (Snitsarev, Whiteis et al. 2002).  ENaCs are 
comprised of three basic subunits, α, β, γ, which have tertiary structures and much 
amino acid sequence homology.  Either the α or δ subunit of ENaCs can form the 
pore structure to permeate Na+. Most of the ENaC regulators, including PIP2 (Ma and 
Eaton 2005), PI3K (Staruschenko, Nichols et al. 2004; Staruschenko, Patel et al. 2004; 
Pochynyuk, Tong et al. 2007), G-protein (Yue, Malik et al. 2002) and [Cl-]i (Bachhuber, 
Konig et al. 2005), have been revealed to interact with the β and γ subunits of ENaC. 
Administration of amiloride and benzamil, both antagonists of ENaCs, results in 
blocking the myogenic constriction of blood vessels (Jernigan and Drummond 2005), 
suggesting a potential role of ENaCs in mediating vascular vessel tone. Changes in the 
plasma Na+ concentration affect EC function and thus control vascular tone via NO 
(Oberleithner, Riethmuller et al. 2007). Additionally, as a stimulator of ENaCs, 
aldosterone has been shown to cause HUVEC swelling (Oberleithner, Schneider et al. 
2003) and surface insertion of ENaC in ECs (Oberleithner, Riethmuller et al. 2006; 
Kusche-Vihrog, Sobczak et al. 2007; Kusche-Vihrog, Sobczak et al. 2008). However, 
many previous efforts have failed to detect ENaC activity in ECs (Nilius and 
Droogmans 2001), generating questions about its function in ECs. In this study, we 
sought to determine whether ENaCs is functionally expressed in ECs and what 
mechanisms regulate ENaCs in ECs. 
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5.2 Materials and methods 
5.2.1. ECs and artery  
Human dermal microvascular endothelial cells (HMEC) and primary cultured human 
dermal microvascular endothelial cells (pHMEC) were kindly donated by Prof A 
Ahmed (University of Birmingham, UK). These cells were maintained as previously 
described (Ades, Candal et al. 1992). pHMECs were used within five passages. The 
aorta and arteries from femoral, pulmonary and tail regions were dissected from 
anesthetized rats or rats killed by cervical dislocation. Vessels were placed in ice cold 
Hanks’ solution containing (in mmol/L): NaCl 137, KCl 5.4, CaCl2 0.01, NaH2PO4 0.34, 
K2HPO4 0.44, D-glucose 8, and HEPES 5, and were carefully prepared by removing 
connective tissue, fat and lateral branches under a dissecting microscope. Endothelia 
from aorta and pulmonary arteries were removed by air bubble flushes as described 
in previous reports. All blood vessels were immediately placed either in liquid 
nitrogen to isolate protein or at 4ºC to isolate mRNA.   
5.2.2. RT-PCR and western blots   
RT-PCR experiments followed standard protocols. Primers against human (Ji, Su et al. 
2006) and rat ENaCs were used as previously described.  A 406-bp product of 
human α-ENaC was amplified by the primers: 5-AAC AAA TCG GAC TGC TTC TAC-3 
(sense) and 5-AGC CAC CAT CAT CCA TAA A-3 (antisense); a 440-bp product of human 
β-ENaC was amplified by the primers: 5-GGG ACC AAA GCA CCA AT-3 (sense) and 
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5-CAG ACG CAG GGA GTC ATAG-3 (antisense); a 325-bp product of human γ ENaC 
was amplified by the primers: 5-GCA CCG TTC GCC ACC TTC TA-3 (sense) and 5-AGG 
TCA CCA GCA GCT CCT CA-3 (antisense); a 456-bp product of human ζ-ENaC was 
amplified by the primers: 5-CGA AGC ATG GAC GGG AGA ATG-3 (sense) and 5-GGT 
GCC AGT GAC GCT CAA AGA-3 (antisense). Thirty cycles of 94°C for 0.5 min, 56°C for 
1 min, 72°C for 1.5 min were performed, followed by a single 10-min cycle at 72°C for 
extension. 
A 168-bp product of rat α-ENaC was amplified by the following primers: 5-TGG TAC 
CGC TTC CAT TAC AT-3 (sense) and 5- GTA GCA GTT CCC GTA CAT GG-3 (antisense). A 
378-bp product of rat β-ENaC was amplified by the primers 5-TGG CAA CTG CTA CAT 
CTT CA-3 (sense) and 5- ATG TGG TCT TGG AAA CAG GA -3 (antisense). A 302-bp 
product of rat r-ENac was amplified by the primers 5-CGC CCT CCT CGT CTT CTC TTT 
C-3 (sense) and 5-TGG CCT TTC CTT TCT CGT TCT C-3 (antisense). Thirty cycles of 94ºC 
for 0.5 min, 57ºC for 1 min, 72ºC for 1 min were performed, followed by a single 10 
min cycle at 72ºC for extension. 
A 329 bp product of human CYP 2C was amplified by the following primers: 5'-GCT 
AAA GTC CAG GAA GAG ATT G-3' (forward) and 5'-GCT GAG AAA GGC ATG AAG TA-3' 
(reverse) (Fujitaka, Oguri et al. 2001). Thirty five cycles of 94ºC for 0.5 min, 51ºC for 
0.5 min, 72ºC for 1 min were performed, followed by a single 10 min cycle at 72ºC for 
extension. 
For western blotting, arteries were quickly frozen in liquid nitrogen and homogenized 
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with CelLytic M lysis/extraction reagent and Protease Inhibitor cocktail (Sigma).  
Protein concentrations were determined by the Bradford Assay method. Equal 
amounts of total protein were loaded into the SDS-PAGE gel wells. β-actin was used 
as the inner marker to calibrate the protein quantity. Samples prepared with 5x 
loading buffer, were separated on 10% SDS-PAGE gels and then transferred to 
nitrocellulose membranes, which were rinsed with Tris-Buffered Saline Tween-20 
(TBS-T) and then blocked in TBS-T containing 5% milk for 1 hour (at room 
temperature). The membrane was incubated with the first antibody, α-ENaC 
antibody (1:500, CHEMICON/1:500 Santa Cruz Biotechnology sc-21012)  or eNOS 
antibody (1:2500, BD BIOSCIENCES, PRODUCT:610 297) overnight at 4°C, followed by 
washes in TBS-T and incubation with the secondary antibody (1:10000, HRP, BioRad) 
for 1 hour at room temperature. Membranes were washed with TBS-T and blots were 
detected by ECL plus.  
5.2.3. Knockdown experiments  
Expression of the α subunit of ENaC was decreased using validated on-Targetplus 
siRNA (smart pool ENaC channel, Cat No. L-006504-00) from Thermo Fisher Scientific 
(Dharmacon). Negative controls were employed using a negative control siRNA 
(non-targeting pool, Dharmacon) and vehicle alone. DharmaFectin 1(T-2001-01) 
transfection reagent was used for transfection. The knockdown experiments were 
carried out according to the manufacturer’s instructions.  Knockdown effects were 
examined by RT-PCR and western blot analysis after 24 and 48 hours. 
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5.2.4. Electrophysiology 
Cells were seeded onto a coverslip at approximately 30% confluence. The coverslip 
was used within 72 hours after preparation. After a high resistance seal (over 2 GΩ) 
was obtained, cell-attached recording was performed immediately. Subsequent to 
cell-attached recording, an inside-out or outside-out configuration was formed 
according to the standard procedure. The membrane resistance was monitored 
regularly to ensure the quality of recording. The pipette was pulled by a two stage 
vertical puller (Narishige PP-83). The resistance of the pipette in bath medium was 
around 5.8 MΩ.  
Currents were recorded with an Axon 1D amplifier and Axon clampex 9.0. The data 
was acquired at 20 kHz and filtered by a 5 kHz low pass filter. The channel events 
were analyzed by pclampfit 9.0 (single channel search in analyze function). Data was 
further filtered at 200 Hz before analysis. A 50% threshold cross method was utilized 
to determine valid channel openings.  When multiple channel events were 
observed in a patch; the total number of functional channels (N) in the patch was 
determined by observing the number of peaks detected on all point amplitude 
histograms. NPo, the product of the number of channels and the open probability, or 
the open probability (Po) itself, was used to measure the channel activity within a 
patch. The NPo was calculated according to previous descriptions (Yue, Malik et al. 
2002). Because the recording membrane patch usually contained multiple channels, 
the changes in NPo (not Po) were directly observed and compared in most cases. Due 
to the variance of channel open probability, the first two-three minute single channel 
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recording (inside out recording) in normal bath medium was normally used as the 
control. The open probability (NPo) of ENaC during applications of modulators was 
directly compared with the NPo of the control.  The ratio thus obtained was 
employed to determine the effects of modulators on ENaC activity. The data are 
presented as means ± S.E.M., and the statistical differences were compared using 
Student’s paired t test, taking P < 0.05 as significant. 
Bath solutions contained (in mM): 115 NaCl, 4.5 KCl, 1 MgCl2, 1 CaCl2, 5 HEPEs, 5 
Na-HEPEs, pH 7.2. The pipette solution contained (in mM): 115 NaCl, 4.5 KCl, 0.1 
EGTA, 5 HEPEs, 5 Na-HEPEs, pH 7.2. In some experiments, the low Na+ bath medium 
contained (in mM): KCl 120, MgCl2 1, 5 Na-HEPEs, 5 HEPEs, 0.2 EGTA, pH 7.2. Stock 
solutions of PPOH (Cayman), DDMS (Cayman), 11,12-EET (Biomol) and amiloride 
(Biomol) were made up according to the chemical data sheet. All recording solutions 
were made on the day of experiments. The solvent at the same dilution was tested 
alone in controls and had no effect. 
5.2.5. Flow setup 
After the outside-out configuration was obtained, the patch pipette was moved 
toward a perfusion tube (ID 0.5 mm) to a distance within 200 µm. A syringe pump 
(Harvard Apparatus, Harvard, Mass) connected through tubing to the glass pipette 
(ID 0.5 mm) provided fluid flow. The flow value was set to 1 ml/min, which resulted 
in a laminar shear force of 1.5 dynes/cm2 in the tube according to equations 
described previously (Oancea, Wolfe et al. 2006). Although the shear force decayed 
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exponentially as fluid left the tube, we assumed the drop to be minimal at a distance 
of 200 µm. The single channel currents obtained by outside-out recordings were 
compared between static bath and flow stimulation. 
5.3 Results  
5.3.1. Expression of ENaC channels in cultured ECs and arteries 
Desired products of RT-PCR revealed that the α-subunit of ENaCs, but not the β, γ 
and δ subunits, was expressed in cultured HMEC and HUVEC (figure 5.1a). Positive 
bands for the β, γ and δ subunits were obtained in A549 cells (data not shown). In 
order to elucidate whether ENaCs were also present in ECs in situ, several rat arteries 
from aorta, femoral and tail were examined with PCR primers against the α, β and γ 
subunits of ENaC. The positive products with expected sizes indicated that the α, β 
and γ subunits of ENaC (figure 5.1b) were expressed in rat blood vessels. Consistent 
with the PCR results, the protein of the α-subunit of ENaC was found in a variety of 
blood vessels e.g. aorta, pulmonary, femoral and tail (figure 5.1c), and the kidney.  
Previous studies (Drummond, Gebremedhin et al. 2004; Grifoni, Gannon et al. 2006) 
have demonstrated that the β and γ subunits of ENaC are present in the smooth 
muscle of cerebral artery and are involved in smooth muscle cell migration. To 
determine the location of the α-subunit of ENaC, the blood vessels with or without 
ECs were investigated to check the protein level of α-subunit of ENaC. The protein 
level of eNOS was utilized as a marker to quantify the ECs in the artery segments 
 159 
(figure 5.1d). The semi-quantification was performed by the intensity of targeted 
protein in calibration with β-actin of distinct samples. In parallel to the decrease of 
32.5 ± 13.3 % of eNOS in endothelium stripped vessels (n=4) , the protein level of the 
α-subunit of ENaC channel also decreased by 21.1 ± 5.1%, suggesting the presence of 
an α-subunit of ENaC in ECs of blood vessels.  
5.3.2 ENaC currents were detected in HMEC-1 and pHDMEC.  
The α subunit of ENaC alone can form the pore structure and permeates amiloride 
sensitive Na+ currents (Canessa, Schild et al. 1994). We utilized 120 mM Na+ saline in 
both pipette and solutions, which gave symmetrical Na+ across the membrane in the 
excised recordings. Prior to excised-membrane recording, cell-attached recording was 
performed when a tight seal was achieved. It was hard to detect ENaC currents in 
cell-attached recordings. Six recordings from 340 cells exhibited small conductance of 
channels (4.72 ± 0.52 pS as calculated from the slope between Vp= +0 mV and 
Vp=+40 mV). The currents exhibited flickering and short opening times. However, 
when excised outside-out configurations were formed after termination of 
cell-attached recording, an inward current with a conductance of 4.83 pS was found 
in 153 of 340 cells. The currents were further identified by their conductance and by 
their amiloride sensitivity. Figure 5.2a shows a recording of ENaC activity in an 
outside-out patch clamped at -100, -80 and -40 mV, respectively.  The average 
channel slope conductance was 4.83 ± 0.29 pS (n=120) between -100 and -40 mV.  
In outside-out recordings, amiloride at a concentration of 0.5 or 5 µM was applied 
into the bath to confirm that the currents were mediated by ENaC channels. 0.5 µM 
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amiloride induced flickering current and reduced the open probability (Po) (figure 
5.2b). Amiloride at a concentration of 5 µM almost abolished ENaC currents (n=12). 
Inward currents of similar conductance were also observed in inside-out recordings. 
IV curves obtained from either inside-out or outside-out exhibited a similar linear 
slope (conductance) (figure 5.2c). When 120 mM Na+ medium was replaced with low 
Na+ medium (5 mM), ENaC currents exhibited longer opening times. The I-V curve 
(each point represented the analysis of data from six to eight cells was linearly fit, γ2 
= 0.99) was shifted to the right (figure 5.2c), suggesting a Na+ selectivity for this 
channel. Recordings were carried out in both HMEC and pHMEC.  
Inconsistent with a previous study (Kelly, Lin et al. 2003), the conductance of ENaC in 
HMEC was around 4.8 pS. Specific knockdown experiments against the α subunit of 
ENaC were therefore performed to confirm these small conductance inward currents 
were mediated by ENaC. The knockdown effect was examined by RT-PCR and 
Western blot analysis. After 24 hours, mRNA of the α subunit of ENaC was 
significantly decreased, resulting in a negative PCR product after 20 PCR cycles, 
whereas a positive PCR product was shown in knockdown control cells (Fig3a). 
Consistent with the expression result of ENaC, protein levels of the α subunit of ENaC 
were significantly decreased after 48 hours (figure 5.3b). In parallel with the decrease 
of ENaC protein in HMEC, the probability (17 out of 200 recordings) of detecting such 
conductance currents (around 0.3 pA at Vp=60 mV and 0.4 pA at Vp=80 mV) in the 
inside-out recording from the ENaC knockdown groups (N=3) was also reduced, when 
compared to the control groups trasfected by the negative control siRNA (80 out of 
180 recordings) (N=3).  
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Our data show that functional ENaCs are expressed in HMEC-1 and pHMEC. However, 
the significant differences in channel open probability between the cell-attached and 
excised membrane recordings suggest that membrane ENaCs in intact cells are 
strongly inhibited by intracellular molecules. 
5.3.3 ENaC currents were inhibited by 11, 12-epoxyeicosatrienoic acid (EET) 
 Low ENaC activity was observed in cell-attached recordings, but high ENaC activity 
was detected in excised membranes, suggesting the presence of cellular inhibition of 
ENaC. EET was proposed as one of the candidate inhibitors, because of the 
predominant expression of CYP in blood vessels (Elbekai and El-Kadi 2006; Fleming 
and Busse 2006). To determine the effect of EET on ENaC currents in endothelial cells, 
11,12-EET at the concentration of 200 nM was applied to the bath, after either the 
inside-out or outside-out configurations were formed. Figure 4 demonstrates that 
11,12-EET almost abolished all ENaC activity and reduced NPo from 0.67 ± 0.12 to 
0.08 ± 0.05 (n=4). This inhibition was reversed when EET was washed off.  It was 
apparent that EET, as the product of cytochrome P450 (CYP) –epoxygenase, could 
effectively inhibit ENaC.  
MMS-PPOH (15 µM), an antagonist of CYP4502C, was incubated with cells for 12 
hours prior to experiments. Sixty cells were examined.  ENaC currents were 
detected in 21 of 60 excised patch recordings and in six cells of 60 cells by 
cell-attached recordings.  The rate of detected ENaC currents in MMS-PPOH treated 
cells (6 out of 21recordings) significantly increased, compared to the control (6 out of 
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153 recordings) by two-tailed binomial test (p=0.013<0.05). However, treatment with 
DDMS (3 out 90 recordings) did not exert significant effect (p>0.05). The expression 
of CYP450 2C in pHMEC and HMEC was shown by positive RT-PCR products (figure 
5.4c). The results also suggested the unknown cellular molecular in addition to 
11,12-EET exerted strong inhibition on ENaCs. 
5.3.4 ENaC activities enhanced by flow 
To assess the effect of shear force on ENaC activity, the outside-out recording was 
employed as a standard protocol. In the outside-out configuration, the extracellular 
loop of ENaC faces the fluid flow and it resembles the situation in the intact cells, 
when channels are activated by shear force. ENaC currents were detected in an 
excised outside-out recording in the static bath.  In the outside-out recording 
configuration, the open probability (Po) of ENaC was increased from 0.325 ± 0.17 to 
1.1 ± 0.3 (n=4) (p<0.05) by fluid flow (figure 5.5a). However, when 1µM amiloride 
was present in the fluid, the flow failed to enhance the Po (n=4). This result 
suggested that ENaCs can change their open probability directly in response to flow.  
5.4 Discussion  
Our data show that the α subunit of ENaC was functionally expressed in cultured ECs 
and ECs in blood vessels. However, the activities of ENaCs in intact ECs, such as HMEC 
and pHMEC, were strongly inhibited by intracellular molecule, including 11,12-EET. 
ENaC in ECs mediated Na+ currents, only when intracellular inhibitors were removed. 
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In outside-out recording mode the channel open probability of ENaC was significantly 
enhanced by flow, indicating the capability of ENaCs to respond to the shear force. 
Our results suggest that ENaC may play an important role in vascular physiology as a 
new candidate in mediating shear force. 
The α subunit of ENaC alone can form the pore structure and permeate amiloride 
sensitive Na+ currents (Canessa, Schild et al. 1994). For maximal ENaC activity, each 
subunit is required in equal numbers to form the proper stoichiometry (Staruschenko, 
Adams et al. 2005). Although the PCR results demonstrate the presence of only an α 
subunit in cultured ECs, there may be a difference in channel composition between 
cultured ECs and intact ECs in vivo. We observed the conductance of ENaC in HMEC 
and pHMEC to be much smaller than  previously reported (Kelly, Lin et al. 2003). 
One possible explanation for this conductance difference is distinct channel 
complexes in different cells, where these include co-localized proteins, ion channels 
and cytoskeleton filaments. When short actin filaments are present on the 
presumptive cytoplasmic surface of the channel, the single channel conductance of 
ENaC is decreased by half from 13 to 6 pS (Jovov, Tousson et al. 1999). In the absence 
of CFTR, ENaC currents with 13 pS conductance are predominant. However, a shift of 
ENaC gating into its 40 pS conduction state is observed  in bilayer experiments when 
CFTR is present (Ismailov, Awayda et al. 1996). In bilayers, the α, β and γ components 
of ENaC from rabbit reticulocyte cell lysate display three subconductive states of 13, 
26 and 39 pS (Ismailov, Berdiev et al. 1997), with a characteristic gating pattern. The 
bovine ENaC-α exhibits a main transition state of 39 pS with a very rare 13 pS, 
whereas the rat renal ENaC-α has a main transition state of 13 pS (Fuller, Ismailov et 
 164 
al. 1996). In contrast, α,δ, and γ of rat colon ENaC obtained from transfected sf9 cells 
possess  amiloride sensitive currents with a conductance of 6 pS (Rao, Mehdi et al. 
2000) in bilayers. The conductance of rat ENaC measured in oocytes is around 5 pS 
(Fuller, Ismailov et al. 1996). Taken together; these reports strongly suggest that 
ENaC kinetics are varied, likely due to the nature of the channel complex. Our 
observations were based on experiments in the native endothelial cells, while the 
other work was carried out in expression systems and bilayers. The difference in 
cytoskeleton, co-localized ion channels and other complex proteins might lead to the 
different channel conductances and channel gating kinetics. In addition, our results 
were further supported by gene knockdown experiments. 
Laminar shear stress induces a reversible increase in benzamil sensitive Na+ currents 
in oocytes transfected by ENaC (Carattino, Sheng et al. 2004; Carattino, Sheng et al. 
2005). Our results and those of previous study (Althaus, Bogdan et al. 2007) have 
shown that laminar flow led to an increased open probability of ENaC without 
affecting the number of active channels. ENaC could serve as the mechanical sensor 
(Drummond, Gebremedhin et al. 2004) in response to flow. Na+ entry via ENaC into 
ECs will depolarize ECs to change the membrane potential. The enhanced 
intracellular Na+ could subsequently reverse the Na+-Ca2+ exchanger to increase 
[Ca2+]i (Sedova and Blatter 1999) (Teubl, Groschner et al. 1999) and facilitate activity 
of the Na+-K+ pump in the basolateral membrane of ECs to reduce the interstitial K+, 
which exerts its effect on smooth muscle. In addition, the electrogenic absorption of 
Na+ via ENaC creates trans-epithelial osmotic gradients that might represent the 
main driving force for water movement via aquaporins expressed in ECs (Schnitzer 
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and Oh 1996; Levick 1997). However, ENaC in intact ECs remains silent. The above 
speculations on the role of ENaC might only be relevant when intracellular inhibitors 
are compromised, for example in inflammation. They therefore suggest that ENaC 
might significantly alter the response of ECs to shear forces under specific conditions. 
Influx of Na+ mediated by ENaC might then directly depolarize ECs or facilitate 
membrane depolarization. 
The activity of ENaC in ECs is inhibited by intracellular molecules such as 11,12-EET, 
suggesting a complex regulation of ENaC in blood vessels. EET is derived from 
CYP4502C, which is abundant in the endothelium, where it mediates cell 
proliferation and regulates blood vessel tone (Pritchard, Tota et al. 1990; VanRollins, 
Kaduce et al. 1993; Mombouli, Holzmann et al. 1999; Zou, Yang et al. 2001). It has 
been demonstrated to be regulated by laminar flow (Spector and Norris 2007) 
(Brooks, Lelkes et al. 2002) and PPAR (Liu, Zhang et al. 2005; Pozzi, Ibanez et al. 2007). 
The dynamic processes of generation and degradation of EET in ECs is predicted to 
alter the activity of ENaC. Although it has been reported that the expression of 
CYP-2C decreases following cell isolation (Fleming, Michaelis et al. 2001; Michaelis, 
Fisslthaler et al. 2005),  expression and activity of CYP-2C are determined by many 
factors including the isolation protocol, culture condition (Pozzi, Ibanez et al. 2007; 
Michaelis, Xia et al. 2008), mechanical (Fisslthaler, Popp et al. 2001) and chemical 
stimulus (Fisslthaler, Hinsch et al. 2000). Intracellular generation of EETs by CYP is 
profoundly regulated by mechanical forces and other stimuli.  In addition, recent 
studies have suggested that PPARα (Spector and Norris 2007) and γ (Liu, Zhang et al. 
2005) can be activated under the flow and exert an anti-inflammatory effect. 
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Activation of PPARγ has been shown to up-regulate the expression of the α (Hong, 
Lockhart et al. 2003) and γ (Guan, Hao et al. 2005) subunits of ENaC and to increase 
the activity of ENaC via the serum and glucocorticoid regulated kinase pathway 
(Guan, Hao et al. 2005; Vallon and Lang 2005). The presence and activity of ENaC in 
ECs may therefore be profoundly regulated by multiple known and unknown factors, 
resulting in dynamic responses to shear forces. In addition, blockade of EET 
generation fails to completely reverse inhibition of ENaC, suggesting additional 
cellular molecular inhibitors.  Further study is required to identify these inhibitors. 
Nevertheless, this finding implies that ENaC channels in endothelial cells are tonically 
inhibited and only activated when endogenous intracellular inhibitors are removed 
under specific conditions e.g. inflammation.  
It has been established that P2X4 receptors mediate shear-induced Ca2+ influx in 
bovine and human endothelium, in the presence of extracellular ATP (Yamamoto, 
Korenaga et al. 2000). The ECs in P2X4 (P2X4 -/-) knockout mice do not have a normal 
response to flow, such as the influx of Ca2+ and subsequent production of NO, 
resulting in high blood pressure (Yamamoto, Korenaga et al. 2000). A key element in 
mediating P2X4 induced-shear response is the release of ATP from cells to serve the 
paracrine stimulation. CFTR and volume regulated anion channels, as endogenous 
ATP release pathways (Reigada and Mitchell 2005), are typically co-localized with 
ENaC (Yang, Ajonuma et al. 2004; Choi, Son et al. 2006; Leroy, Prive et al. 2006) and 
reciprocally interact with ENaC in term of their respective functions (Schreiber, Konig 
et al. 2003; Bachhuber, Konig et al. 2005; Carattino, Edinger et al. 2005; Nagel, Barbry 
et al. 2005). Another role of ENaC might be to coordinate amount of ATP released by 
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CFTR and VRAC in ECs.  
In summary, the α subunit of ENaC is widely expressed in ECs, but the ENaC activity is 
strongly inhibited by cellular molecules. When inhibition is removed, ENaC can sense 
flow directly by changes in channel open probability, thereby modulating Na+ entry, 
resulting in membrane depolarization. In coordination with other channels and 
transporters, ENaC may affect [K+]o in the vicinity of nearby smooth muscle cell, and 
may modulate the release of ATP from ECs. It may also be involved in the regulation 
of vascular tone. As a novel candidate for sensing shear force, ENaC might play an 
important role in vascular biology. 
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Fig 5.1 
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Fig.5.1. ENaC expression in ECs.  
A) Transcripts for the α subunit of ENaC, but not the β, γ or ζ subunits, were detected 
in cultured human ECs. B) Transcripts for α, β and γ subunits of ENaC were found in 
isolated arteries including aorta, tail artery and femoral artery. The transcript for 
actin was used as the sample control. C) The α subunit of ENaC protein was detected 
in aorta, femoral, tail and pulmonary artery. Rat kidney was used as the positive 
control. D) Aorta and pulmonary arteries stripped of ECs possessed less eNOS protein 
and α subunit protein, in comparison with normal aorta and pulmonary artery  
(white arrow bar in A, B indicates 500 bp). 
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Fig 5.2 
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Fig.5.2. ENaC currents detected in excised membrane recordings.  
A) Small conductance currents were elicited in an outside-out recording held at -100, 
-80 and -40 mV respectively. The lower trace in each panel represented the current 
fluctuations was expanded in a smaller time scale. B) In an outside-out recording, 
bath application of amiloride at a concentration of 0.5 µM significantly reduced the 
NPo of small conductance currents detected in ECs. 5 µM amiloride almost abolished 
the small conductance currents detected in ECs. C) Summary plots of I-V curves 
obtained in excised membrane recordings. Each point represents data from six to 
eight cells.  
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Fig 5.3 
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Fig.5.3. Knockdown of ENaC significantly reduced the possibility of detecting 
currents.   
A) A positive PCR result of the α subunit of ENaC was only detected in control groups 
after 20 cycles of PCR.  B) A significant decrease in the α subunit of ENaC was 
revealed by Western blot analysis. C) The top trace represents an example recording 
of inward current revealed in knockdown and control cells when the pipette was held 
at +60 mV in the inside-out recording. In conjunction with a decrease in expression of 
α subunit of ENaC, the probability of detecting ENaC currents was reduced as shown 
in the bar graph. * represents significance P<0.05. (white arrow bar in A, B indicates 
500 bp). 
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Fig.5.4. ENaC currents in ECs sensitive to 11,12-EET.  
In an inside-out recording, bath application of 11,12-EET at a concentration of 200 
nM almost abolished ENaC currents. ENaC currents partly recovered subsequent to 
removal of 11,12-EET. A). The bar graph shows the effects of amiloride and 11,12-EET 
on NPo of ENaCs from ECs. B) 11,12-EET exerted a remarked inhibition on ENaC from 
either outside or inside the membrane. *, represents significance P<0.05.  C) 
Transcripts for the CYP 2C were detected in pHMEC and HMEC. 
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Fig.5.5. Flow enhanced NPo of ENaC from ECs.  
A) In an outside-out recording, laminar flow significantly enhanced the NPo of ENaC 
in comparison to the static bath. Lower panel figures show the current fluctuations 
on an expanded time scale. B) The bar graph showed the effects of flow on NPo of 
ENaCs. Each column represents the data from 4-6 cells. *, represents significance 
P<0.05. 
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Chapter 6 
Role of Epithelial sodium channels (ENaC) in endothelium function 
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6.1 Introduction 
Vascular endothelial cells (ECs), which form a monolayer lining the luminal surface of 
all blood vessel walls, not only provide a selective barrier between circulating blood 
elements and underlying tissues but also serves a number of important vascular 
functions. One of the most important EC functions is that ECs act as a sensing 
interface which converts mechanical stimuli such as shear stress resulting from the 
blood flow into biochemical signals that initiates various vascular responses. This 
aspect of EC function is perhaps best exhibited by the endothelial-dependent vessel 
dilatation in response to increased blood flow rate. The precise tuning of 
vessel-motion by ECs is crucial to control the blood pressure and protects blood 
vessels from the adverse effects of various pathogenetic factors. Among the many 
putative mechano-transducers, endothelial ion channels are considered to be a 
particularly important candidate that mediates the first setting of EC responses (in a 
range of seconds and minutes) to changes in blood flow. Intensive studies have been 
launched to identify the potential shear force-sensing ion channels in ECs and an 
increasing number of channels have been suggested to participate in the process 
(Nilius and Droogmans 2001). We have identified that the epithelial Na+ channel is 
one of the mechano-transducing ion channels in human endothelial cells and its 
activity is tightly and actively regulated by various endogenous vascular signaling 
molecules including heme, HO-1 and CO. however, the overall impact of the ENaC 
mediated blood flow sensing is negative, since hyperactivity of the channel resulting 
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from systemic inflammation is a potent pro-atherosclerosis factor which causes 
endothelial cell dysfunction manifested by a decreased NO bioactivity and impaired 
shearforce sensitivity, and eventually leads to the initiation and progression of 
vascular diseases.   
Epithelial sodium channels (ENaCs) are of immense importance, controlling Na+ 
transport across epithelia and thus playing a central role in all aspects of fluid 
clearance as well as numerous other functions. Accumulated evidence has suggested 
that ENaCs are expressed in a variety of endothelial cells. Administration of amiloride 
and benzamil, both antagonists of ENaCs, results in blocking the myogenic 
constriction of blood vessels (Jernigan and Drummond 2005), suggesting a potential 
role of ENaCs in mediating vascular vessel tone. Changes in the plasma Na+ 
concentration affect EC function and thus control vascular tone via NO (Oberleithner, 
Riethmuller et al. 2007). Additionally, as a stimulator of ENaCs, aldosterone has been 
shown to cause HUVEC swelling (Oberleithner, Schneider et al. 2003) and surface 
insertion of ENaC in ECs (Oberleithner, Riethmuller et al. 2006; Kusche-Vihrog, 
Sobczak et al. 2008). However, role of ENaC in endothelium remains unclear. In 
hypertensive subjects with hyperaldosteronism, endothelium dependent 
flow-mediated vasodilatation is impaired (Nishizaka, Zaman et al. 2004). A decreased 
L-arginine conversion to NO are shown in these hypertensive patients after salt 
loading (Ni and Vaziri 2001). In addition, HO and its metabolic products e.g. carbon 
monoxide (CO) have been implicated in regulation of basal tone and the initial level 
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of blood pressure (Johnson, Lavesa et al. 1996; Johnson, Colombari et al. 1997; 
Kozma, Johnson et al. 1997; Johnson, Kozma et al. 1999; Sabaawy, Zhang et al. 2001). 
However, the mechanisms remain unclear. 
6.2 Specific methods and materials 
6.2.1 HUVEC cells  
Primary cultured HUVEC cells were from Lonza and Promocell ltd. Cells were grown 
in the HUVEC medium (Lonza) in a 37C and 5% CO2 incubator. Cells were used within 
5 passages.  
6.2.2 Electrophysiology recording 
Single channel recordings were performed as previously described. Briefly, a coverslip 
on which HUVECs were grown was transferred into a recording chamber mounted on 
a Nikon inverted microscope (Nikon TE 2000U). Patch pipettes with a resistance of 6 
MΩ was fabricated from a borosilicate glass capillary (1.5 mm od, 0.86 mm id) (Sutter) 
on a Sutter Puller (P97). Bath solutions contained (in mM): 110 NaCl, 4.5 KCl, 1 MgCl2, 
1 CaCl2, 5 HEPEs, 5 Na-HEPEs, pH 7.2. Pipette solution contained (in mM): 110 NaCl, 
4.5 KCl, 0.1 EGTA, 5 HEPEs, 5 Na-HEPEs, pH 7.2. Single channel currents were 
recorded with an Axon 1D amplifier and Axon clampex 9.0. The data were acquired at 
20 kHz and low pass filtered at 5 kHz. During post-experiment analysis, data were 
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further filtered at 200 Hz. Single channel events were listed and analyzed by 
pclampfit 9.0 (single channel search in analyze function). 50% threshold cross 
method was utilized to determine valid channel openings.  When multiple channel 
events were observed in a patch, the total number of functional channels (N) in the 
patch was determined by observing the number of peaks detected on all point 
amplitude histograms. NPo, the product of the number of channels and the open 
probability calculated as described previously (Yue, Malik et al. 2002), or the open 
probability (Po) itself, was used to measure the channel activity within a patch.  
Initial, 3-4 minute, single channel records were normally used as the control. The 
activity of ENaC during application of chemicals was normalized to the activity during 
the control period to assess the effects of chemicals on ENaC. In some cases ENaC 
activity during application of chemicals was also compared to that of ENaC after 
chemicals were washed off. These data were used to confirm the effects of chemicals. 
Data are presented as means ± s.e.m. and statistical differences were compared 
using Student’s paired t test, taking P < 0.05 as significant and marked by *.  
Patch pipettes with the resistance of 6 MΩ were fabricated from borosilicate glass 
capillary (1.5 mm od, 0.86 mm id) (Sutter) on a Sutter Puller (P97). Conventional 
whole cell recording was performed as previously descriped. The bath solution 
contained (in mM):  NaCl 110, KCl 4.5, MgCl2 1, CaCl2 1, glucose 10, HEPEs 5, 
HEPE-Na 5. The pipette solution contained (in mM): KCl 40, K-gluconate 100, MgCl2 1, 
CaCl2 1, EGTA 0.1, Na2ATP 4, Glucose 10, HEPEs 10, GTP 2.  pH by KOH to 7.2. In the 
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case of perforated whole-cell recording, the normal pipette solution contained 10-20 
μg/ml amphotericin B. On the day of experiment, 0.1 g amphotericin B (Sigma) was 
weighted and dissolved with 0.1-0.5 ml DMSO to make a stock solution. 0.5 μl stock 
solution was added into 1 ml pipette solution to make up final pipette solution, 
which containing amphotercin B 10-20 μg/ml. DMSO as a vehicle in same dilution 
within the pipette solution was tested. No effect was observed. 
6.2.3 Western blot analysis and PCR 
For western blotting, arteries were quickly frozen in liquid nitrogen and homogenized 
with CelLytic M lysis/extraction reagent and Protease Inhibitor cocktail (Sigma).  
Protein concentrations were determined by the Bradford Assay method. Equal 
amounts of total protein were loaded into the SDS-PAGE gel wells. β-actin was used 
as the inner marker to calibrate the protein quantity. Samples prepared with 5x 
loading buffer, were separated on 10% SDS-PAGE gels and then transferred to 
nitrocellulose membranes, which were rinsed with Tris-Buffered Saline Tween-20 
(TBS-T) and then blocked in TBS-T containing 5% milk for 1 hour (at room 
temperature). The membrane was incubated with the first antibody, α-ENaC 
antibody (1:500, CHEMICON/1:500 Santa Cruz Biotechnology sc-21012)  or HO-1 
antibody (AB-cam), HO-2 antibody (AB-cam) and caveolin-1 antibody (AB-cam)    
overnight at 4°C, followed by washes in TBS-T and incubation with the secondary 
antibody (1:10000, HRP, BioRad) for 1 hour at room temperature. Membranes were 
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washed with TBS-T and blots were detected by ECL plus.  
RT-PCR experiments followed standard protocols. Primers against human (Ji, Su et al. 
2006) ENaCs were used as previously described.  A 406-bp product of human 
α-ENaC was amplified by the primers: 5-AAC AAA TCG GAC TGC TTC TAC-3 (sense) 
and 5-AGC CAC CAT CAT CCA TAA A-3 (antisense). 
6.2.4 Knockdown experiments  
Expression of the α subunit of ENaC was decreased using validated on-Targetplus 
siRNA (smart pool ENaC channel, Cat No. L-006504-00) from Thermo Fisher Scientific 
(Dharmacon). Negative controls were employed using a negative control siRNA 
(non-targeting pool, Dharmacon) and vehicle alone. DharmaFectin 1(T-2001-01) 
transfection reagent was used for transfection. The knockdown experiments were 
carried out according to the manufacturer’s instructions. Knockdown effects were 
examined by RT-PCR and western blot analysis after 24 and 48 hours. 
6.2.5 Isolation of caveolae compartment  
HUVEC were grown to confluence in 75ml culture flasks and used for fractionation. 
The homogenates in MBS (25 mM 2-(N-morpholino)-ethanesulfonic acid (MES), pH 
6.5, 0.15 M NaCl) containing 1% Triton X-100 were adjusted to 40% sucrose by the 
addition of 2 mL of 80% sucrose prepared in MBS and placed at the bottom of an 
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ultracentrifuge tube. A 5–30% discontinuous sucrose gradient was formed above (4 
mL of 5% sucrose/4 mL of 30% sucrose, both in MBS lacking detergent) and 
centrifuged at 39,000 rpm for 18 h in an SW41 rotor (Beckman Instruments, Palo Alto, 
CA, USA). A light-scattering band at the 5–30% sucrose interface was collected or 
fractionated into 12 subfractions(32). A 100 µL aliquot of each fraction was used to 
measure alkaline phosphatase activity. After direct addition of substrate solution 
(p-nitro-phenyl phosphate, R&D systems, Minneapolis, MN, USA), the absorbance at 
405 nm was measured. 
6.2.6 Flow setup 
After the outside-out configuration was obtained, the patch pipette was moved 
toward a perfusion tube to a distance within 160 µm. A syringe pump (Harvard 
Apparatus, Harvard, Mass) connected through tubing to the glass pipette provided 
fluid flow (figure 2a).  
The shear force applied upon cell surface was calculated according to equation 
(Oancea, Wolfe et al. 2006): 
 
Where:  ρ is the density of water) 
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        V is The fluid velocity and calculated by V = Q/A, where A=πd2/4 ( d is the 
flow application pipette diameter). Q is the flow rate generated by the 
syringe pump measured in m3/s 
Rx=V*X/µ where X is the distance between pipette and cell, µ is the 
kinematic viscosity of the water 
In our setup, d was approx 120 µm and X about 160 µm. ρ=1025kg/m3 and µ=1.139 X 
10-6m2/s. Accordingly, 1 ml/min of flow generated 0.49 dyne stress; 3 ml/min of flow 
was 3.67 dyne; 5 ml/min was 8.42 dyne; 8 ml/min was 17 dyne.  
6.2.7 Chemicals and stock solutions 
Benzamil and amiloride were purchased from Biomol International. Haem, PP9, 
MP11, FeSO4, NADPH and ZnPP9 were from Sigma-Aldrich. SnPP was from Tocris. 
Biliverdin was from Frontier Scientific. Stock solutions (1 mM) of these reagents in 10 
mM NaOH were made weekly and kept at -20 °C in aliquots. All the solutions were 
thawed and immediately before use. [ruthenium(CO)3Cl2]2  was freshly dissolved in 
DMSO on the day of experiments. Ruthenium (III) chloride hydrate and ruthenium 
(DMSO)4Cl2 were also freshly prepared accordingly. The medium containing certain 
concentration of CO donor is made of 30 minutes ahead of experiments. Partial 
pressures of medium O2 were measured and monitored by O2 meter (WPI ISO2). 
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Hypoxic medium was obtained by N2 bubbling. 
6.3 Results 
6.3.1 ENaCs expressed in HUVEC were functional 
Consistent with our previous work (Wang, Meng et al. 2009), small conductance 
inward currents were detected in HUVEC. In the inside-out recordings, a range of 
currents were elicited by different voltages (figure 6.1a). Analysis of these results 
concluded the conductance of this channel was 4.8 pS (figure 6.1b), which is similar 
to that of ENaC founded in renal tubular cells (Wei, Lin et al. 2004). With respect to 
the conventional blockers for ENaC, e.g. amiloride and benzamil, ENaC activity was 
significantly reduced when 1μM amiloride was included in the pipette solution 
(ismilov) (figure 6.1c). To ensure that this small conductance currents were mediated 
by ENaCs, knockdown experiments against the human α subunit of ENaC were 
therefore performed. The knockdown effect was examined by RT-PCR and Western 
blot analysis. After 24 hours, mRNA of the human α subunit of ENaC was significantly 
decreased, resulting in a negative PCR product after 20 PCR cycles, whereas a 
positive PCR product was shown in knockdown control cells (not shown). Consistent 
with the RT-PCR results, western blot analysis indicated that protein levels of the 
human α subunit of ENaC were significantly decreased after 48 hours (Figure 6.1d). In 
parallel with the decrease of ENaC protein in HUVEC, the probability (60 out of 110 
recordings) of detecting such conductance currents (around 0.3 pA at Vp=60 mV and 
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0.4 pA at Vp=80 mV) in the inside-out recording from the ENaC knockdown groups 
(N=3) was also reduced, when compared to the control groups trasfected by the 
negative control siRNA (80 out of 180 recordings) (N=3).  
6.3.2 ENaCs were activated by flow. 
The ENaC superfamily has been demonstrated to be able to sense mechanical stress 
(Adams, Anderson et al. 1998; Hong, Mano et al. 2000) and transduce the stress into 
electrical events, resulting in membrane depolarization (Snitsarev, Whiteis et al. 
2002). Structurally, ENaCs contain only two trans-membrane domains and a large 
extracellular region with cysteine-rich domains and glycosylation sites, which will be 
rationally anticipated to sense flow. In a conventional whole-cell recording by 
rupturing the membrane to form whole-cell configuration, flow at the speed of 5 
ml/min (equivalent to 8.42 dyne) significantly augmented inward currents mediated 
by ENaC, which was completely reversed by benzamil (10μM) (figure 6.2a). Shear 
stress on stimulated the ENaC mediated whole-cell current on a dose dependent 
manner (figure 6.2c).  
6.3.3 ENaCs were activated by stretch 
Alternatively, the ENaCs were also activated by stretch/pressure. To mimic the 
pressure of blood flow on endothelium, a positive pressure was applied through the 
patching pipette to apical membrane of HUVEC in inside-out recordings. Pressure (10 
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mmHg) significantly increased ENaC activity (figure 6.3a) almost 1.5 fold in a 
repeated manner. Intriguingly, flow also stimulated ENaCs even when channels were 
covered within the patching pipette in cell-attach recordings (figure 6.3b). It 
suggested there is an unknown mechanism through which ENaCs are indirectly 
activated by flow. The candidates might include the molecules co-localized with 
ENaCs.  
6.3.4 ENaCs co-localized with caveolin-1, HO-1 and HO-2.   
Previous reports have demonstrated that ENaCs are present within caveolae(Hill, 
Butterworth et al. 2007) and regulated by lipid rafts (Hill, An et al. 2002). Accordingly 
(Hill, Butterworth et al. 2007), HUVEC were lysed and membranes separated by 
density on sucrose gradients at 39,000 rpm, SW41 rotor for 18 hours (Beckman 
Instruments, Palo Alto, CA, USA). Total 12 fractions were obtained after 18 hours. 
Each fraction was precipitated and then immune-blotted with antibodies against 
α-subunit of ENaC, caveolin-1, hemeoxygenase-1 (HO-1) and hemeoxygenase-2 
(HO-2). Low density membranes which correspond to lipid rafts are found near the 
top of the gradient in fractions of 4 and 5 while non-raft markers are found at higher 
sucrose densities in fraction 8-12. Caveolin-1 was found in fractions 4 and 5. 
Meanwhile, α-subunit of ENaC, HO-1 and HO-2 were also detected in these fractions 
(figure 6.3c), suggesting ENaCs are expressed within caveolae. It might co-localize 
with caveolin-1, HO-1 and HO-2. Flow mechanically deforms the endothelial cell 
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membrane. The deformation of apical membrane will affect caveolae structure, 
resulting in modulation of ENaC activity. It will be manifested by the observation that 
flow indirectly activates ENaCs. 
6.3.5 Regulation of ENaC by Haem and CO 
Application of haem at nanomolar concentration to the intracellular side of the 
channels (inside-out recordings) consistently and significantly reduced the open 
probability (NPo) of ENaCs (figure 6.4a, b). In inhibition of ENaCs by haem did not 
require any exogenously added enzyme and cofactor. No change of unitary current 
amplitude was observed. Upon washout of haem, the reversal of inhibition was slow 
and sometimes partial.  
Application of 1 nM NADPH alone had no effect on activity of ENaC. In the presence 
of O2 and NADPH, hemeoxygenase converts haem to biliverdin, iron and CO (Williams, 
Wootton et al. 2004). Modulation of the activity of ENaC by CO resembled that seen 
upon co-application of haem and NADPH (figure 6.4a, b), suggesting that the 
stimulatory effect of these agents might indeed reflect the generation of CO by 
hemeoxygenase. However, when haem exceeding the concentration of 60 nM, 
reduction of NPo of ENaC occurred, suggesting that haem and CO act competitively 
in their effects on ENaC expressed in HUVEC. 
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Activity and density of HO appear the determinant factor in the regulation of ENaC 
activity. In HO-1 knock down HUVEC, 20 nM haem plus NADPH exerted a similar 
inhibitory effect on ENaC as 20 nM haem. However, ENaCs exhibited more active in 
presence of 20 nM haem plus NADPH when HO-1 was over-expressed in HUVEC 
(figure 6.4c).  
6.3.6 Regulation of HO expression and ENaC activity by TPA 
TPA (phorbol 12-myristate 13-acetate) is a potent tumor promoter and it can activate 
protein kinase C in vivo and vitro (DeRiemer, Strong et al. 1985; Sagi-Eisenberg, 
Lieman et al. 1985). In addition, it is also regarded as a common inflammatory factor. 
In this study, TPA at a concentration of 100 ng/ml was added into the growing 
medium 24 hours prior to experiments. A western blot analysis showed that HO-1 
expression was significantly increased after 24 hours stimulation of TPA, whereas 
caveolin-1, HO-2 and α subunit of ENaC remained unchanged (figure 6.5a). TNF-α 
exerted similar stimulation effects on caveolin-1, HO-1, HO-2 and ENaCs.  
Over-expression of HO-1 leads to higher amount of HO products e.g. CO, resulting in 
increase of ENaC activity. To avoid the dialysis of cellular messengers by patching 
pipette solution, perforated whole-cell recording was therefore employed. Inward 
currents mediated by ENaCs were bigger and exhibited a bigger increase in TPA 
stimulated HUVEC, comparing with the control HUVEC (figure 6.5b).  
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6.3.7 Increase of [Na+]i impeded cationic amino acid transporter (CAT) activity 
In hypertensive subjects with hyperaldosteronism, endothelium dependent 
flow-mediated vasodilatation is impaired (Nishizaka, Zaman et al. 2004). A decreased 
L-arginine conversion to NO are shown in these hypertensive patients after salt 
loading (Ni and Vaziri 2001). eNOS requires L-arginine as a substrate to generate NO. 
L-arginine transport across the membrane is via CAT, which utilizes the Na+ gradient 
across cell membrane as a driving force. Increase of [Na+]i reduced the activity of CAT 
evoked by extracellular L-arginine in a dose-dependent manner (figure 6.5c). It 
suggested that activation of ENaC might exert a complex effect on vascular regulation 
in response to flow, likely negative and passive effect.  
6.3.8 Inhibition of inward rectified K (IRK) channels by CO 
IRKs are predominantly expressed in endothelial cells and generally regarded as a 
flow sensor. Shear stress activates IRK, channels, resulting in membrane 
hyperpolarization in endothelial cells, consequent enhancement of Ca2+ influx and 
stimulation of eNOS. Since increased flow apparently activates ENaC channels though 
regulation of HO-1, we investigated whether HO activity (generation of CO) might 
contribute to the regulation of IRK channels in HUVECs. IRK-like currents in HUVECs 
were activated by flow (figure 6.5a) and identified by their I-V curve, reversal 
potential and sensitivity to Ba2+ and TEA. When cells were exposed to CO in the flow 
medium (CO donor at a concentration of 20 μM) the IRK currents were significantly 
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attenuated. To clarify our observation, we transfected HEK cells with IRK 2.3 plasmid. 
Typical IRK currents were then observed and they are reversed at -60 mV and 
sensitive to Barium. 1 mM Co donor also induced a significant blockage on IRK 
currents as shown in igure 6.6 
6.4 Discussion 
In this study, we demonstrated that ENaC expressed in HUVEC are functional. ENaCs 
in HUVEC could be activated directly and indirectly by flow and stretch. ENaCs, HO-1 
and HO-2 were expressed within caveolae on apical membrane of HUVEC. 
Deformation of membrane also stimulated ENaC via caveolae. However, activity of 
ENaC in an intact cell remained low due to the tonic inhibition of haem. HO acts as a 
modulator and O2 sensor, its substrate (haem) and product (CO) inhibiting and 
stimulating (respectively) the activity of ENaC. TPA as well as other inflammatory 
factors could increase expression of HO-1, which leading to high activity of ENaC and 
their sensitivity to flow. Nevertheless, the increase of [Na+]i impeded the activity of 
CAT, resulting in reduction of NO in response to flow. In addition, ENaC may mediate 
the toxic effect of CO on HUVEC. 
Laminar flow increases the open probability of ENaC without affecting the 
conductance of ENaCs. ENaC can therefore serve as a mechanical sensor (Drummond, 
Gebremedhin et al. 2004) in response to flow. Activation of ENaC will permeate Na+ 
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entry, subsequently depolarize ECs. The increase of [Na+]i will facilitate the Na
+-K+ 
pump in the basolateral membrane of ECs to reduce the interstitial K+, which results 
in hyperpolarization of smooth muscles (Jiang, Nuttall et al. 2005; Pritchard, 
Parvatiyar et al. 2007) which partly in control of vascular tone. However, it is complex 
in NO production by activation of ENaC. The increase of [Na+]i will reverse the 
Na+-Ca2+ exchanger (NCX) to augment [Ca2+]i (Sedova and Blatter 1999) (Teubl, 
Groschner et al. 1999), which is in favour of NO generation. On the other hand, eNOS 
requires L-arginine as a substrate to generate NO. L-arginine across membrane is via 
cationic amino acid transport (CAT), which utilizes Na+ gradient across cell membrane 
as a driving force. Increase of [Na+]i will impair L-arginine transport, resulting in 
reduction of NO generation. Nonetheless, the significant effect of ENaC appears to 
mediate NO-independent vessel dilation, which is due to SMC relaxation. The 
increase in intracellular Na+ results in basolateral Na+-K+ATPase hyperactive, causing 
K+ content decrease in the myo-endothelial fluid, which hyperpolarize smooth 
muscle cells. However, the ENaC mediated NO-independent vessel-dilation is weak to 
adapt rapid change in blood flow, resulting in high pressure when high flow passes 
through narrow vessels. It is rational that vessels exert dilation in response to the 
high speed flow. The vessel dilation is mainly induced by NO released from 
endothelium and smooth muscle cell (SMC) relaxation due to SMC hyperpolarization. 
Between these two factors, effect of NO takes a major account on vessel dilation.  In 
conclusion, ENaCs may cause SMC hyperpolarization and hance slight vessel dilation, 
but it reduces NO production, which is pathlogical. Moreover, the slight vessel 
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dilation might not be sufficient to adapt the increase of flow, resulting in high 
pressure. 
TNF has been shown to stimulate Na+ uptake in distal tubule cells isolated from 
diabetic rats (DiPetrillo, Coutermarsh et al. 2003; DiPetrillo, Coutermarsh et al. 2004). 
Activity and expression of HO determine CO. Expression of HO could be regulated by 
many factors, majorly inflammatory factors. High expression of HO occurs in many 
chronic diseases and vascular diseases. In these situations, ENaC participates in 
endothelial shear force sensing. Consequently, vessels may exhibit good dilation 
initially in response to flow (Sabaawy, Zhang et al. 2001), but appear slight dilation in 
a long term. The mismatch between the flow and diameter of vessel will lead to high 
blood pressure and or damage of endothelium, resulting in the other vascular 
diseases related to endothelium dysfunction. Interestingly, recent reports have 
shown that plasma sodium in the high physiological range stiffens endothelial cells 
and reduces the release of NO, whereas potassium softens vascular endothelium and 
increases NO release (Oberleithner, Callies et al. 2009). In addition, accumulated 
cellular Na+ mediated by ENaC appeared to initiate or activate cellular necrosis, 
which appeared blisters on cell membrane and membrane damage.  
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Figure 6.1 ENaCs expressed in HUVEC were functional. a, examples of current traces 
elicited at different voltages in inside out recordings. The voltage on the left to the 
current traces represented the pipette command voltages. b. I-V curved constructed 
from the results of inside-out recordings. The conductance was approx 4.8 pS. Each 
point represented the mean (±SEM) of 8-10 cells. c. 1 μM amiloride significantly 
reduced the channel open probability but not conductance. Example traces of 
currents detected in the cell-attach recording with or without 1μM amiloride in the 
pipette solution are shown in the left panel. Extracellular amiloride significantly 
inhibited channel activity (right panel). d. knockdown of ENaC in HUVEC significantly 
attenuated the probability to detect currents with this conductance. In parallel to 
reduction of ENaC in HUVEC by si-RNA against human ENaC (top panel), probability 
to detect such currents was significantly attenuated from 60 out of 110 to 18 out of 
110.  
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Figure 6.2 Flow activated ENaCs. a. In a conventional whole cell recording, ENaC 
currents were elicited by a voltage-ramp protocol (as shown in inset of a). Cells were 
hold at 40 mV. A voltage ramp started from +60 mV and ended at -100 mV in a period 
of 500 mS (Tong, Gamper et al. 2004). The ramp protocol was repeated in every 5 S. 
Flow at a speed of 5 ml/min, which is equitant to 8.42 dyne, significantly enhanced 
the inward currents mediated by ENaC, which was reversed and blocked by benzamil 
(10 μM). b. Flow significantly increased the whole cell currents mediated by ENaC, 
but failed to do so when benzamil were present in medium. Each column 
represented the mean (±SEM) of 6-8 cells. c. Flow enhanced ENaC activity. X axis 
represented shear stress against on cell membrane and y axis represented the 
increase ratio of whole cell current density carried by ENaC. Each point was averaged 
from 4-5 cells.   
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Figure 6.3 Stretch activated ENaCs. a. In an inside-out recording, positive pressure 
(10 mmHg) via the patch pipette on outside membrane of HUVEC activated ENaC 
currents in a repeatable manner. Traces were obtained when pipette voltage was 
held at 80 mV. Application of pressure is shown by the grey bars above the upper 
current trace. Selected parts of currents (marked by bars below the upper trace) are 
shown with an expanded time scale in the lower panel as in the numeric traces.  b. 
Stretch significantly increased ENaC activity by 1.5 fold. Each column represented the 
mean (±SEM) of 8 cells. c. Flow indirectly activated ENaCs. In a cell-attach recording, 
flow significantly increased ENaC open probability, suggesting the present of an 
indirect mechanism. Application of flow is shown by the grey bars above the upper 
current trace. Selected parts of currents (marked by bars below the upper trace) are 
shown with an expanded time scale in the lower traces. Each column represented 
the mean (±SEM) of 5 cells.  c. Caveolae compartmentalization of ENaC, HO-1 and 
HO-2 in HUVEC. Total cell lystaes were loaded on the discontinuous sucrose gradients 
for 18 hours (39,000 rpm, SW41 rotor). 12 fractions were obtained and subjected to 
Western blot analysis. Caveolin-1 was concentrated in fractions 4-5, where ENaC, 
HO-1 and HO-2 were also present.  
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Figure 6.4 Haem alone inhibited ENaC whereas Haem plus NADPH activated ENaC in 
HUVEC. a. Traces were obtained in the inside out configuration with a pipette voltage 
of +80 mV.  2nd panel shows effects of haem or haem plus NADPH (1μM) on ENaCs. 
Bottom two traces represents effects of 20 nM haem plus NADPH on ENaCs from 
HUVEC of HO-1 overexperssion (HO-1+) or HO-1 knockdown (HO-1-),  respectively.  
b. Concentration dependent effects of haem or haem plus NADPH on ENaC activity. 
Data were fitted with a sigmoidal dose-effect curve. Hill coefficient is 0.99, based on 
the equation: Y=minimum+(maximum-minimum)/(1+(X/X0)^p). Each point was 
averaged from 6-8 cells. Blue line with black square symbols represents effect of 
haem alone. c. Haem (20 nM) plus NADPH significantly increased ENaC activity 
whereas haem at this concentration inhibited ENaC. In presence of Haem (20 nM) 
plus NADPH, ENaC from HUVEC with knockdown of HO-1 were inhibited whereas 
ENaC from HUVEC with overexperssion of HO-1 were further activated. Each column 
represented the mean (±SEM) of 10 cells. 
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Figure 6.5 TPA facilitated flow response mediated by ENaCs in HUVEC. a. Incubation 
HUVEC with TPA (100 ng/ml) in medium significantly augmented HO-1 expression but 
not HO-2 and ENaC in 36 hours.  b. stimulation of TPA significantly enhanced ENaC 
whole cell currents and flow response mediated by ENaC. Perforated whole cell 
recordings were applied in this section. In the perforated whole-cell recordings, 
stimulation of either TPA or TNF significantly increased ENaC whole cell current. Each 
column represented the mean (±SEM) of 10 cells.  c. Increase of [Na+]i attenuated 
the activity of CAT. The inward current evoked by extracellular L-arginine were 
significantly reversed by increase of [Na+]i in a manner of dosage dependence. Each 
point represented the mean (±SEM) of 4-6 cells. The curve was fitted by Exp-decay 
(first) on the equation y=A1*exp(-x/t1)+y0.  
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Figure 6.6 CO inhibited IRK. a. In HUVEC cell, 20 μM CO donor significantly inhibited 
IRK component. b. In HEKs transfected with IRK, 1 mM CO donor significantly 
attenuated IRK currents and 100 μM Ba2+ further caused a reduction of IRK currents. 
c. different effects of 1 mM CO donor, 100μM CO donor and 100 μM Ba2+ on IRK 
currents. d. 1 mM CO donor, 100μM CO donor and 100 μM Ba2+ on IRK currents 
significant reduced IRK currents in comparing with the control and vehicle group. 
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Chapter 7 
 
Discussion 
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7.1 The effect of lipids on ENaC 
The bath application of AA in cell-attach configuration significantly reduced the ENaC 
open probability whereas bath application of ETYA under the same condition slightly 
reduced the ENaC NPo. Bath application of LA also reduced the ENaC NPo slightly. 
However, in the excised membrane recording configuration, where the ion channel 
loses its intracellular environment and AA cannot be metabolized, intracellular 
application of AA only induced a slight inhibitory effect on ENaC. The extent of this 
inhibition effect is similar to that of the both extracellular and intracellular 
application of ETYA and LA. This finding is consistent with the previous result that the 
blockade of CYP-epoxygenase pathway of AA abolished its inhibition effects over 
ENaC(Wei, Lin et al. 2004; Wei, Sun et al. 2006), suggesting the metabolites of AA 
rather than AA itself are responsible for the strong inhibition of ENaC. The slight 
inhibition of unchanged AA, ETYA and LA over ENaC indicate that these lipids exert 
only nonspecific effects on channel activity. Previous studies demonstrated that AA 
and LA are capable of directly modulating ion channels such as TRP (Chyb, Raghu et 
al. 1999), BK (Denson, Wang et al. 2000) and K+ channels(Kim and Clapham 1989; 
Ordway, Walsh et al. 1989; Oliver, Lien et al. 2004), and these regulations are not 
resulted from alterations of the membrane fluidity. The potential explanation for the 
result that ENaC is not under direct regulation by these lipids in this study is perhaps 
due to the channel structural property.  
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7.2 The direct effect of PGs on ENaC 
Bath application of PGE2 significantly enhanced the ENaC NPo in inside-out 
recordings and the effect was reversible as channel NPo returned to control level 
when PGE2 was washed away. Intracellular application of PGF2α also enhanced the 
channel activity without affecting ENaC conductance. In addition, PGE2 at a 
physiological concentration of 2µM increased channel activity by over 50%.  The 
recordings were acquired from channels that were physically isolated from 
intracellular environment and E-prostanoid receptor antagonists were included in the 
pipette solution during the recordings. Thus it is reasonable to conclude that the 
up-regulation of ENaC by PGs observed here are direct.  
PGF2 and PGE2 are the major products of cyclooxygenase-initiated arachidonic acid 
metabolism in the kidney and is synthesized at high rates along the nephron 
(Bonvalet, Pradelles et al. 1987; Farman, Pradelles et al. 1987). PGE2 is the major 
prostaglandin produced along the collecting duct and potently regulates the Na+ and 
water homeostasis in kidney. Previous studies have extensively investigated their 
effects on epithelial solute and water transport through various E-prostanoid 
receptors (EP-receptors). Our results that both PGE2 and PGF2α are able to directly 
stimulate ENaC activities have provided new explanation for the distinct effects of 
PGs on the renal Na+ reabsorption. The dual effects of PGE2 on the epithelial solute 
and water transport are generally considered the results of the activation of different 
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EP receptors. In addition to this, PGF2 and PGE2 are also able to stimulate ENaC 
channel when they are present in the luminal space because of their membrane 
permeability. Thus, it is clear that the direct modulation of ENaC by PGs contributed 
to their distinct overall effects on renal epithelial reabsorption. Our finding may 
contributes to further explaining the following previous experiments; infusion PGs in 
renal filtrates increases Na+ reabsorption (Hornych, Bedrossian et al. 1975; Lazzeri, 
Barbanti et al. 1995; Breyer and Harris 2001). 
7.3 11,12-EET is a potent inhibitor of ENaC – both in kidney and vessels 
EET inhibits Na+ reabsorption in kidney. Both intracellular and extracellular 
application of 11,12-EET significantly inhibited ENaC activity and reduced channel 
NPo. This inhibition was reversible as channel activity returned to normal when 
11,12-EET was washed off. Thus, it is apparent that EET, a product of AA metabolism 
by cytochrome P450 (CYP)-epoxygenase, is one potent inhibitor of ENaC and the 
significant inhibition effects of AA on ENaC activity is mediated by its metabolite 
11,12-EET. Previous studies indicated that EETs are important regulators in vascular 
and renal systems. EETs have been shown to inhibit the amiloride-sensitive ion 
transport in renal epithelial cells and modulate Na+ transport in kidney(Staudinger, 
Escalante et al. 1994; Escalante, Staudinger et al. 1995; Sakairi, Jacobson et al. 1995). 
Previous studies also suggested that EETs regulate Na+ transport primarily by 
regulating the membrane-bound transport proteins or by interacting with other 
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intracellular factors such as prostaglandin synthesis pathway(Sakairi, Jacobson et al. 
1995; Nusing, Schweer et al. 2007). Our finding demonstrated that EET is able to 
directly modulate the ENaC activity and this direct regulation is contributed to EET’s 
overall effects on epithelial Na+ reabsorption in kidney. 
EET protect ECs by inhibiting ENaC. The inhibition of ENaC by EETs in endothelial 
cells underlines the diverse effects of EETs in vascular system. We found that 
11,12-EET is able to inhibit the activity of ENaCs expressed in endothelial cells(HMEC). 
Bath application of 11,12-EET significantly decreased channel NPo in both inside-out 
and outside-out recording configurations, and these inhibitory effects are reversible 
since channel activity returned to control levels when EET was washed off.  EETs are 
primarily synthesized in endothelial cells by CYP epoxygenases(Rosolowsky and 
Campbell 1996). Our subsequent studies demonstrated that ENaC is functionally 
expressed in endothelial cells but they are only active when intracellular 
environment is absent. Thus, it is reasonable to conclude that the inactivity of ENaC 
on endothelial cells at least partially results from intracellular inhibitors such as EETs.  
One physiological role of this EETs-mediated ENaC inhibition is perhaps to maintain 
intracellular homeostasis. The endothelial cells are polarized cells but there is no 
evidence indicating their Na+ reabsorption function. On the contrary, the 
endothelium is in fact function as barrier between the blood and underlying tissues.  
The apical Na+ influx in endothelial cells may induce intracellular Na+ build up and 
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disturb the ion composition in the interstitial space, resulting smooth muscle cells 
disorder or edema. Excessive intracellular Na+ produces various pathological impacts 
such as disturbed cellular osmotic pressure and irregular changes in membrane 
potential, and the most importantly, excessive intracellular Ca2+ build up. One of the 
important roles of ion channels in endothelial cells is the fine-tuning of the 
electrochemical gradient for Ca2+. The Na+- Ca2+ exchanger, one of the diverse Ca2+ 
entry pathways, extrudes 1 Ca2+ ion out from the cell in exchange for 3 Na+ entry 
down its electrochemical gradient. Thus a desirable Na+ gradient is vitally important 
in maintaining the cellular free Ca2+ ; a decreased Na+ gradient induced by abnormal 
Na+ influx would increase intracellular Ca2+.  Chronic imbalance in ion homeostasis 
may result in cellular dysfunction or even endothelial cell damage. Thus, under 
physiological condition, Na+ channel is constantly inhibited. Furthermore, EETs have 
been repeatedly suggested as an EDHF (endothelial derived hyperpolarize factor) in 
the vascular system(Hu and Kim 1993; Harder, Campbell et al. 1995; Campbell, 
Gebremedhin et al. 1996; Pratt, Rosolowsky et al. 1996; Fisslthaler, Popp et al. 1999; 
Kroetz and Zeldin 2002; Sun, Sui et al. 2002), causing vascular relaxation in various 
vascular beds. Previous studies demonstrated that this EDHF effect of EETs is mainly 
mediated by their ability to activate BKCa channels either directly or indirectly, causing 
smooth muscle cell hyperpolarization which in turn produces vaso-dilation. Our 
finding that EETs are potent inhibitors of ENaC may help to further understand the 
above regulation pathway since ENaC is also suggested to participate in the 
relaxation of artery smooth muscle cells(Drummond, Gebremedhin et al. 2004; 
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Jernigan and Drummond 2005; Jernigan and Drummond 2006; Guan, Pollock et al. 
2009; Jernigan, Speed et al. 2009; VanLandingham, Gannon et al. 2009). However, 
the interaction between ENaC, EETs and other smooth muscle ion channels need to 
be further investigated.  
7.4 Heme is a potent inhibitor of ENaC – both in kidney and vessel   
We have demonstrated that nanomolar concentrations of haem applied to the 
cytoplasmic surface of the membrane inhibited ENaCs in both M1 and HUVEC. 
Different concentrations of haem from 1nM to 10µM were applied to cytoplasmic 
medium to interact with ENaCs and a half-maximal inhibition concentration of 
23.3nM and 51.2nM were determined respectively in M1 and HUVEC cells, and the 
inhibitory effects are comparable to the dissociation constant values of other 
hemoproteins and heme-binding proteins. Although reported values for total cellular 
heme vary considerably and exact concentrations of heme in the cytoplasm are not 
known, the evidence suggests that cytoplasmic heme reaches levels more than 
sufficient to elicit the effects shown in our work; Intracellular haem may increase 
10-fold when 30 µM heme is present in the extracellular medium.  The ubiquitous 
existence of haem in the circulation and renal system permit great physiology 
relevance to its regulation over ENaC activity. Heme is synthesized on the matrix side 
of the inner mitochondrial membrane and is exported to distinct intracellular 
compartments, most being used for the formation of haemoproteins including 
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hemoglobin, myoglobin, cytochromes and nitric oxide synthesis. However, heme is 
also pathologically liberated from heme proteins such as myoglobin and hemoglobin 
after cellular injury, hypoxia and/or stress, leading to an elevated content of free 
cellular heme, which causes various cell damages as seen in rhabdomyolysis induced 
myohemoglobinuric acute renal failure. 
A self-protective mechanism during heme induced tubular injury. Our finding that 
cellular HEME inhibits ENaC activity have revealed a negative feedback 
self-protective mechanism by which tubular epithelial cells could alleviate the 
damage caused by pathologically elevated intraluminal heme content. Previous 
investigations in the pathology of the heme protein induced renal failure revealed 
that the endocytic reabsorption of heme protein by renal tubular epithelial cells is 
the main cause of tubular epithelia damage. The increased concentration of 
intraluminal heme initiated the heme protein endocytosis, inducing cellular heme 
elevation in tubular epithelial cells. However, as we have demonstrated, ENaCs are 
extremely sensitive to intracellular heme build-up since nanomolar concentration of 
which could cause channel open probability decrease. Therefore, it is obviously that 
the initial heme entry, even a small amount, impairs the Na+ and water reabsorption, 
resulting in a reduced amount of total filtered load reabsorption including heme 
protein and an accelerated toxic substance secretion. Furthermore, the ENaC 
mediated diuresis is able to shorten the circulating half life of heme proteins within 
renal tubules, reducing the time period of intraluminal heme presence. The ultimate 
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goal of all these diuresis induced effects is to minimize the risk of further entry of 
heme into tubular epithelial cells. It is therefore rational to conclude that the tubular 
epithelial cells are able to protect themselves from the heme toxicity by limiting 
heme entry, and this protection mechanism is working in a “feedback” fashion since 
it can only be triggered by a small elevation of intracellular heme. This proposed 
feedback protection has been perhaps best proved by the observations that when 
the kidney GFR remains undisturbed, the nephrotoxic effects of heme are minimized.  
It is well established that decreased GFR either induced by intravascular volume 
depletion or by renal vasoconstriction is the prerequisite condition of heme induced 
acute tubule necrosis as seen in rhabdomyolysis induced acute renal failure. Diuresis 
also has been proved to be crucial in the clinical prevention and treatment of the 
heme protein induced acute renal failure. Volume expansion therapy, one of the 
most effective early treatments, is working by promoting GFR to enhance the diuresis 
and dilute out the intraluminal heme proteins.  
Heme protects endothelial cells by inhibiting ENaC. The inhibitory effect of heme 
over ENaC in endothelial cells is similar to that of the EETs as described in 7.3. 
However, according to our results, endothelial ENaCs seem to be more sensitive to 
intracellular heme than it to 11,12-EET, suggesting the former is perhaps more potent 
in inactivating ENaC under physiology conditions in the vascular system. Thus, the 
physiology role of this heme mediated inhibition in vascular endothelium is perhaps 
also similar to that of the EETs, to maintain a desirable intracellular environment.  
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7.5 An oxygen-sensitive regulation mechanism of ENaC 
As we have demonstrated, intracellular heme presence tonically inhibits ENaC activity. 
However, we have also found that when heme co-existed with NADPH and oxygen on 
the cytoplasmic surface of the cell membrane, its effect on channel NPo was 
dramatically reversed; ENaC activity was significantly stimulated. Furthermore, this 
stimulation was mimicked by the CO, a product of hemeoxygenase activity. 
Modulation of the activity of ENaC by CO resembled that seen upon co-application of 
heme and NADPH, suggesting that the stimulatory effect of these agents indeed 
reflect the generation of CO by hemeoxygenase. However, this stimulation effect did 
not occur under hypoxic conditions due to the fact that activation of hemeoxygenase 
requires adequate oxygen supply. To further investigate this regulation pathway, we 
performed HO-1 over-expression and knockdown experiments while keep other 
participators and reaction conditions unchanged. The ENaC open probability 
exhibited a strict HO-1 dependent manner. Thus, this regulation mechanism has been 
clearly present, heme together with hemeoxygenase are two potent regulators of 
ENaC activity both in endothelial cells and renal epithelial cells, and this regulation is 
strictly dependent upon oxygen tension. Our finding provided a new insight into the 
pathology of renal dysfunctions/failures induced by hypoxia and ischemia. 
The oxygen-sensitive regulation pathway helps to protect tubular cells during 
hypoxia. According to our findings, the oxygen-sensitive regulation pathway may 
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help to sustain the intracellular ion homeostasis and cellular osmotic pressure by 
inhibiting the apical Na+ entry during hypoxia induced renal dysfunctions. It is well 
demonstrated that hypoxia induced renal failure is associated with a significant 
decrease in tubular Na+ reabsorption with undisturbed GFR or in some cases 
increased GFR and increased urine flow. Studies of mammalian and amphibian renal 
function during hypoxia indicated that when adequate oxygen supply is deprived 
(Kakuta, Namba et al. 1992; Cock, Wlodek et al. 1996; Peters, Tijsen et al. 1998), 
fractional reabsorption of Na+ in renal tubule is significantly decreased, while both 
GFR and urine flow remaining stable or increased. This hypoxic inhibition of Na+ 
reabsorption is in a dose dependent manner and is reversible as normoxia restored 
the renal function to control level (Kakuta, Namba et al. 1992; Cock, Wlodek et al. 
1996). Thus it is clear that oxygen deprivation impairs the renal tubular reabsorption 
capacity and exerts a diuretic effect upon the kidney. Subsequent studies indicated 
that hypoxia induced renal reabsorption dysfunction is due to the inability of renal 
epithelial cells to sustain cellular ion gradients following depletion of intracellular ATP 
(Allis, Endre et al. 1989; Schonefeld, Noble et al. 1996). Na+- K+-ATPase activity relies 
heavily on oxidative phosphorylation for energy supply, so deprivation of adequate 
oxygen supply results in cellular ATP depletion which in turn down-regulates or even 
completely impedes Na+- K+-ATPase activity. The impaired Na+- K+-ATPase transport 
across the basolateral membrane of epithelial cells therefore reduces the 
trans-epithelial Na+ movement (Spencer, LeFurgey et al. 1991). However, Na+ 
reabsorption across the epithelial cells occurs via a two-step mechanism; apical Na+ 
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entry through ENaCs and basolateral extrusion by Na+ pump. The apical Na+ entry is 
the rate limiting step of the transepithelial Na+ transport as its activity is tightly 
controlled. Thus, based on our finding that hypoxia down-regulates ENaC activity, we 
conclude that inadequate oxygen supply decreases renal Na+ reabsorption, which at 
least partially contributes to limiting apical Na+ entry. Furthermore, the slowed rate 
of Na+ intake is crucial to sustain the intracellular ion homeostasis especially during 
prolonged hypoxic conditions. It is imaginable that if the Na+ entry is maintained 
while its extrusion is strictly limited, the intracellular Na+ would be dramatically 
increased in a short period of time. This abnormal intracellular Na+ build-up induces 
various pathologic consequences such as cellular ion imbalance and a hypertonic 
cytoplasm environment which would finally cause membrane rupture. Thus, it is 
clear that during hypoxic conditions, a limited Na+ entry is vitally important to protect 
tubular cells from further damages.  In conclusion, the oxygen-sensitivity of ENaC at 
least partially contributes to the overall oxygen-sensitivity of tubular epithelial cell 
and in fact protects the intracellular environment from Na+ overloading during 
hypoxia.   
The role of oxygen-sensitive regulation pathway in the protection of HO-1 against 
reperfusion injury: Another potential role of the oxygen-sensitive regulation is 
indicated in the protective role of HO-1 against ischemic acute renal failure. Ischemic 
acute renal failure, which is due to the reperfusion injury of the kidney, accompanies 
acute tubular epithelial cell injure, and it is the major form of ARF. The reperfusion 
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injury caused ARF after ischemia is likely due to the reactive oxygen species (ROS) 
generated by reperfusion as a result of the rapid release of heme from microsomal 
cytochrome P450 (Paller, Hoidal et al. 1984). Specifically, renal tubular epithelial cells 
are the target in the reperfusion injury. Previous studies demonstrated that kidney 
adapts to oxidative stress by inducing heme oxygenase activity, mainly HO-1 (Ishizuka, 
Nagashima et al. 1997; Shiraishi, Curtis et al. 2000; Baan, Peeters et al. 2004; Poole, 
Wang et al. 2005; Goncalves, Cenedeze et al. 2006; Goncalves, Cenedeze et al. 2006). 
HO-1 expression is increased in the cortex or in the outer medulla immediately 
following reperfusion and reaches a maximum in hours (Horikawa, Ito et al. 1998; 
Akagi, Takahashi et al. 2005). Substantial evidence indicates that the induction of 
HO-1 effectively alleviates reperfusion injury whereas inhibition of HO worsens it. 
Since HO-1 is the rate limiting step in heme degeneration, it is generally regarded to 
contain cell demerge by eliminating microsomal free heme content in the tissue. 
According to our finding, another outcome of HO-1 mediated heme degeneration is 
to significantly enhance ENaC activity, which restores the crucial renal function and 
reduces the tissue oedema by potentating surface fluid reabsorption. 
Oxygen-sensitive regulation pathway is crucial in the ENaC mediated fluid clearance 
in lung epithelium during perinatal period: The oxygen sensitive regulation pathway 
is likely to play an important role in the rapid removal of lung liquid during the 
perinatal period, since the process requires transient and significant increases in 
epithelial Na+ conductance. Previous studies demonstrated that fetal lung is 
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transiently and permanently switched from a secretory to an absorptive phenotype 
tissue only during the very last stages of gestation and birth is associated with a fall in 
lung water content which begins immediately after birth and is largely complete 
within 2 hours. The changes in the oxygen environments are implied to be the key 
triggers that initiate the ENaC mediated liquid absorption process, and oxygen is a 
key factor that responsible for the permanent switch of lung epithelial function from 
secretory to absorptive. In previous studies, cAMP-mediated increase in Na+ 
absorption was considered to be the main contributor of the spontaneous 
absorption of lung liquid during labour (O'Brodovich, Hannam et al. 1990; Walters, 
Ramsden et al. 1990). Thyroid hormone (T3), adrenaline and glucocorticoid 
hormones were also believed to be involved in the process. Other hormones that are 
able to slow secretion or accelerate absorption in the fetal lung at birth by regulating 
ENaC include vasopressin PACAP, serotonin and glucagon. However, none of the 
hormonal regulation mentioned above could comprehensively account for the rapid 
epithelial permeability increase after birth. Since the fetal lung fluid absorption is a 
very swift process, which happens immediately after birth and finish within hours, 
both hormone-mediated elevations in ENaC subunit mRNA and surface expression 
are unlikely to account for such dramatic and transient increase in Na+ transport. 
Physiological increase in PO2 can only activate ENaC subunit promoter after PO2 has 
been raised for 24-48 hours (Baines, Ramminger et al. 2001). Furthermore, 
accumulating evidence indicates that the oxygen-evoked increase in Na+ conductance 
happens before any elevation in ENaC mRNA abundance or in some cases with no 
 
 
222 
 
change in ENaC mRNA abundance in fetal distil lung endothelial cells (Pitkanen, 
Tanswell et al. 1996; Richard, Ramminger et al. 2003). Nevertheless, oxygen was able 
to stimulate Na+ conductance in hormone free medium (Richard, Ramminger et al. 
2003). In conclusion, all these results suggest a mechanism which is able to enhance 
the Na+ conductance immediately and directly before the hormonal-mediated effects 
when there is a change in the ambient oxygen content. Based on our finding that 
HO-1 and heme can significantly increase ENaC activity only during the presence of 
oxygen, it is rational to propose that the oxygen, heme and HO-1 regulation pathway 
is the underline mechanism by which oxygen, at least partially, initiated the transient 
and significant increase in Na+ transport during the perinatal period. To further 
substantiate the hypothesis, the availability of the other two factors, namely heme 
and HO-1 in lung epithelial cells need to be evaluated. The expression of HO-1 in lung 
has been well investigated; it is expressed in various cells in lung such as alveolar 
type II cells and its expression is highly inducible. The exact cellular concentration of 
heme in lung epithelial cells is unknown, but it is still reasonable to assume that the 
cytoplasmic heme reaches the level to permit the reaction because; the ubiquitous 
presence of heme in body and the extreme low quantity of heme required for the 
reaction. However, further works are required to completely validate the hypothesis 
such as determining the exact expression rate of HO-1 and heme in lung epithelial 
cells during perinatal period and investigating the lung ENaCs activity under different 
ambient oxygen contents. 
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7.6 Identify ENaCs in endothelial cells  
ENaC is functionally expressed in ECs. α- but not β- and γ- ENaC subunit expression 
were detected in cultured endothelial cells. This homolegous ENaC channel 
composed by only α-subunits exhibited similar biophysical characterizations as seen 
in other tissues where all ENaC subunits are expressed. ENaC single channel currents 
were examined and the current and voltage relation for this channel has been 
determined. Current-voltage (I-V) curves obtained from either inside-out and 
outside-out exhibited a linear slope and when 120 mM of Na+ medium was replaced 
with low Na+ medium (5 mM) in bath the I-V curve was shifted to the right which 
displayed a  [Na+]i dependence of channel conductance. The channel in cultured 
endothelial cells possess a conductance approximately 4.83 pS which is similar to 
that of the channels found in the mouse collecting duct cells where all α-, β- and 
γ-ENaC are expressed. To further indentify this channel, pharmacological 
experiments were performed. Extracellularly applied amiloride at the concentration 
of 0.5µM induced flickering current and reduced the Po, whereas 5µM bath 
amiloride almost abolished ENaC currents. Thus it is clearly that ENaCs expressed in 
endothelial cells exhibit similar biophysical properties; high selectivity for sodium 
over potassium, high-sensitivity to amiloride, a unitary conductance of 4.7 pS and 
voltage independence of both the open probability and conductance. However, the 
currents mediated by these channels exhibited slightly more flickering pattern and 
shorter dwell time in compare to the currents obtained from mouse collecting duct 
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cells. To further determine whether the amiloride sensitive currents were mediated 
by ENaC channels, specific knockdown experiments against the α-subunit were 
performed. Consistent with the significant decrease in mRNA and protein expression, 
the probability to detect the current with such conductance dropped nearly 8-fold, 
indicating that these small conductance inward currents were indeed mediated by 
ENaC.  
ENaC is constantly inhibited in ECs. When investigating channel activity by patch 
clamping, ENaC currents were rarely acquired in cell-attached configuration. However, 
after excising the patch of cell membrane enclosed in the pipette tip from the cell, 
ENaC currents were immediately observed in most of the cases. The explanation for 
this phenomenon is that certain intracellular molecules are constantly exerting 
inhibitory effects on the channel. According to our previous results, heme and 
11,12-EET are such intracellular inhibitors since HO-1 induced heme degradation 
completely liberated ENaC from inhibition. 
We concluded that this inhibition of ENaC in ECs is essential to protect ECs from 
various damages induced by cellular ion imbalance (detailed discussion in 7.3). For 
example, intracellular Na+ elevation induces Na+-K+ ATPase hyperactivity, causing 
excessive potassium lost in the interstitial space between smooth muscle cells and 
endothelial cells. Furthermore, high cellular Na+ content interfere with 
membrane-bound transporters which utilize Na+ entry as driving force such as Ca2+ 
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pump. Thus, ENaC inhibition is important in maintaining intracellular ion 
homeostasis. 
 7.7 Investigations of the machano-sensitivity of ENaC in endothelial cells 
The DEG/ENaC superfamily members have long been known for their 
mechano-transducer ability. However, there is no direct evidence that native ENaCs 
can be activated by mechano-stimulation. We have thoroughly investigated the ENaC 
mechano-sensitivity and we found that various mechano-stimulation, including 
membrane stretch, shear force and perhaps membrane deformation are able to 
activate channel. Pressure and shear stress are the main hemodynamic forces which 
are directly induced by blood flow and are responsible for the triggering of the 
endothelium-derived vasodilatation. Thus the stretch test performed by applying 
positive pressure was conducted to evaluate the effect of blood pressure on ENaCs 
and the flow test was performed to varify the effects of shear stress on ENaCs. By 
performing this intensive investigation, we have acquired the most direct and 
comprehensive evidence that ENaC expressed in endothelial cells are activated by 
both mechanical forces. As we have demonstrated in HMEC cells and HUVEC cells, 
when the intracellular inhibitors were absent, flow and membrane stretch are able to 
either directly or indirectly enhance the open probability of ENaC without affecting 
channel conductance. In HMEC cells, single ENaC channel open probability in 
outside-out configuration was significantly increased by exposure to the shear flow. 
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In the HUVEC cells, single ENaC channel open probability was significantly increased 
by mechanical stretch and exposure of the intracellular membrane to shear flow. It is 
noticeable that the flow induced increase in channel NPo was obtained from 
cell-attach recording configuration where target ENaC channels were in fact isolated 
from the bath environment and there is no direct contact between the channels and 
flow (mechano stimulation).  
The molecular basis of the mechano-sensitivity of ENaC: Based on our results that 
ENaC is mechano-sensitive in the excised cell membrane, we believe that ENaC can 
be, at least, activated by cell membrane tension and curvature.  
MEC channel in C. elegans touch receptor neurons, which is composed of DEG 
subunits MEC-10 and MEC-4, was the first recognized mechano-transducing channels 
in animal cells. Although exact gating mechanism of the MEC channel still remains 
unclear, most of the researchers believe that this channel is gated by a “tethering” 
mechanism in which the ion channel binds either to the cytoskeleton or the 
extracellular matrix, thus any disturbance of this network would stress the structure 
and hence gate the channel. Several associated proteins have been indentified on 
both the intracellular and extracellular side of the membrane and are believed to 
either directly or indirectly interact with the channel core complex. These proteins 
are required to maintain the localization of the channel on the plasma membrane, 
and also participate in the channel gating during mechanical stimulation. The 
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associated protein is responsible for stressing the channel pore structure and hence 
gating the channel during mechano-stimulation (Markin and Hudspeth 1995; Markin 
and Hudspeth 1995; Garcia-Anoveros and Corey 1997; Bianchi 2007). Although the 
fact that DEG subunits share a common topology with ENaC subunits was the first 
hint of the mechano-sensitivity of ENaC, the molecular basis of their 
mechano-transduction mechanism is unlikely to be same, as there is no evidence 
that ENaC has requires associated protein as the MEC channel does. Another possible 
scheme is that releasing of signal molecules from other cells or cellular organelles 
during mechano-stimulation activates ENaC (Welsh, Price et al. 2002). However, this 
model is unequivocally rejected in this case since ENaC in the excised membrane 
exhibits mechanical-sensitivity. In addition, this hypothesis is also excluded by the 
rapid response of ENaC to mechano-stimulation both in whole cell and cell attach 
configuration. Thus, the most possible explanation would be the cell membrane 
tension and/or curvature caused by mechano-forces directly controls the channel 
gating.   
The evidence supporting the idea that membrane tension activates ENaC can be 
summarized as:  1), the biophysical characterizations of lipid bilayers; 2) the 
observation that ENaC is symmetrically activated by both negative pressure and 
positive pressure in membrane patching; 3) the fast activation and slow inactivation 
during mechano-stimulation 4) evidence that reconstituted ENaC in lipid bilayers 
exhibits mechano-sensitivity. Accumulating evidence suggests that the lipid bilayers 
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are capable of rapidly developing tension during mechano-stimulation and the 
bilayers tension exerts stress on the inserted ion channels. The stress transduced by 
the cell membrane may affect the channel structure and hence gate the channel. 
Furthermore, the flexibility of lipid bilayers can be described as fast expansion but 
slow restoration, which means the membrane tension is quickly developed but 
slowly dispelled. In vivo, this characterization is manifested by the fast activation and 
slow inactivation of channel, as seen in our results (chapter 6).  Based on all this 
evidence and reasoning above, we conclude that ENaC is gated by membrane 
tension. 
The understanding of mechano-sensitivity of ENaC in endothelial cells can help to 
elucidate the role of this channel in other mechano-transducing tissues.  For 
example, β- and γ- ENaC  subunits are found to be expressed in the 
mechano-transduction site in baroreceptor nerve terminals and are suggested to be 
components of the baroreceptor mechano-transducer as an amiloride analog could 
block the baroreceptor nerve activity and baroreflex control of bold pressure 
(Drummond, Welsh et al. 2001; Drummond, Gebremedhin et al. 2004). RT-PCR 
results indicated that α-, β- and γ- ENaC subunits are expressed in rat trigeminal 
ganglia and immunocytochemistry results demonstrated that α-, β- and γ- ENaC are 
localized in the perikarya of the trigeminal neurons and in a minor fraction of the 
neurons termination site in the vibrissal follicle-sinus complex (Fricke, Lints et al. 
2000), suggesting a possible role of ENaC in mechano-transduction in these neurons. 
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However, the mechano-transduction is poorly understood on the molecular level. 
There is no consensus in the gating of mechano-sensitive ion channel and different 
channel seems to have different gating mechanism. Thus, this area still needs 
extensive studies in future. 
7.8 ENaCs are localized within caveolae and co-localized with caveolin, HO-1 and 
HO-2 
Our results that ENaC channels are co-localized with caveolin, HO-1 and HO-2 
indicates that HO-1 and ENaC are sufficiently closely associated in vivo to enable the 
oxygen regulation pathway to function and this co-localization may provide a novel 
insight into the role of CO as an important endogenous gaseous signal molecule. 
The close association of ENaC and HO-1 further validates the oxygen-sensitive 
regulation pathway. The spacial distribution of HO-1 in cell membrane is an 
important factor in validating the HO-1 and oxygen regulation pathway since ENaC is 
activated by the byproduct of the HO-1 mediated heme degradation. The close 
spacial association of HO-1 and ENaC grants immediate and reliable regulation. 
The generation site of second messengers is important in its downstream regulation, 
especially under the circumstances that the production rate of certain signal 
molecules is extremely low or their biophysical properties are unstable, for example 
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Ca2+. Transient and dramatic regional Ca2+ elevation is believe to be crucial to initiate 
many high-threshold Ca2+ processes when the cellular free Ca2+ level remains 
constant in the rest of the intracellular space. In the heme degradation case, with the 
close association of ENaC and HO-1, a transient and regional generation of CO could 
lead to immediate and dramatic ENaC activation. 
ENaC is one of the most immediate recipients of CO. CO, an endogenous gaseous 
signaling molecule has drawn more and more attentions in the most recent decade. 
It has been suggested to play important physiological roles in many tissues. Our 
finding that ENaC is closely located to the CO generation site and ENaCs are potently 
regulated by CO indicated that ENaC, at least in vascular system, is one of the most 
immediate recipients of this gaseous messenger. This finding contributes to 
elucidating the diverse functions of CO and the spatial distribution determination 
approach could be an effective research strategy in identifying the potential CO 
recipient ion channels. 
7.9 ENaCs are acting as mechano-transducers when inflammatory factors are 
present. 
Inflammatory factors release ENaCs from inhibition. To further validate the 
physiology role of ENaC mediated shear force sensing, we found that TPA as a 
common inflammatory factor, is able to release ENaC from inhibition by enhancing 
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HO-1 expression. The original hypothesis is that HO over-expression as a result of TPA 
stimulation leads to an increase in CO production, which may compensate the 
inhibitory effects of both heme and 11,12-EET. The experimental results confirmed 
the hypothesis. The western blot results indicate that the expression level of HO-1 
and HO-2 were significantly enhanced. The ENaC mediated Na+ currents were 
observed both in whole cell and cell attach configuration, suggesting that ENaC is 
activated when the intracellular environment remains undisturbed. In addition, the 
whole cell currents obtained from the cells deprived of intracellular medium 
exhibited a similar increase. Thus, it is clear that inflammatory factor induced HO-1 
neutralized the effects of the cellular inhibitory molecules. In other words, under 
certain conditions, ENaCs are released from inactivation and start to act as 
mechanotransducers. 
ENaC serves as a mechano-transducer when inflammatory factors are present. 
Whole cell recordings were performed to evaluate the effects of flow-induced shear 
force on ENaCs under physiological conditions. HUVECs were incubated in 
inflammatory factors. The results demonstrated that ENaC activity was stimulated by 
shear flow application in a dosage dependent manner, suggesting that native ENaC is 
able to sense flow-induced mechano-stimulation. The mechano-transduction process 
in this case can be described as flow-induced shear force is converted to Na+ influx by 
ENaC channel. This Na+ influx, however, can cause many cellular responses as listed in 
the following sections. 
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7.10 [Na+]i elevation impairs cationic amino acid transporter (CAT) activity 
We have demonstrated that the ENaC mediated Na+ influx impairs the CAT capacity, 
causing a decreased L-arginine transportation and a subsequent decrease in NO 
generation as eNOS requires L-arginine as a substrate. This observation may underly 
the pathogenesis of endothelial dysfunction seen in the presence of proatherogenic 
factors such as seen in inflammation and hypertension. It also suggests that the 
overall impact of the activation of endothelial ENaC is likely to be negative. 
It is well established that NO is not only a potent vasodilator but also inhibits platelet 
aggregation, smooth muscle cell migration and proliferation, monocyte adhesion and 
adhesion molecule expression, thus protecting the vessel wall against the 
development of atherosclerosis and thrombosis (Busse, Luckhoff et al. 1987; Botting 
and Vane 1989; Furchgott and Vanhoutte 1989; Mugge, Forstermann et al. 1989; 
Faint 1992; Simon, Stamler et al. 1993; Vanhoutte 1993; Vanhoutte, Boulanger et al. 
1995). The incompetence of endothelial cells to produce sufficient NO may lead to 
the initiation of vascular deseases such as atherosclerosis. There is strong evidence 
that endothelial dysfunction is closely releted to inflammation and hypertension.   
For example, in hypertensive subjects with hyperaldosteronism, endothelium 
dependent flow-mediated vasodilatation is impaired (Nishizaka, Zaman et al. 2004). 
A decreased L-arginine conversion to NO is shown in these hypertensive patients 
after salt loading (Ni and Vaziri 2001). There is also convincing experimental evidence 
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suggesting that proinflammatory factors lead to a reduced bioavailability of 
endothelium-derived NO (Bhagat, Moss et al. 1996; Hingorani, Cross et al. 2000; 
Kharbanda, Walton et al. 2002). In addition, human studies have demonstrated that 
acute proinflammatory stimuli cause short-term impairment of 
endothelium-dependent dilatation in arteries and resistance vessels (Hingorani, Cross 
et al. 2000). The following studies further demonstrated that high-dose aspirin 
treatment prevents the development of endothelial dysfunction induced by such 
stimuli (Kharbanda, Walton et al. 2002). Previously, the dysfunction of ECs 
manifested by a decreased NO production was mainly believed to be as a result of 
the downregulated expression of eNOS (Vallance, Collier et al. 1997; Verma and 
Anderson 2002). However, based on our findings, the reduced L-ariginine transport 
resulted from the activation of ENaC contributes, at least partially, to the EC 
dysfunction under the pathological conditions. Therefore, we suggest that activation 
of endothelial ENaC exerts complicated effects on the vascular responses to flow; 
however, the overall outcome is more likely to be negative. 
7.11 A possible role of ENaC in myogenitic tone 
The ENaC’s effects on endothelial cells are in favor of vasoconstriction. Thus it is likely 
that the ENaC may contribute to maintain the myogenic tone. Myogenic tone is a 
major contributor to vascular resistance to blood flow and blood pressure. Previous 
studies indicated that various vasoconstrictors as well as mechano-stimulations are 
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able to cause smooth muscle cells depolarization and hence vasoconstriction. The 
vasoconstriction could be both endothelium-derived and endothelium-independent, 
for example, hormones such as vasopressin cause vasoconstriction through 
endothelial cells whereas intravascular pressure increase induced vasoconstriction is 
endothelium-independent (Meininger & Davis, 1992). Either mechanism exerts their 
effects by increasing the intracellular Ca2+ content in smooth muscle cells. ENaC 
mediated Na+ increase in endothelial cells, as we have demonstrated, impairs both 
NO and EDHF production, resulting in a depolarized smooth muscle cells and an 
increased intracellular free Ca2+ concentration. Thus it is reasonable to presume that 
ENaC may contribute to maintain the vessel tone and blood pressure. 
7.12 CO, the by-product of heme degradation inhibits inward-rectifying K+ channel 
(IRK) 
We have demonstrated that CO inhibited IRK current in HUVECs and in HEK cells 
expressed with IRK.  This finding may help to understand the role of inflammation in 
the initiation, complication and progression of atherosclerosis. Inflammation has long 
been recognized as a pivotal factor in the pathogenesis of atherosclerosis. The 
presence of inflammation factors not only leads to an increased expression of cell 
adhesion molecules, cytokines and chemokines, which facilitate leukocyte 
attachment to the endothelium and transmigration into the extracellular matrix, but 
also cause endothelial dysfunction, resulting in an impaired endothelial-dependent 
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vasodilatation (Bhagat, Moss et al. 1996; Davis, Yeung et al. 1996; Vallance, Collier et 
al. 1997; Hingorani, Cross et al. 2000; Kharbanda, Walton et al. 2002; Stocker and 
Keaney 2004; Pepys, Hawkins et al. 2005). This incompetence of the endothelial cells 
to initiate dilatation was previously considered to result from the reduction in NO 
generation as described in 7.10. However, recent NOS knockout experiments in mice 
suggest that endothelium-derived hyperpolarizing factor (EDHF) is also one 
important instrument by which ECs induce SMC relaxation since the EDHF-mediated 
vessel dilation compensated for the absence of endothelial NO. Furthermore, 
following studies suggest that EDHF rather than NO plays an increasingly prominent 
role in the vascular response to shear force as arterial diameter decreases; especially 
in resistance vessels where NO-independent vasodilation plays a dominant role.  
Therefore, insufficient NO production alone can not account for the impaired 
endothelial-dependent vasodilatation.  
Our finding suggest that the inflammation induced endothelial dysfunction is a 
collective result of insufficient NO production and impaired EDHF generation and 
release. Earlier studies have demonstrated that an increase in K+ conductance is 
among the most immediate cellular responses to shear force which in turn triggers 
the generation and release of the EDHF by ECs. This increasing in K+ conductance has 
been proved as a result of the activation of IRK channels because of the observations 
that shear stress activates IRK current in aortic endothelial cells and in oocytes and 
HEK cells expressed with exogenous endothelial Kir2.1 channels.  Furthermore, we 
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have demonstrated that proinflammatory factors upregulate HO expression, which in 
turn accelerates heme degradation and increases CO production. The excessive CO 
generation inhibits KIR and subsequently blunts the shearforce sensing, causing an 
impaired EDHF function in endothelial cells. Thus, we conclude that inflammation 
impair the endothelial-dependent vasodilation by disrupting both the 
endothelial-derived NO and EDHF action. 
7.13 A comprehensive discussion about an ENaC mediated shear force sensing 
mechanism in endothelial cells and its physiological impact  
7.13.1 A summary of experiments results 
1, ENaCs are expressed in vascular endothelial cells. 
2, ENaCs are active only when their intracellular environment is absent 
3, 11,12-EET and heme potently inhibit ENaC from the intracellular membrane 
4, ENaC is mechano-sensitive 
5, HO-1 induction neutralize the inhibition of ENaC 
6, HO-1 can be induced by inflammatory factors 
7, endothelial expressed ENaC can serve as mechano-transducers when 
inflammatory factors are present. 
8, CO, the byproduct of heme degradation by heme-oxygenase, inhibits 
inward-rectifying potassium channel.  
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7.13.2 Inflammation shifts the endothelial cell shear force sensing from 
IRK-mediated to ENaC-mediated 
7.13.2.1 Inflammation impairs the IRK-mediated shear force sensing 
Earlier studies have demonstrated that shear stress activates the inward-rectifying K+ 
current and increases cell membrane permeability to K+. Following studies have 
further demonstrated that shear stress causes an increase in K+ current in oocytes 
and HEK cells expressing the exogenous endothelial Kir2.1 channel. These previous 
studies indicate that the IRK channel is one of the sensing elements for shear stress, 
and the IRK-mediated K+ conductance increase is among the most immediate cellular 
responses to shear force. The increase of IRK mediated membrane permeability to K+ 
leads to endothelial cell hyperpolarization, resulting in a facilitated Ca2+ entry by 
increase its driving force, which in turn initiates the generation and release of the 
endothelium-derived EDHF and EDRF, casing the underline SMC relaxation and hence 
vasodilatation. Based on these results, it is obvious that the activation of IRK channel 
is the prerequisite in the whole endothelium-dependent vasodilatation in. Therefore, 
the inhibition of IRK by inflammation severely desensitizes EC shear force sensing and 
blunt the ability of vessel to adapt flow. However, in this case, Na+ channels start to 
assume the duty of shear force sensing and EDHF generation. 
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7.13.2.2 ENaC mediated shear force sensing replaced the IRK mechanism during 
inflammation 
Similar to the EC expressed IRK channel, endothelial ENaC is also mechano-sensitive, 
and able to transfer the mechano-signal to bioelectrical signals. We have 
demonstrated that during the presence of inflammation factors, an increase in Na+ 
conductance predominates the first setting of cellular response to flow. The ENaC 
mediated flow sensing can be described as follow; shear stress activates ENaC and 
causes an increased Na+ entry rate. To extrude excessive in tracellular Na+, the 
activity of the Na+-K+ exchanger is facilitated. The hyperactive basolateral Na+-K+ 
pumps extrude Na+ into and absorb K+ from the myo-endothelial interstitial space by 
a ratio of 2/3 (Na+/K+), causing a reduced K+ content in the interstitial space. The 
interstitial fluid is the extracellular fluid for smooth muscle cells and the decrease in 
extracellular K+ causes smooth muscle cells hyperpolarization and subsequently 
relaxation. However, this ENaC mediated NO independent vaso-dilation is incapable 
of adapting to the rapid changes in blood flow and is cytotoxic in the long run.  
7.13.3 The overall impact of ENaC mediate shear force sensing mechanism: the first 
step toward atherosclerosis 
The ENaC mediated inadequate vaso-dilation may serve the vascular shear force 
sensing temporarily, however, it causes negative consequences to endothelial cells in 
the long term. The excessive Na+ influx is toxic to endothelial cells. Since the 
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epithelial Na+ channel is a “leak channel”, and the electrochemical gradient across 
the endothelial cell membrane is in favour of Na+ entry, the release of endothelial 
ENaCs from inhibition leads to an increased Na+ influx even though the ECs are at 
rest. This Na+ in flux has multiple negative consequences; 1, it may disturb the resting 
membrane potential of ECs, causing ECs to constantly stay at a slightly depolarized 
state; 2, elevated cellular Na+ is in favour of Ca2+ retention as described in 7.9, high 
cellular Ca2+ may result in various negative effects including cell damage; 3, high 
cellular Na+ reduce the NO generation. Previous studies have demonstrated that NO 
is produced by endothelial cells not only in response to stimulation but also at rest. 
The constant NO generation is critical in the inhibition of platelets aggregation and 
adhesion molecules expression, and is helpful to maintain vessels at a relatively 
dilated status by preventing excessivel vasoconstrictions. Once the 
endothelium-dependent NO production is hampered, the progression of 
atherosclerosis will be accelerated. Nevertheless, since the ENaC is 
mechano-sensitive, the presence of shear stress will only exaggerate the process and 
augment the reverse effects.  
In conclusion, the activation of ENaC exerts multiple negative effects on endothelial 
cells including damage to the cell and cell function. Persistent activation of ENaC will 
inevitably lead to vascular diseases such as atherosclerosis.  
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7.14 Conclusion 
Epithelial sodium channels (ENaC) are of immense importance, controlling Na+ 
transport across epithelia and thus playing a critical role in all aspects of fluid 
clearance as well as numerous other functions. Disorders of ENaC lead to various 
pathological conditions such as water and electrolyte imbalance which finally results 
in cardiovascular diseases e.g. hypertension. By employing electrophysiology and 
molecular biology techniques, we have identified profound regulation mechanisms of 
ENaC in distal renal epithelial cells and vascular endothelial cells by lipid metabolites, 
heme and mechanical forces. Our results also revealed a novel O2 sensitive regulation 
pathway of ENaC channels, in which hemeoxygenase acts as the O2 sensor and the 
substrate and product of which either inhibits or stimulates ENaC activity. This 
mechanism may eventually introduce novel clinic treatments for disease such as 
renal failure, kidney reperfusion injury, hypertension, pulmonary edema and 
pre-clampsia. Additionally, I have identified the expression and the 
mechano-sensitivity of ENaC in endothelial cells, determined the effects of 
inflammatory factors on HO-1 expression, and validated the effects of the HO-1 
mediated heme degradation pathway on both ENaC and Kir channels. By piecing all 
these findings together, a scenario clearly appeared. ENaC is expressed on 
endothelial cells, and this expression not only retained the channel function as a Na+ 
entry pathway but also possesses mechano-sensing ability. However, the reason why 
the physiological role of this expression has not been noticed is that ENaCs are 
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constantly inhibited by certain cellular contents in ECs. ENaCs are kept silent until 
their environment changes, in this case, the appearance of inflammation. 
Pro-inflammatory factors greatly upregulate the highly inducible protein HO-1, which 
in turn facilitates heme degradation and hence increases CO generation. CO potently 
increases the bioactivity of ENaC, releasing the channel from inhibition, while on the 
other hand exerts a strong inhibitory effects on Kir channels. This aspect of CO’s 
impact on ECs can be therefore described as that CO shifts the duty of 
mechano-sensing from Kir to ENaC. Eventually, endothelial cells start to response to 
shear stress by increasing the Na+ influx rate. The ENaC mediated shearforce-sensing 
mechanism under inflammatory conditions, however is unfortunately not a 
supplement or subsidiary to the shearforce sensing of the endothelial cells; on the 
contrary, it acts as a bridge that “direct” the pro-pathogenesis factors such as 
inflammation to endothelial cell dysfunction and even damage, which eventually lead 
to various vascular diseases.  
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